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Abstract 
The work detailed in this thesis describes the development of a suitable synthetic 
strategy for the synthesis of pyrrolo[2,1-c][1,4]benzodiazepine (PBD) natural products 
(1-3) - antitumour antibiotics which are capable of covalently binding to DNA and exhibit 
potent in vitro and in vivo cytotoxicity. 
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The synthetic sequence involved the introduction of the key stereocentre by 
asymmetric alkylation and construction of the C-ring dihydropyrrole moiety by ring-
closing enyne metathesis (RCEYM). Studies into the metathesis rearrangement involved 
investigations into the employment of relay-ring closing metathesis (RRCM) on substrate 
A (R = C02Allyl) to aid delivery of the chosen catalyst. However, these attempts proved 
unsuccessful and the metathesis substrate was redesigned to include an allylic alcohol 
moiety (A; R = CH20H) which led to the successful metathesis rearrangement and 
delivered the dihydropyrrole moiety with an allylic alcohol side chain (B; R = CH20H). 
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Following the metathesis rearrangement, subsequent oxidation of the allylic alcohol 
moiety (B; R = CH20H) proved difficult and thus, was extensively investigated to provide a 
suitable protocol for the synthesis of the required dimethyl amide (B; R = CONMe2) 
associated with porothramycin (2). 
A brief investigation into appropriate nitrogen protecting groups led to the use of 
the 2-trirnethylsilylethanesulfonyl (SES) protecting group. Unfortunately, there were 
problems related to the removal of the SES group from the dihydropyrrole B (PG 2 = SES; R 
= CONMez) and this led to the development of substrate C which successfully participated 
in an intramolecular substitution upon SES deprotection to give amide D. Studies into the 
conversion of this compound to the desired natural product by way of an oxidation and 
Staudinger reaction were also undertaken, however, results obtained could not 
conclusively determine that porothramycin (2) had been synthesised. 
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The sum of the efforts presented in this thesis, whilst not delivering a total synthesis 
of the target compound (2), does provide a suitable and feasible protocol with which to 
synthesise the target natural product (2) as well as other compounds in the same class 
(1 & 3). 
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Chapter 1 Introduction 
Small molecules with the ability to interact in a sequence specific manner with DNA 
have created great interest and potential for the design of novel chemotherapeutic agents 
or small molecules for gene recognition and regulation. 
Pyrrolo[2,1-c][t4Jbenzodiazepines (PBDs), also known as the "anthramycins}J, are 
produced by various Streptomyces species (Figure 1.1)..1 These antitumour antibiotics are 
capable of covalently binding to DNA through the formation of an aminal linkage between 
the exocyclic amine in guanine and the Cll carbinolamine present in compounds 1-3 or 
the imine as observed in compound 4. 2 They have also been shown to display potent in 
vitro and in vivo cytotoxidty which is attributed to their abihty to disrupt endonuclease 
-
activity and inhibit DNA transcription.3 Their ability to bind to DNA lies in the ever present 
l la-(S) absolute configuration - giving these molecules the essential twist to allow them 
to fit into, and interact v1ith1 the minor groove.4,s 
1 a R=H (anthramycin) 
1 b R=Me (anthramycin methyl ether) 
OH sibtromycin 3 
OMe H OR 
I N :- H (Y 
~N~CONMe2 
0 
2a R=H (porothramycin A) 
2b R=Me (porothramycin 8) 
HO'l(YN~ 
Me~N~ 
0 
DC-81 4 
Figure 1.1 - Examples of pyrrolo[2f1-c] [1 f4Jbenzodiazepines 
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1.1 Anthramycin 
Anthramycin (1), the PBD that gives rise to the name for this class of compounds, 
was first observed in 1963 by Tendler and Korman in a fermentation broth which was 
shown to exhibit antibiotic properties and in vivo antitumour activity.6 Initial studies 
indicated activity against several gram-positive strains of bacteria and inhibition of 
sarcoma and adenocarcinoma tumours but no activity against gram-negative bacteria and 
leukemia.6 The presence of both antibiotic and antitumour properties gives rise to the 
classification of anthramycin as an antitumour antibiotic. 
In 1965, anthramycin (1) was isolated and characterised by Leimgruber and co-
workers.7 The methods used in the isolation of anthramycin led to 3 forms - the 
hemiaminal-bearing anthramycin (1a), the more stable anthramycin methyl ether (1b), 
and the dehydro congener - anhydroanthramycin (5) (Figure 1.2). At the same time, 
Leimgruber also reported the isolation and characterisation of a minor fermentation 
product, which was dubbed the "yellow pigment" 6 . and later determined to be 
desdihydroxydesmethylanthramycin (Figure 1.2).7 
M~~~-{£ 
~ N~ CONH2 
0 
1 a R=H (anthramycin) 
1 b R=Me (anthramycin methyl ether) 
OH MeylyN~ 
~ N~ CONH, 
0 
anhydroanthramycin 5 
H 
C(~CONH2 
0 
"yellow pigment" 6 
desdihydroxydesmethylanthramycin 
Figure 1.2 - Compounds identified in fermentation broth of Streptomyces refuineus var. 
thermotolerans7 
A further report by Leimgruber and co-workers discussed the elucidation of the 
structure of anthramycin (1) and indicated that the structure elucidation was aided by the 
investigation of the "yellow pigment" 6.8 
The structure of compound 6 was determined using NMR, other spectroscopic 
studies, such as IR and UV, and analysis of products obtained from chemical 
transformations of the original molecule. The (E)-configured double bond on the side 
chain was assigned based on the coupling constant U = 15 Hz) between the respective 
protons present at C12 and C13, and the conjugated primary amide was identified by a 
transformation to, and identification of, the conjugated nitrile. 8 With this data gathered 
from compound 6, Leimberger proposed a tricyclic structure 6 which allowed for all 
heteroatoms (with the empirical formula C1sH1s N20 2 as determined by HRMS) and 
fun ctional groups identified .7 
2 
There were two possible parent tricyclic structures; the first being a 
pyrrolobenzodiazepine core 7, and the second being a pyridoquinazoline core 8. The 
comparison of spectroscopic properties (UV, IR and NMR) between the parent 7 and the 
tetrahydropyrrole derivative of the 'yellow pigment' 6 were very similar, indicating the 
presence of a pyrrolobenzodiazepine core. This was also supported by the observation of 
fragments attributed to the indicated fragmentation a/b (Figure 1.3) in the mass spectrum 
of compound 6 and other transformation products.8 
H ' 
~15 
0 
pyrrolobenzodiazepine core 7 
H 
C(D 
0 
pyridoquinazoline core 8 
Figure 1.3 - Two possible tricyclic cores (7 and BJ identified for ''yellow pigment" 68 
Having elucidated the structure of the 'yellow pigment' 6, Leimgruber and co-
workers turned their attention to anthramycin methyl ether (1b).8 A comparison of 
spectroscopic data obtained from compounds 6 and lb showed many common features 
and after further examination of NMR data, Leimgruber proposed the structure lb. The 
structure was confirmed through several transformations of anthramycin methyl ether 
(lb) with main studies concerning the structure of the A-ring and the configuration of the 
Cl 1 stereocentre. 
The A-ring was confirmed by firstly forming the phenolic ether 9, then hydrolysis 
and esterification to give methyl 3-methoxy-4-methyl-anthranilate (10) which was 
. 
identical by comparison with an authentic sample (Scheme 1.1). 
Me~: ~~p~e CH N I 2 2 
~ N 
,,,-;;:, ~ CONH 
0 2 
anthramycin methyl ether 1 b 9 
OMe 
Me ~ NH2 
~ OMe 
0 
10 
Scheme 1.1 - Fragments obtained from hydrolysis of anthramycin methyl ether (lb) 
The relative configuration of the Cl 1 and Cl la stereocentres were confirmed by the 
absence of coupling between the two respective protons indicating a dihedral angle of 90°, 
whereas in the Cll-epimer of anthramycin (1), coupling is observed between the Cll and 
Clla protons. The dihedral angle of 90° was also confirmed by an inspection of Dreiding 
models. 
3 
The assignment of the absolute stereochemistry as 11-(R) and lla-(S) was 
determined by Leimgruber and co-workers in their total synthesis of anthramycin (1), 
which is discussed later in this chapter.9 
1.1.1 Pyrrolo[2,1-c] [1,4]benzodiazepines in clinical trials 
As a new and upcoming antibiotic antitumour drug in the 1960s, anthramycin (1) 
and others of the same class were subjected to clinical trials.10 PBDs were observed to be 
most effective for gastrointenstinal and breast tumours as well as lymphomas and 
sarcomas, however, the clinical studies were limited due to observations of cardiotoxicity 
and acute tissue necrosis at the site of injection. 11 It had been thought that cardiotixicty 
could arise from the formation of ortho-quinone imine products, such as compounds 12 
and 14 - which are known to be cardiotoxic (Scheme 1.2).12 
0 OH 
~N~ 
OH H OH /R o N N~ .,,,:;, R O 12 
R N .,,,:;, ~ OH 0 R ~ N-0 /)i 0 11 ~ 
o N ~ N 
.,,,:;, R .,,,:;, R 
0 0 
13 14 
Scheme 1.2 - Oxidation/tautomerisation of PBDs to ortho-quinone imines 
1.1.2 Structure activity relationship of pyrrolo[2,1-c] [1,4]benzodiazepines 
Although there are downsides to using PBDs as antibiotic antitumour agents due to 
their side effects, there are still countless variations of naturally isolated "anthramycin-
type" PBDs and their analogues which show potential clinical significance. 1.12 With this 
knowledge and new PBDs continually being isolated, it is difficult to discount their 
biological activity and rule them out as candidates in the search for new antitumour 
agents.12-14 
Through the years, studies and reviews of PBDs, especially in the field of medicinal 
chemistry, have identified them as scaffolds for the design and synthesis of anti-tumour 
drugs and have highlighted the versatility of these small molecules as well as their high 
cytotoxicity.1s.16 However, as with all drugs, in addition to cytotoxicity, detrimental effects 
to the host must also be taken into account. 
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PBDs generally have varying substitutions on the A-ring and C-ring as well as 
differing degrees of saturation on and around the C-ring. Due to the great number of 
variations which may be imposed on the general PBD core, structure activity relationship 
studies have been undertaken to determine the influence of various substitutions on DNA 
binding and their biological activities.1s 
A review by Hurley and Thurston15 1n 1984 provided the first SAR study of the 
anthramycins. Through the use of space-filling models, they presented a detailed summary 
of predicted structure activity relationships displayed in Figure 1.4. These results reassert 
the importance of the carbinolamine and lla-(S) stereocentre present in the 
anthramycins which give them their inherent ability to bind to DNA. The rest of the 
structure may accommodate a wide range of substituents however, small or narrow 
substituents are preferred. In reference to the hydroxyl groups on the A-ring, the presence 
of such groups at either C7 or C9 were predicted to cause cardiotoxicity by way of ortho-
quinone formation - a side effect observed during clinical trials.10,11 
OH at C9 or C7 
predicted to cause Carbinolamine for DNA binding 
cardiotoxicity \ 
Long narrow substituents \ ~ (S) con:igu.ration provid.es 
can be accommodated ~ 9 N ?" ~ / essential right-hand twist 
B ~ 10 11 y 
[ A B 113 1 Substrtuents larger than y ' N C , .,,C2fl protons prevent DNA binding 
Bulky substuents o cd\3s cy 
may be accommodated ~ 
(C2a & C3~ Narrow substrtuents 
accommodated along minor groove 
(C213 & C3a) Bulky substituents 
prevent DNA bind ing 
Figure 1..4 - Pyrrolo[2,1-c][1,4]benzodiazepine nucleus showing predicted structure activity 
relationships15 
A decade later, after extensive studies on the binding of PBDs to DNA,s,17-20 Thurston 
and co-workers21 investigated the effect of A-ring modifications on the binding behaviour 
and cytotox:kity of PBDs. The study was based on DC-81 ( 4), which carries a saturated and 
unsubstituted C-ring. At the condusion of this study,, although it was found that electron 
donating substituents1 such as OH or OMe, exhibited greater binding affinity, the presence 
of an unsaturated :5ubstituted C-ring had a much greater influence on DNA binding and 
cytotoxicity (Table 1.1).21 
The thermal denaturation studies (Table 1.1 ),, which determined the melting 
stabilisation (13..Tm) of double-stranded calf thymus DNA (CT-DNA) following incubation 
,mth various PBDs at 37 °CI indicated that unsaturated C-ring compounds, such as 
anthramycin methy] ether (lb) and sibiromycin (3),. had the highest DNA-binding affinity 
5 
as they produced the largest LiT m shifts. 21 These unsaturated compounds were also found 
to have the highest cytotoxicity when examined against three cell lines (L121 O leukemia, 
ADJ/PC6 plasmacytoma & CHl human ovarian) with ICso values ranging from 0.000017-
0.32 µM. The saturated C-ring compounds such as DC-81 (4) were observed to have much 
smaller LiT m shifts and higher ICso values. 
Cytotoxicity (ICso µM)* 
Li Tm (°C)t after 
incubation for: Compound 
L1210 ADJ/PC6 CHl Oh 4h 18 h 
Me«L 
I : N ,/, / CONH, 0.022 0.0028 0.32 9.4 11.2 13.0 
0 
anthramycin methyl ether 1 b 
· OH H QH M~'H 
0 ° N /7 0.0029 0.000017 0.04 15.7 15.9 16.3 
. Me ~ M~ O MeH 
, HO OH sibiromycin 3 
. .. 
Hon;_~ 
Me O N 0.38 0.33 0.10 0.3 0.5 0.7 
0 
DC-81 4 
Table 1.1 - Cytotoxicity (/Cso) and thermal denaturation (LJ Tm) of various PBDs 
· -·- · ··*Dose of PBD required to inhibit cell growth by 50% compared to PBD-free controls tThermal 
denaturation studies with CT-DNA (incubation at 37 °[)21 
The results obtained from the SAR study suggested that the flattening of the C-ring 
caused by C-ring unsaturation led to a better fit into the minor groove of DNA and hence, 
higher DNA-binding affinity and higher cytotoxicity. These conclusions were also 
confirmed during a further study into the effect of unsaturation on the cytotoxicity and 
DNA-binding reactivity of PBDs. zz 
The observations gathered from the various structure activity relationship studies 
point towards porothramycin (2) - with no hydroxyl group in the C9 position, an 
unsaturated and substituted C-ring, and a single electron donating group on the A-ring - as 
a good starting point for the synthesis of potent antitumour drugs. 
6 
1.2 Porothramycin 
Porothramycin (2) was first isolated from Streptomyces a/bus by Tsunakawa and co-
workers in 1987 in both the natural hydroxyl form [porothramycin A (2a)J and the methyl 
ether form [porothramycin B (2b)J - present when isolated or purified using methanol.23 
Both forms of natural product 2 have been shown to display antibacterial and potent 
antitumour properties. 
The analysis of physio-chemical and biological properties of the porothramycins 
indicated a resemblance to the anthramycins. They did, however, have a distinct structural 
difference when analysed by 1 H NMR spectroscopy as the presence of three contiguous 
aromatic protons was a first among the group of known PBDs.23 
Further analysis of the porothramycins by base hydrolysis produced two UV-
absorbing compounds, which were determined to be the 1,2,3-trisubstituted aromatic 
compound 15 and 2-formyldihydropyrrole-4-N,N-dimethylacrylamide (16) (Scheme 1.3) . 
With these two fragments and the absolute stereochemistry assigned by analogy with 
known PBD antibiotics as 11-(R) and 11a-(S), the structure of the porothramycins A and B 
were determined to be 2a and 2b, respectively, differing only by the functional group at 
Cll.23 
OMe H QR 
c<-~CONMe2 
0 
2a R=H (porothramycin A) 
2b R=Me (porothramycin B) 
base 
OMe 
CXNH2 COOH 
15 
+ 
-
~ H 
~ CONMe2 
16 
Scheme 1.3 -Analysis of porothramycin (2) by base hydroly sis 
The interesting structure and biological activity of porothramycin (2) presents this 
small molecule as a good target for natural product synthesis towards an antitumour drug 
and a stepping stone for the synthesis of other natural PBDs and analogues. 
7 
1.3 Syntheses of pyrrolo [2, 1-c] [1,4 ]benzodiazepines 
Being biologically significant and bearing synthetically interesting moieties, the 
PBDs present themselves as desirable targets in the field of synthetic organic chemistry. 
As such, there have been several syntheses of both anthramycin (1) and porothramycin 
(2) reported to date and a summary of each synthesis will be presented herein. 
1.3.1 Previous total syntheses of anthramycin 
1.3.1.1 Leimgruber synthesis of anthramycin 
In 1968, following the structure elucidation and characterisation of anthramycin (1) 
1n 1965, Leimgruber and co-workers reported the first total synthesis of this natural 
product, and by doing so confirmed its unique structure.7-9 
The synthesis (Scheme 1.4) began with the acylation of L-hydroxyproline methyl 
ester (17) with the desired benzoyl chloride 18 to give amide 19, which was subsequently 
reduced with sodium dithionite and cyclised in the presence of acid to form lactam 20. 
Manipulation of the C-ring began with the oxidation of the secondary alcohol to the 
co_rresponding ketone 21 using Jones' reagent and a Horner-Wadsworth-Emmons reaction 
with _the sodium salt of triethyl phosphonoacetate to yield dihydropyrrole 22. The ester 
moiety of compound 22 was partially reduced to the corresponding aldehyde using 
DIBAL-H, followed by a conversion to the sodium bisulfite adduct and reaction with 
potassium cyanide to form cyanohydrin 23. The secondary alcohol of compound 23 was 
dehydrated through a mesylation and elimination reaction sequence to provide the 
corresponding vinyl nitrile, which was subsequently debenzylated to form phenolic nitrile 
2_4. The desired (EJ-isomer of conjugated nitrile 24 was condensed with benzaldehyde 
dimethyl acetal and then hydrolysed using polyphosphoric acid to form the desired 
benzoxazoline amide 25. The carbonyl group at C11 was reduced using sodium 
borohydride in methanol, and the benzoxazoline functionality was hydrolysed under 
acidic conditions in methanol to yield anthramycin methyl ether (lb) (2.6°/o over 15 
steps ).9 
In the years following Leimgruber's total synthesis of anthramycin,9 there were a 
number of investigations into the synthesis of the pyrrolobenzodiazepine core, however, a 
new total synthesis of this PBD wasn't published until the 1980s.24.zs The development of 
palladium-catalysed chemistry in the 1970s led to the employment of such chemistry in 
the total synthesis of natural products and the two syntheses of anthramycin following 
this period both involved palladium. 26 
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Scheme 1.4 - Leimgruber and co-workers' synthesis of anthramycin methy l ether (1b) 9 
1.3.1.2 Ishikura synthesis of anthramycin 
The first, a formal total synthesis of anthramycin (1) by Ishikura (Scheme 1.5), 
utilised a palladium-catalysed carbonylation procedure previously developed in the group 
to close the B-ring and form the desired tricyclic structure.2?-29 Beginning with the 
synthesis of an A-ting carrying the desired handle for the carbonylation procedure, 3-
chloro-2-toluidine (26) was converted to 3-chloro-2-cresol (27), which was then nitrated 
to give both the undesired 4-nitro and desired 6-nitro chlorocresol 28 in a 1:1 ratio . With 
compound 28 in hand, methylation of the phenol, followed by a tin reduction and 
bromination afforded the desired 3-toluidine 29, which was then coupled to a L-
hydroxyproline derivative 31 to produce amide 32. 
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Scheme 1.5 - !shikura and co-workers'formal total synthesis of anthramycin methyl ether {1b) 27 
Protection of the secondary arnide and hydroxyl group of compound 32 followed by 
reqioyal .of the trifluoroacetamide yielded the free secondary amine 33, which was now 
ready to undergo carbonylation. A palladium-catalysed carbonylation then produced the 
desire·d diazepinone derivative 34, albeit in 27°/o yield. Having successfully constructed 
dilactam 34, dechlorination, selective MOM deprotection and oxidation of the secondary 
alcohol yielded ketone 35, which was then globally deprotected and 0-benzylated to 
produce 21, an intermediate previously prepared in the Leimgruber synthesis of 
anthramycin methyl ether (lb ).9 
Although the key step of palladium-catalysed carbonylation was not very efficient, 
the Ishikura formal synthesis of anthramycin demonstrated that palladium catalysed 
coupling reactions were a viable route for the synthesis of the PBD core. 27,29 
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1.3.1.3 Pena and Stille's synthesis of anthramycin 
The second synthesis of anthramycin (1) involving palladium was published in 
1989 by Pena and Stille (Scheme 1.6).30 In this case, the palladium catalysed reaction was 
used to introduce the acrylamide side chain in a more efficient manner than the 8 steps 
required in Leimgruber's synthesis.9,3o 
Beginning with some familiar chemistry, acylation of L-hydroxyproline ethyl ester 
(36) with benzoyl chloride 18 followed by several functional group interconversions 
yielded the previously observed intermediate 20.9 Removal of the benzyl protecting group 
followed by condensation with benzaldehyde dimethyl acetal produced benzoxazoline 37, 
and a Swern oxidation of the secondary alcohol yielded ketone 38. The vinyl triflate 39 
required for coupling was prepared using triflic anhydride in pyridine which participated 
in a Heck-type coupling with acrylamide to form amide 40. Once again, reduction of the 
carbonyl at Cll and hydrolysis of the benzoxazoline yielded anthramycin methyl ether 
(lb). The ability to couple vinyl triflate 39 to other partners also allows for the 
preparation of analogues. 
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Scheme 1.6 - Pena and Still e's total sy nthesis of anthramy cin methy l ether {lb )30 
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1.3.2 Previous syntheses of porothramycin 
The stereoselective synthesis of ( + )-porothramycin [( + )-2] has previously been 
completed three times - by Fukuyama and co-workers (1993),31 Langlois and co-workers 
(1993),32 and more recently by Vanderwal and co-workers in 2010.33 It may be noted that 
the syntheses put forward by Fukuyama and Langlois bear very similar disconnections in 
that they involve the elongation of the side chain via an olefination reaction and the 
closure of the B-ring through the addition of an aniline moiety to an aldehyde. 
1.3.2.1 Fukuyama synthesis of porothramycin 
The synthetic strategy described by Fukuyama (Scheme 1. 7) began with the 
conversion L-glutamic acid ( 41) to amino ester 42.31 The A-ring was introduced by 
acylation of amino acid derivative 42 with 3-methoxy-2-nitrobenzoyl chloride ( 43) to 
form amido ester 44, which was subsequently reduced and acetylated to produce amido 
alcohol 45. A cyclisation-elimination reaction of compound 45 with quinolinium 
camphorsulfonate delivered the C-ring in enamide 46, which was formylated and 
olefinated under Vilsmeier-Haack and Wittig conditions, respectively, to form conjugated 
amide 4 7 bearing the required side chain. 
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Reduction of the nitro group to the aniline derivative followed by a deacetylation 
and acylation with allyl chloroformate afforded carbamate 48. Oxidation of the primary 
alcohol under Swern conditions inititated a spontaneous intramolecular nucleophilic 
addition to establish the B-ring as a single stereoisomer, while the amine was liberated by 
way of a palladium-catalysed deprotection to afford porothramycin A (2a). However, due 
to instability of hemiaminal 2a, it was converted to the methyl ether 2b by crystallisation 
in methanol. This was the first total synthesis of porothramycin (2) and yielded the target 
2a in 9.2% in 18 steps. 
1.3.2.2 Langlois synthesis of porothramycin 
In light of the Fukuyama synthesis, Langlois and co-workers published their 
synthesis of ( + )-porothramycin [( + )-2] (Scheme 1.8) which makes use of previously 
established chemistry used to form other natural PBDs.9,31,34,35 Pyrrolidone 49 was 
acylated with 3-methoxy-2-nitrobenzoyl chloride ( 43) to introduce the A-ring and form 
imide 50. A regioselective reduction of the pyrrolidone carbonyl group of compound 50 
yielded amido alcohol 51, which was consequently deprotected using p-toluenesulfonic 
acid in the presence of methanol and acylated to afford the methyl ether carbinolamide 52. 
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Elimination of the methyl ether functionality in compound 53 with quinolinium 
camphorsulfonate produced enamide 46, an intermediate previously observed in the 
Fukuyama synthesis.31 Once again, a formyl group was introduced using the Vilsmeier-
Haack reaction, however, in this synthesis, the amide side-chain was delivered by a 
Horner-Wadsworth-Emmons reaction to give the desired dimethylamide 53. The end 
game of the synthesis involved deacetylation and oxidation of the primary alcohol 
followed by reduction of the nitro group to the corresponding aniline which led to a 
spontaneous cyclisation. The cyclised product, presumably porothramycin A (2a), was not 
isolated but directly treated with methanol to produce porothramycin B (2b) in 13% yield 
over 11 steps. 
Using the above-mentioned synthetic sequence, Langlois and co-workers have also 
prepared several porothramycin analogues, such as 54 and 55 (Scheme 1.8).32,36 
1.3.2.3 Vanderwal synthesis of porothramycin 
· The most recent re·ported · synthesis of ( + )-porothramycin [( + )-2] published by 
... 
Vanderwal and co-workers in 2010 (Scheme 1.9) involved the synthesis of the advanced 
intermediate 53 observed in Langlois' synthesis (Scheme 1.8).33 
The synthesis began with the acylation of a-substituted amino ester 56 with 3-
methoxy-2-nitrobenzoyl chloride ( 43) to _ give the corresponding amide 57, which was 
converted into the precursor 58 for the . key Zincke ring-opening ring-closing cascade 
reaction . . The Zincke reaction proceeded smoothly to give dihydropyrrole 59 and the 
aldehyde thus formed was converted into the desired dimethylamide 60. The removal of 
the TBS ether then provided the primary alcohol 53 which corresponds to he 
intermediate as synthesised by Langlois and co-workers.33 
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1.4 New strategies towards the syntheses of PBDs 
The syntheses of PBDs over the decades demonstrate the continual efforts made 
towards the efficient assembly of these molecules, in particular the desired 
dihydropyrrole moiety (Zincke reaction), the side chain (palladium catalysed cross-
coupling reaction) and the tricyclic core (palladium-catalysed carbonylation). Recent 
literature also describes the use of various reactions in the efficient synthesis of PB Os and 
two such reactions are the Staudinger reaction and olefin metathesis. 
1.4.1 Staudinger reaction 
The most common way to close the B-ring and obtain the desired tricycle, as 
encountered in many of the syntheses presented above, is by reduction of the nitro-group 
on the A-ring to give the corresponding aniline followed by condensation or cyclisation 
with a carbonyl functional group attached to the C-ring. In 1995, Eguchi and co-workers 
and Molina and co-workers successfully employed the Staudinger reaction, a reaction 
involving the coupling of azide 61 to the aldehyde functionality present in the C-ring to 
establish the tricyclic imine 62 en route to their syntheses of DC-81 (4) (Scheme 1.10).37,38 
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Scheme 1.10 - Staudinger reaction to form B-ring of DC-81 (4)37,38 
1.4.2 Olefin metathesis 
Olefin metathesis is a versatile reaction with a broad substrate tolerance and can be 
performed on dienes, enynes, and diynes. Careful catalyst selection (Figure 1.5) may allow 
for a variety of reactivities and substrate tolerance, as well as stereo- and regio-
s~lectivity.39 It is the development of enyne metathesis, which has been used extensively to 
install semi-cyclic dienes similar to that observed in the C-ring of PBDs, such as 
anthramycin (1 ), that has seen its use in the synthesis of this class of compounds. 
PCy3 
I ,, Cl R ., 
Cl .,.... lu=\ Ph 
PCy3 
Grubbs' catalyst 
1st generation 
G-1 
I\ 
Mes--NyN-Mes 
R ., ,Cl 
c1 ..... 1~ Ph 
PCy3 
Grubbs' catalyst 
2nd generation 
G-11 
Hoveyda-Grubbs 
catalyst 
1st generation 
HG-I 
I\ 
Mes-- NV N- Mes 
--~:=o.,,CI Cl.,.. I 
.. I/ ~ 
~ -
Hoveyda-Grubbs 
catalyst 
2nd generation 
HG-II 
Figure 1.5 - Catalysts for olefin metathesis 
~ 
N Ph 
(CF3)iMeCO,, . J'o0 Me 
(CF3)iMeCO~ Me 
Schrock catalyst 
16 
1.4.2.1 Employing metathesis in the synthesis of PBDs 
In 2004, Mori and co-workers used ring-closing enyne metathesis (RCEYM) to install 
the required diene moiety in their anthramycin analogue 69 (Scheme 1.11).40 Starting 
from L-methionine (63), the metathesis precursor 64 was synthesised in 5 steps. RCEYM 
was effected with Grubbs' 1st generation catalyst (G-1) to form the 2,5-dihydropyrrole 65 -
with the double bond in the wrong position. Subsequent deprotection and acylation with 
benzoyl chloride 18 produced amide 66, carrying the PBD skeleton with both the A- and 
C-rings. The B-ring was introduced by reduction of the nitro group to the corresponding 
aniline followed by condensation with the C-ring ester moiety to give tricycle 67. Olefin-
cross metathesis of the terminal alkene in compound 67 with ethyl acrylate using a more 
active catalyst [Grubbs' 2nd generation (G-11) or Hoveyda Grubbs 2nd generation catalyst 
(HG-II)] introduced the conjugated side chain and subsequent isomerisation using 
rhodium(III) trichloride gave the desired 2,3-dihydropyrrole 68. Further deprotection and 
functional group interconversions gave anthramycin derivative 69. 
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Scheme 1.11 - Mori synthesis of anthramycin derivative 6940 
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1.5 Proposed strategy for constructing dihydropyrrole moiety 
While Mari's synthesis showcased the construction of the dihydropyrrole ring 
through RCEYM, there were some short comings. The initial RCEYM of enyne 70 to 2,5-
dihydropyrrole 71 proceeded smoothly in a good yield. However, the elongation of the 
side chain using cross metathesis to give compound 72, which required the additional 
isomerisation step with rhodium(III) chloride produced the desired 2,3-dihydropyrrole 
73 in a low 300/o yield over two steps. 
In order to avoid this additional isomerisation step, it was envisaged that effecting a 
metathesis rearrangement on precursor 74 would deliver the desired 2,3-dihydropyrrole 
73 efficiently (Scheme 1.12). 
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Scheme 1.12 - Comparison ofMori's strategy and proposed synthetic strategy 
1.5.1 Retrosynthetic analysis 
After a review of the previous syntheses of PBDs and the development of new 
strategies for the construction of the PBD framework, a retrosynthetic analysis was put 
forward for the synthesis of ( + )-porthramycin [( + )-2] (Scheme 1.13). The B-ring and 
resulting N10-C11 carbinolamine could be delivered from azido alcohol 75 by way of a 
partial oxidation and a Staudinger reaction. 37,3B Compound 75 would, in turn, be produced 
from a chemoselective acylation of a suitable aromatic compound with dihydropyrrole 7 6. 
The protected dihydropyrrole 7 6, bearing the desired side chain, would be installed by the 
key step, a ring closing enyne metathesis (RCEYM) of 77 followed by an olefin cross 
metathesis (OCM). The starting material for the key step can be accessed through an aza-
Michael addition of the amine of protected amino alcohol 78. The functionality and 
stereocentre observed in compound 78 will be introduced by an asymmetric alkylation of 
protected glycine imine 79, followed by functional group interconversions.41 
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Scheme 1.13 - Retrosynthetic Analysis 
1.5.2 Attempts at RCEYM by previous group members 
The long history of this project within the group has seen the RCEYM attempted on 
numerous substrates with varying results.42,43 A summary of results is presented in 
Scheme 1.14. 
The successful RCEYM of enyne 80 to dihydropyrrole 81 wa3 observed once to give 
the desired product in 20°/o yield (Eq. 1), however, this result could not be replicated and 
synthesis of enyne metathesis substrate 80 was met with difficulties and low yields.42 The 
conversion of the sulfonamide protected enyne 82 to dihydropyrrole 83 (Eq. 2) w as 
observed to proceed in ca. 50°/o yield several times however, due to limits on mate r ial and 
difficulties relating to the installation of the N-vinyl group, this method was abandoned. 
Further attempts to effect RCEYM using oxazolidinone protected enyne metathesis 
precursors 84 and 86 with various side chains (to give dihyropyrrole 85) or w ith an N-
vinyl substituent (to give dihydropyrrole 87) were unsuccessful. 
An analysis of the substrates employed in the metathesis rearrangement indicated 
that the nature of protecting groups used were all electron withdrawing groups such as 
carbamates, sulfon~amides and oxazolidinones. Given the limited success of these 
substrates, it was proposed that the metathesis rearrangement be attempted with a 
substrate bearing an electron donating protecting group such as p-methoxybenzyl (PMB) 
in order to investigate the role of the protecting group in aiding the desired 
transformation. 
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Scheme 1.14 - Previous attempts on RCEYM to form 5-membered C-ring 
It can also be argued that the inability of the substrates to undergo RCEYM may be 
due to the inactivity of the N-vinyl alkene, thus leading to no or very slow initiation with 
the ruthenium catalyst. As such, it was hoped that relay-ring closing metathesis (RRCM) 
could be applied to our substrate in order to aid the loading of the ruthenium into the 
correct position and subsequently provide the desired dihydropyrrole. 
1.5.3 Relay-ring closing metathesis 
An excellent example of the advantages of using relay metathesis was demonstrated 
by Hoye and co-workers in 2004 (Scheme 1.15).44 Using diene 88 bearing two 1,1-
disubstituted ethylene units, Hoye demonstrated that it was not possible to do a ring 
closing metathesis (RCM) as loading of the catalyst did not occur to give ruthenium 
carbene 89. However, when starting from triene 90, now bearing a monosubstituted 
alkene unit, ruthenium was readily loaded onto the double bond (91) and a kinetically 
favoured RCM then relays the ruthenium onto the previously unreactive 1,1-disubstituted 
olefin to give the desired ruthenium carbene 89. A second RCM then takes place to give the 
cyclic product 92. 
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Scheme 1.15 - Example of relay-ring closing metathesis by Hoye and co -workers44 
All reactions done in DCM, 45 °C; E-= C02Et 
It was proposed that by using a substrate bearing a tethered terminal olefin , such as 
in compound 93, the ruthenium catalyst could be relayed onto the N-vinyl alkene (94) and 
subsequent RCEYM would deliver the desired dihydropyrrole 95 (Scheme 1.16). 
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Scheme 1.16 - Proposed relay-ring closing metathesis substrate 93 
1.5.4 Phase transfer catalysis 
The above-mentioned synthetic plan (Section 1.5.1) requires the synthesis of the 
protected amino alcohol building block 78 in a stereoselective manner from glycine imine 
79 (Scheme 1.13). Previous studies within the group have indicated that the introduction 
of the desired (S)-stereocentre can be done by an asymmetric alkylation using 
organocatalysts.4t 45 More specifically, the transformation can be performed using 
cinchona-derived phase-transfer catalysts (PTCs), such as 96 and 97. 
Br 8 ]S Br 8 ]S 
(B~ (i)v 
,,,0 ~ j ,,,0 ~ j 
.,,-,::, ( d ( NC 
96 97 
Figure 1.6 - Cinchona-derived phase transfer cataly sts for asy mmetric alkylation 46 
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These catalysts were developed by Jew and co-workers46 during their investigation 
into the electronic effects of the N+ arylmethyl unit and both were found to deliver the 
desired a-substituted amino . esters, such as 98, from glycine imine 79, in excellent yields 
and ee's (Scheme 1.17). 
79 
96 or 97 
propargyl bromide 
50% aq. KOH 
PhMe:CHCl3 (7 :3) 
93%, 98% ee (96) 
92%, 98% ee (97) 
Ph 0 
P)==Ny1lotsu 
98~ 
Scheme 1.17 - Example of asymmetric alkylation using phase-transfer catalysts 96 and 97 
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1.6 Aims 
The aim of the project is to synthesise the dihydropyrrole moiety, as observed in 
compound 101, by performing a relay-ring closing metathesis en route to the total 
synthesis of ( + )-porothramycin [( + )-2]. In a forward sense, this would firstly involve the 
asymmetric alkylation of glycine imine 79 in the presence of PTC 97 to give the a-
substituted amino ester 98, which after several functional group interconversions would 
provide the amino alcohol 99 protected as the PMB amine (Scheme 1.18). The use of the 
PMB protecting group will be used to investigate the effect of the protecting group on the 
metathesis rearrangement. The protected amino alcohol 99 would then participate in an 
aza-Michael addition reaction to give the metathesis substrate 100 containing the tether 
required for a relay ring closing metathesis. Subsequent ~RCM would hopefully deliver the 
dihydropyrrole which can be further elaborated to dimethylamide 101 and used to access 
porothramycin A (2a) 
Ph O I,,,,, )=NJ~ 
Ph O propargyl bromide 
79 
(+)-porothramycin A (2a) 101 
____ _ ., 
~-----
99 
l 
TBS~ 
PMBN~o 
II~ 
0 
100 
Scheme 1.18 - Proposed synthetic route to ( + J-porothramycin A [( + )-2aj 
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Chapter 2 Dihydropyrrole synthesis via relay-
ring closing metathesis 
2.1 Synthesis of phase-transfer catalyst 97 
Before synthesis of our metathesis substrate could commence, the synthesis of the 
phase transfer catalyst (PTC) was required for the asymmetric alkylation. As observed 
previously (Scheme 1.17), PTC 96 and 97 both gave similar yields and ee's and as such 
PTC 97 was chosen for its shorter synthetic route. 
Following a synthetic sequence reported by Jew and co-workers, (-)-cinchonidine 
(102) was subjected to palladium on charcoal under a hydrogen atmosphere to give (-)-
hydrocinchonidine (103) in good yield (Scheme 2.1).46 Subsequent N-alkylation with 2-
cyanobenzyl bromide produced the ammonium bromide salt 104 and 0-allylation 
afforded the desired PTC 97 in 52°/o overall yield from (-)-cinc·honidine (102). 
10% Pd/C, H2 
MeOH, rt 
' OH 16 h, 76% 
0 
(-)-cinchonidine (102) 103 
2-cyanobenzyl 
bromide 
Et0H/DMF/CHCl3 
(v/v/ v - 5:6:2) 
100 °C, 4 h 
8 
~' ·~ 
8 ~ Br ®Y Br~ ',o ~ J ®~ 
( NC 50% aq. KOH 
11 0H ~ J 
68% (2 steps) NC 
97 104 
Scheme 2.1 - Preparation of Phase Transfer Catalyst 9 746 
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2.2 Synthesis of relay ring closing metathesis precursor - PMB 
With PTC 97 in hand, synthetic efforts were turned towards the synthesis of relay-
ring closing metathesis (RRCM) precursor 100. 
The synthesis began with the alkylation of readily available glycine imine 79 in the 
presence of PTC 97 and propargyl bromide, as described by Jew and co-workers, to give 
the a-substituted amino ester 98 (Scheme 2.2).46 Due to potential sensitivity of the 
diphenylmethylidene protecting group to flash chromatography on silica, the alkylated 
product 98 was not isolated but instead deprotected in the presence of aqueous citric acid 
and acylated with p-methoxybenzoyl chloride to give amido ester 105 in 590/o yield and 
95% ee from imine 79. The formation of the p-methoxybenzoyl amide as opposed to the 
desired p-methoxybenzyl (PMB) derivative was due to ease of access to the former and 
ability to access the latter using reduction conditions in the next step. This synthetic 
strategy also eliminated the possibility of over alkylation in the presence of PMB-Cl to give 
dfbenzylamines. Amido ester 105 was subsequently reduced ·with lithium aluminium 
hydride to give the primary alcohot which was then protected as the tert-
butyldimethylsilyl (TBS) ether to give the protected amino alcohol 99. The aza-Michael 
addition to readily synthesised allyl propiolate posed some minor challenges however, 
changes in solvent and temperature ultimately produced the aza-Michael adduct 100 in 
. . 
good yields. 
propargyl bromide, 
Ph O 97, 50% KOH 
··p)=NJo tBu PhMe:CHCl3 (7:3) 
.. - 79 -20 °C, 3 d 
TBS~ ··''~ 
PMBN~O~ 
0 
100 
i. 30%w/ v citric acid 
THF, rt, 16 h 
ii. p-methoxybenzoyl 
chloride, Et3N 
DCM , rt, 16h 
59% (3 steps) 
95% ee 
allyl propiolate 
MeCN, !l , 16 h 
99% 
Scheme 2.2 - Synthesis of RRCM precursor 100 
i. LiAIH 4, THF 
rt, 3 h 
ii. TBSCI , imid. 
DMAP, DCM 
rt, 16 h 
72% (2 steps) 
PMBH~OTBS 
~ 
99 
The aza-Michael addition with allyl propiolate allowed for the efficient introduction 
of the required enamine moiety, as well as the desired 1,6-diene for relay-ring closing 
metathesis (RRCM). 
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2 .2 .1 Proposed mechanism for metathesis rearrangement 
Having successfully synthesised the desired metathesis substrate 100, it was 
proposed that in the presence of a ruthenium catalyst, the diene-yne 100 would deliver 
the dihydropyrrole 112 (Scheme 2.3). This would occur by the initial loading of the 
ruthenium catalyst onto the terminal alkene to give ruthenium carbene 106, which would 
subsequently undergo a cyclisation to metallocyclobutane 107 and ring opening to 
produce a cyclic alkene byproduct, butenolide 108, and a second ruthenium carbene 109. 
This species would then undergo another cyclisation to give the metallocyclobutene 110, 
which would ring open to give vinyl carbene 111. Re-entry of the substrate, diene-yne 
100, would then deliver the dihydropyrrole 112 and the ruthenium carbene 106 which 
can then carry on in the cycle. 
TBSO/''y-''~ 
PMBN~O~ 
H 
TBSO~ II 
PMBN~ 
100 O 112 
H 
TBS~ )Ru] TBSO~r''~ [Ru] \ 
R 
PMBN~ PMBN~J 
111 ...._,_'l G-11 or HG-II t 106 [Ru] l 
TBSO~ TBso]·'''~ 
PMBN~ PMBN, ~ 
110 [Ru] \ Y 
107 [Ru] 
"'Tsso] ·''~ { 
PMBNJ[Ru] 
t)=o 
0 
109 
108 
Tsso]·'''~ 
PMBN~O~ 
100 O 
Scheme 2.3 - Proposed mechanism for metathesis of diene-yne 100 to dihydropyrrole 112 
2 .2 .2 Attempts at relay ring closing metathesis 
The metathesis precursor 100 was subjected to vanous metathesis reaction 
conditions (Table 2.1). Unfortunately, all attempts to obtain the desired dihydropyrrole 
112 were unsuccessful and resulted in either no reaction or the formation of the 
undesired tetraene product 113 (Scheme 2.4). The catalysts employed for these reactions 
were Grubbs' znct generation catalyst (G-11) and Hoveyda-Grubbs znct generation catalyst 
(HG-II) as they were readily available and known to be more reactive than Grubbs' 1 st 
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generation catalyst (G-1).47 The solvents and temperatures chosen for the reactions were 
all typical of those employed for metathesis rearrangements. The use of titanium 
isopropoxide as an additive was also trialed to disrupt potential coordination of the 
ruthenium complex to the heteroatoms present.48 All reactions were performed on a small 
scale and as such, the results of the reactions were determined after analysis by ESI mass 
spectroscopy. 
100 
conditions 
(see Table 2.1 
& Table 2.2) 
H 
_  _  _ • TBS~::t)---1 
112 
+ 
108 
Scheme 2.4 -Attempted RRCM of diene-yne 100 to dihydropyrrole 112 
Entry Catalystt 
1. 
2 
3 
- ·4 
5 
6 
7 
8 
9 
10 
11 
HG-II 
HG-II 
G-11 
HG-II 
G-11 
HG-II 
G-11 
. G-11 
HG-II 
G-11 
HG-II 
Solvent 
DCM 
DCM 
DCM 
C6D6 
C6D6 
C6D6 
C6D6 
toluene 
toluene 
toluene 
toluene 
Atm. Additive* . Temp (°C) Result* 
Ar Ti(OiPr)4 
ethylene Ti(OiPr)4 
ethylene Ti(OiPr)4 
Ar 
Ar 
Ethylene 
Ethylene 
Ar 
Ar 
Ethylene 
Ethylene 
45 
45 
45 
50 
50 
50 
50 
80 
80 
80 
80 
No reaction 
113 (trace) 
113 (trace) 
No reaction 
No reaction 
113 (trace) + 100 
113 (trace) 
No reaction 
No reaction 
113 (trace) 
113 (trace) 
Table 2.1 - Conditions used for RRCM/RCEYM of 100; t 10 mo/% catalyst Joad111g for all reactjons 
. unless otherwise statecl· I 20 mo/% of additive was used in all reactions unless otherwise stated 
*Results determined by analysis of ESr MS 
Attempts to perform the metathesis rearrangement under an inert (argon) 
atmosphere at various temperatures with ( entry 1) or without ( entries 4, 5, 8, 9) titanium 
isopropoxide present, led to no reaction. 
To overcome the difficulties faced under an argon atmosphere, the reactions were 
attempted under an atmosphere of ethylene (entries 2, 3, 6, 7, 10, 11) which may 
accelerate and encourage the turnover of vinyl carbene 111 to deliver dihydropyrrole 112 
in the metathesis reactions.49 Unfortunately, in all instances where ethylene was 
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employed, the formation of the undesired tetraene 113 - derived from the enyne cross 
metathesis between ethylene and the alkyne moiety within the molecule (Scheme 2.4) -
was observed. This was determined by the analysis of the ESI mass spectrum obtained 
from the crude reaction mixture which displayed ions corresponding to the proton adduct 
and sodium adduct of tetraene 113, at m/z 372 and 394 respectively. 
Due to the small scale nature of these reactions, typically 5-10 mg, and the non-
quantitative nature of mass spectroscopy, the amount of product generated has been 
reported and described as trace. A crude 1H NMR spectrum obtained of the undesired 
tetraene 113 confirmed the formation of the ethylene cross-metathesis product. It showed 
a spectrum very similar to that of the starting dienyne 100 with the addition of a one 
proton doublet of doublets at 8 6.30 U = 17.7, 10.8 Hz) and a four proton multiplet at 8 
5.10-5.00 attributed to the new diene moiety as well as the disappearance of the one 
proton triplet at 8 2.03 U = 2.8 Hz) attributed to the terminal alkyne. A cleaner sample of 
the tetraene could not be obtained as subsequent columns led to significant loss of mass. 
These results may be attributed to the presence of residual amounts of ruthenium leading 
to possible complexation and degradation. 
From the results obtained, it was postulated that the catalyst either does not interact 
with the substrate to form the initial ruthenium carbene 106 or, after formation of this 
species, does not interact with the second alkene present in the molecule to produce 
metallocyclobutane 107, thus preventing the formation of dihydropyrrole 112 (Scheme 
2.3). It isl however/ also worth noting that if any step of the catalytic cycle presented in 
Scheme 2.3 fails to occur1 then the production of dihydropyrrole 112 would not proceed. 
H 
TBS0~_// 
PMBN,__ff 
112 
RRCM/ 
RCEYM 
... )( 
~ 
~ ,, 
TBSO ( 
PMBN ~ O~ 
113 O 
TBso] ··''~ 
PMBN~ O~ 
[Ru]= 
114 
10,0 0 
Scheme Z.5 - Enyne cross metathesis of ethylene with diene-yne 100 
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The formation of the tetraene byproduct 113 involves the alkyne moiety of the 
substrate 100 participating in an enyne cross metathesis with ruthenium carbene 114, 
derived from the reaction . of either G-II or HG-II with ethylene, to produce 
metallocyclobutene 115. Subsequent ring opening delivers vinyl carbene 116 which, itselt 
undergoes a cross metathesis with ethylene to generate the tetraene 113, with the allyl 
ester moiety intact. The ruthenium carbene species 114 can then interact with another 
molecule of metathesis precursor 100 and maintain the cycle. 
It was postulated that the failure in affecting the RRCM and the formation of 
tetraene 113 under ethylene conditions, was due to the poor reactivity of the electron rich 
enamine in substrate 100. Thus, to overcome this problem, it was proposed that the 
nitrogen be protonated to produce a comparatively electron-deficient species. 
Protonation of the amine was attempted using both trifluoroacetic acid (TFA) and 
camphorsulfonic acid (CSA) (Scheme 2.4 & Table 2.2).so Once again, a variety of 
metathesis reactions conditions were trialled and unfortunately the desired 
dihydropyrrole 112 could not be obtained. 
Entry Catalystt Solvent Atm. Additive* Temp. (°C) Result* 
1 G-II DCM Ar TFA 45 Degradation 
2 G-II DCM Ar CSA 45 no reaction 
3 HG-II DCM Ar CSA 45 no reaction 
4 HG-II toluene Ar CSA 80 Degradation 
5 G-II DCM Ethylene CSA 45 113 (trace) 
6 HG-II DCM Ethylene CSA 45 113 (trace) 
7 · HG-II toluene Ethylene CSA 80 113 + 112 (trace) 
Table 2.2 - Conditions used for RRCM/RCEYM of 100 (TFA = trijluoroacetic acid; CSA= 
_c_amphorsulfonic acid; tCatalyst Joad1ng for all reactions were 10 mo!% unless otherwise statect· t 1 
eq. of addjtive was used 1n all reactions unless otherwjse stated *Results determined by analysis of 
Esr MS - due to the non-quantitative nature of mass spectroscopy, the amount of product generated 
has been reported and described as trace. 
Initial attempts to protonate the nitrogen with trifluoroacetic acid and perform the 
metathesis reaction under an inert atmosphere led to degradation ( entry 1) and as such, a 
milder acid, camphorsulfonic acid, was used in all susbsequent reactions ( entries 2-7). 
Attempted reactions under an inert atmosphere either led to degradation or no reaction 
( entries 2-4) and as a result the use of an ethylene atmosphere was trialled again. 
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In most cases, the presence of ethylene in the reaction once again led to the 
formation of tetraene 113 and the appearance of the previously observed resonances at 
8 6.30 and 8 5.10-5.00 in the lH NMR. However, when using toluene as the solvent, in 
addition to the formation of tetraene 113, trace amounts of the proton adduct and sodium 
adduct associated with diene 112 were also observed but no other data could be obtained 
to conclusively confirm the presence of this structure. 
Although this result indicated that an electron deficient enamine was more desirable 
for the metathesis rearrangement, it also showed that the formation of the tetraene 113 
was unavoidable in the presence ethylene. 
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2.3 Synthesis of relay ring closing metathesis precursor - Ts 
Due to the disappointing results obtained from the PMB protected metathesis 
precursor 100, it was clear the protecting group needed to be altered. As such, an electron 
withdrawing sulfonamide protecting group was chosen based on the partial success 
observed previously (Scheme 1.14). Although the earlier metathesis attempts employed 
the 2-trimethylsilylethanesulfonyl (SES) protecting group, the need to synthesise this 
particular protecting group and lack of commercial availability led to efforts being put 
towards the synthesis of a metathesis precursor bearing the commercially available 
p-toluenesulfonyl (Ts) protecting group. 
As such, the p-toluenesulfonyl (Ts) protected amine was formed by re protecting the 
alkylated product 98 with p-toluenesulfonyl chloride to give ester 117 (Scheme 2.6). This 
product was reduced to the corresponding primary alcohol and was then protected as the 
. - . ·-· 
TBS ether 118. The aza-Michael addition of the protected amino alcohol 118 with allyl 
pto'piolate proceeded smoothly to produce 119 in good yields. 
Ph - - 0 
, -r-=NJotsu 
Ph 
79 
propargyl bromide, 
97, 50% KOH 
PhMe:CHC13 (7:3) 
-20 °C, 3 d 
rsso]·'''~ 
TsN~O~ 
0 
119 
i. 30%wlv citric acid 
THF, rt, 16 h 
ii. p-toluenesulfonyl 
chloride , pyr. 
DCM, rt, 16 h 
71 % (3 steps) 
95% ee 
allyl propiolate 
NMM 
MeCN , 0 °C, 2 h 
99% 
Scheme 2.6 - Synthesis of RRCM precursor 119 
2.3.1 Attempts at relay ring closing metathesis 
0 
TsHNJ t 
. OBu 
117 
i. LiAIH4, THF 
rt, 15 min , 87% 
ii. TBSCI , imid. 
DMAP, DCM 
rt, 16 h 
89% 
TsHN~ ~ 
"--: ·orss 
-
~ 
118 
With a new RRCM/RCEYM precursor 119 in hand, it was subjected to various 
conditions (Scheme 2. 7 & Table 2.3). Analysis of the ESI mass spectrum obtained from the 
crude mixture of the initial metathesis reaction attempt displayed the proton adduct and 
sodium adduct associated with dihydropyrrole 120 (entry 1, Table 2.3). The mass 
spectrum also indicated the presence of starting material indicating an incomplete 
conversion and as such, an ethylene atmosphere was employed in an attempt to push this 
reaction to completion. 
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Unfortunately, as observed previously with precursor 100, the use of an ethylene 
atmosphere led to the observation of a proton adduct corresponding to the undesirable 
enyne cross metathesis product 121 in the ESI mass spectrum - albeit with traces of a 
proton adduct corresponding to the desired diene 120 ( entry 2, Table 2.3). The undesired 
tetraene 121 was further confirmed by analysis of a crude lH NMR spectrum which 
displayed a one proton doublet of doublets at 8 6.20 U = 17.7, 10.8 Hz), two doublets at 8 
5.21 U = 17.7 Hz) and 8 5.08 U = 10.8 Hz) and a singlet at 8 4.93 U = 3.5 Hz) attributed to 
the new diene moiety. The spectrum also lacked the one proton triplet at 8 1.85 U = 2.7 
Hz) associated with the terminal alkyne. 
119 
Entry Catalystt 
1 HG-II 
2 HG-II 
3 G-II 
4 HG-II 
5 G-II 
6 HG-II 
7 G-II 
8 HG-II 
9 G-II 
10 HG-II 
11 G-II 
12 HG-II 
13 G-II 
conditions 
see Table 2.3 
H 
-------- TBSO~ 
120 
+ 
108 
Scheme 2.7 - RRCM/RCEYM of diene-yne 119 
Solvent Atm. Additive* Temp. (°C) Result 
DCM Ar 45 - 120 (trace)+ 119 
DCM ethylene 45 121 + 120 (trace) 
DCM Ar 45 120 (trace)+ 119 
toluene Ar 80 120 (trace)+ 119 
toluene Ar 80 120 (trace) + 119 
DCE Ar 90 120 (trace)+ 119 
DCE Ar 90 120 (trace) + 119 
DCM Ar Ti(OiPr)4 45 120 (trace) + 119 
DCM Ar Ti(OiPr)4 45 120 (trace) + 119 
toluene Ar Ti(OiPr)4 80 120 (trace)+ 119 
toluene Ar Ti(OiPr)4 80 120 (trace) + 119 
DCE Ar Ti(OiPr)4 90 120 (trace) + 119 
DCE Ar Ti(OiPr)4 90 120 (trace)+ 119 
Table 2.3 - Conditions used for RRCM/RCEYM of 119; t 10 mo]% catalyst Joad111g for all reactjons 
unless otherwjse stated/ :f: 20 mo]% of addHjve was used 111 all reactjons unless otherwjse stated 
*Results determined by analysis of Esr MS - due to the non-quantitative nature of mass spectroscopy, 
the amount of product generated has been reported and described as trace. 
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Since the formation of the tetrane byproduct 121 appeared unavoidable in the 
presence of ethylene, all subsequent metathesis reactions were performed under an inert 
atmosphere with variations in the catalyst, solvent and temperature. The reaction 
conditions explored represent those generally used for metathesis rearrangements. The 
choice of solvents and thus the resulting temperatures at which the reactions were 
performed at are limited by the availability of the solvent. The time at which the reactions 
were stopped were determined by either complete consumption of the starting material 
or the lack of change observed on the TLC. Attempts to allow the reactions to occur over a 
longer period of time did not improve the result observed and thus reaction times were 
generally kept to less than 3 h. 
The effect of the Lewis acid additive titanium isopropoxide was also investigated 
however, it was observed to have no effect on the reaction ( entries 8-13). In all reactions 
attempted, the mass spectrum revealed ions corresponding to that of dihydropyrrole 120 
and the starting material 119. 
Due to the small scale upon which the reactions were performed ( ".J 5 mg) and the 
analysis of reaction results using ESI mass spectroscopy, the metathesis was repeated on a 
larger scale ( ".J 20 mg) and was observed to proceed in approximately 10°/o isolated yield 
. . 
with a 100/o catalyst loading (Scheme 2.8). The low yield of the reaction suggested that the 
rate of catalyst turnover was low or that there were other unknown factors interfering 
-
with the catalytic cycle (Scheme 2.9). 
The assignment of the structure presented for dihydropyrrole 120 could not be 
conclusively confirmed as the sample obtained was impure and further attempted 
purifications of the compound led to decomposition and significant decrease in mass, 
however, the crude 1H NMR obtained from the reaction had a distinct lack of resonances 
corresponding to the conjugated allyl ester side chain and also lacked the one proton 
triplet at 8 1.85 U = 2.8 Hz) attributed to the terminal alkyne. The mass spectrum 
displayed ions associated with the proton adduct and sodium adduct at 394 and 416 
respectively and the HRMS showed that the species were of the expected composition. 
119 
HG-II (10 mo!%) 
Ti(OiPr)4 
Argon , 
DCE, li , 16h 
10% 
Scheme 2.8 
H 
TBSO~ // 
TsN~ 
120 
More recent efforts to perform the metathesis rearrangement with a 50°/o catalyst 
loading in the hope of obtaining sufficient amounts of material to characterise were 
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unsuccessful and it was postulated that subjection of the compound to flash 
chromatography and residual ruthenium present, even after chromatography, led to the 
degradation of the desired compound. As such, further attempts to isolate the compound 
were not pursued. 
2.3.2 Possible interferences in the metathesis reaction 
2.3.2.1 New substrate for RRCM/RCEYM 
A potential point of interference in the catalytic cycle involved the co-ordination 
between the ruthenium and the carbonyl oxygen to form a species such as 124 and in 
doing so tying up the ruthenium and hindering its ability to perform metathesis reactions 
(Scheme 2.9). 
Tsso]··''~ 
TsN~x .... o~ 
119 (X = C=O) 
122 (X = CH2) 
H 
TBSO~ ;)Ru] 
TsN~ 
128 
r 
H 
H 
TBSO~ II 
TsN~ 
120 
[Ru] \ 
R 
-------
G-11 or HG-II 
TBS~ TBSCY''(''~ 
TsN~ TsN, ~ 
127 [Ru] \ Y 
125 [Ru] 
""TBS~ , ,~ { 
TsNJ[Ru] 
t)=o 
0 
126 
108 
Scheme 2.9 
TBso]··' ~ 
TsN~x .... o~ 
119 (X = C=O) 
122 (X = CH2) 
Tsso]··''~ 
TsN~Ol 
0 ) 
124 '[Ru] 
The chelation of heteroatoms, especially the carbonyl oxygen, to the active 
ruthenium complex is a known occurrence which can significantly alter the activity of the 
catalyst through the formation of a stable complex.s1,s2 In 1996, Fiirstner and Langmann 
postulated that the result of a low yielding metathesis reaction on a homoallylic ester was 
due to sequestering of the catalyst in the form of an unproductive chelate complex of the 
ester carbonyl in proximity to the ruthenium carbene intermediate.s3 This phenomenon 
was also encountered in their synthesis of gloeosporone published in 1997, wherein they 
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described a resolution fo r the problem in the form of using a binary catalyst system 
involving the ruthenium catalyst and titanium isopropoxide.4s 
Unfortunately, the application of the binary catalyst system on substrate 119 did not 
lead to an increase in the formation of the desired product 120 and thus a solution was 
sought to permanently remove carbonyl functionality by designing a new substrate 
bearing an ether functionality to investigate the impact of potential co-ordination of the 
carbonyl oxygen to ruthenium. The allyl ether precursor 122 was accessed by a reduction 
of 119 with DIBAL-H and subsequent 0-allylation with sodium hydride and allyl bromide 
to form the desired compound in an unoptimised 73o/o yield (Scheme 2.10). 
i. DIBAL-H 
.. N H~Br 11. a , :;..;-
119 73% (2 steps) 
Scheme 2.10 
TBso]·'''~ 
TsN~ O~ 
122 
Due to the limited amount of the allylic ether 122 and precedence for the formation 
of the enyne cross metathesis products 113 and 121 in the presence of ethylene (Table 
2_.1 & Table 2.3), the metathesis rearrangement was performed under an inert atmosphere 
b9th with and without titanium isopropoxide. The outcomes obtained from these 
reactions indicated that the removal of the carbonyl group had no effect as the reaction 
~as still stalling well before the starting material was consumed (Scheme 2.11 and Table 
?.4). 
-
. - . . 
Entry 
1 
2 
rsso] ·'''~ 
TsN ~ O~ 
122 
conditions 
(see Table 2.4) 
Scheme 2.11 
Catalystt Solvent Atm. Additive* 
HG-II DCE Ar 
HG- II DC E Ar Ti(O iPr)4 
H 
TBSO~ II 
TsN~ 
120 
Temp. (°C) Result 
90 120 (trace)+ 122 
90 120 (trace)+ 122 
Table 2.4 - Conditions used for RRCM/RCEYM Metathesis of 122; t 10 mo/% catalyst loading for all 
reactions unless otherwise statecl· t 20 m o/% of additJ've was used in all reactions unless oth erwise 
stated *Results determined by analysis of Es r MS - due to the non-quantitative nature of mass 
spectroscopy, the amount of product generated has been reported and described as trace. 
The comparable results obtained from the attempted relay-ring closing metathesis 
of both the allyl ester 119 and allyl ether 122 precursor suggest that co-ordination of the 
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carbonyl oxygen to ruthenium, if present, is not the only feature retarding turnover of the 
catalyst and perpetuation of the catalytic cycle. 
2.3.2.2 Catalyst turnover 
A factor associated with a successful catalytic cycle in enyne metathesis reactions 
involves the interaction of another molecule of substrate, 119 or 122, with vinyl carbene 
128 to release the dihydropyrrole 120 and regenerate the ruthenium carbene 123 which 
can go on to perpetuate the cycle (Scheme 2.9). 
It was hoped that the employment of ethylene in the cycle could aid turnover of the 
catalyst, however, the results obtained have demonstrated that the use of ethylene did not 
aid the reaction but instead acted as a partner for the competing cross metathesis reaction 
to produce tetraene 121. 
· These results have led to the belief that the substrate designed is not suitable for the 
prescribed metathesis rearrangement and a new substrate would need to be designed so 
as to incorporate functionality which will allow for better reactivity and turnover of the 
catalyst without the need for ethylene. 
2.4 Conclusion 
The results obtained from this chapter demonstrate that for the purpose of the 
desired metathesis rearrangement, the use of an electron withdrawing protecting group is 
better than an electron donating group. 
The observations also indicate that the substrates (119 and 122) bearing a tether 
have a poor ability to re-enter the catalytic cycle, subsequently leading to low yield and 
slow turnover of the catalyst. Thus, the substrate will need to be redesigned to incorporate 
functionality that will increase reactivity of the substrate and aid turnover leading to 
perpetuation of the catalytic cycle. 
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Chapter 3 Dihydropyrrole synthesis 
3.1 A new metathesis substrate 
As the devised plan utilising relay-ring closing metathesis had not produced the 
desired result, a new substrate possessing functionality which would promote its re-entry 
into the catalytic cycle and aid turnover of the catalyst was sought. 
3.1.1 Metathesis promoted by allylic alcohols 
Literature reveals that the presence of an allylic alcohol can greatly enhance the rate 
of metathesis reactions. This has been highlighted in an example by Hoye and co-workers 
which compared the relative rate of reaction of allylic alcohols and allylic ethers (Scheme 
3.1).54 In their study, they demonstrated that the presence of an allylic hydroxyl group 
greatly increased the rate of reaction when compared to compounds with similar steric 
bulk (eq. 1 & 3; eq. 2 & 4). 
approx 
relative 
reactivity H OH 
60 
12 
8 
1 
-0 
G-1 
G-1 
G-1 
G-1 
G-1 
HOH 6A ( 1) 
130 131 
(2) 
133 131 
H Me 
6 A (3) 
135 131 
H OMe 
6 A (4) 
137 131 
(5) 
139 131 
Scheme 3.1 - Relative reactivity of metathesis substrates bearing al/ylic alcohols and ethers 
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Another study performed by Imahori and co-workers on the allylic hydroxyl effect in 
RCEYM also demonstrated that the increase in activity was also observed in this particular 
type of metathesis (Scheme 3.2 and Table 3.1).55 
In the absence of an allylic substituent, RCEYM of substrate 140a under and inert 
atmosphere resulted in a low yield of product 141a (entry 1). However, when an ethylene 
atmosphere was employed to aid turnover of the catalyst and re-entry of the substrate, the 
reaction time greatly decreased and the yield increased to 96°/o ( entry 2). This result 
indicated that the substrate alone is not very active to RCEYM and an additional element 
allowing for the increase in reactivity was required. On the other hand, substrate 140b, 
which contains an allylic hydroxyl group, undergoes RCEYM efficiently under an inert 
atmosphere to provide the product 141b in near quantitative yield in 1.5 h (entry 3) 
indicating that it is a far more active substrate. When the hydroxyl group is protected, as 
observed in entries 4 and 5, the rate of reaction is similar to that of the unsubstituted 
substrate 140a further indicating that hydroxyl groups enhance the rate of reaction while 
ethers do not. 
Entry Substrate 
1 140a 
2 140a 
3 140b 
4 140c 
·5 . 140d 
Boe 
140a-d 
G-1 (4 mo!%) 
DCM, rt 
Boe 
141 a-d 
Scheme 3.2 - Metathesis of 1, 7-enynes55 
R Atm. Time (h) 
H Ar 41 
H Ethylene 1.5 
OH Ar 1.5 
0Bn Ar 41 
OTBDPS Ar 41 
Product 
141a 
141a 
141b 
141c 
141d 
Table 3.1 - Conditions for the metathesis of 1, 7-enynes55 
Yield (0/o) 
32 
96 
>99 
44 
7 
The evidence that allylic hydroxyl groups do enhance the rate of metathesis in the 
examples shown by Hoye and Imahori indicated that designing a new substrate which 
carries an allylic alcohol would be desirable. 
Fortunately, in the synthesis of the allylic ether 122 from the allylic ester 119, 
compound 142 bearing an allylic hydroxyl group had already been produced 
(Scheme 3.3). With this new substrate in hand, it was hoped that subjecting it to standard 
metathesis reaction protocols would yield the desired dihydropyrrole 143 with a handle 
to introduce the rest of the sidechain. 
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j DIBAL-H 
TBSO/',l ·''~ 
TsN~OH 
142 
I 
: G-11 
I 
, or 
I 
I HG-II 
I 
I 
• 
H OH 
TBSO~ y----1 
Ts~__J---2 
143 
HG-II 
-10% 
NaH 
allyl bromide 
73% (2 steps) 
H 
TBSO~ // 
TsN~ 
120 
HG-II 
-10% 
TBso]··''~ 
TsN~O~ 
122 
Scheme 3.3 - New proposed enyne metathesis precursor 
It is postulated that the mechanism by which the metathesis occurs (Scheme 3.4) 
would involve the loading of ruthenium onto the alkene to give ruthenium carbene 126 
which would subsequently undergo a RCEYM to deliver vinyl carbene 128. A final cross 
metathesis with an allylic alcohol, either from the substrate 142 or cis-but-2-ene 1,4-diol 
(144) would hopefully deliver dihydropyrrole 143 bearing a side chain which can be 
manipulated later in the synthesis. The employment of diol 144 as_an additive would limit 
the possibility of obtaining products incorporating styrene-like units from G-11 or HG-II in 
the final step as well as aid turnover of the catalyst due to the presence of an allylic 
alcohol. 
TBSCY'f ''~ 
TsN~OH 
142 
G-11 or HG-II 
TBS 
H~OH 
144 
H 
143 
H~OH 
144 
[Rul=\ 
. \._OH 
145 
TBso]··''~ 
TsN"=[Ru] 
126 \ 
H 
TBS~ 
Ts~-0 
127 [Ru] 
J 
H 
TBS~ ;)Ru] 
TsN~ 
128 
142 or 144 
Scheme 3.4 - Catalytic cycle for metathesis of enyne 142 
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3.2 Synthesis 
As allyl propiolate is not a commercially available reagent, the allylic alcohol 142 
was obtained instead from the reduction of ester 146 obtained from the aza-Michael 
addition of the protected amino alcohol 118 with the commercially available ethyl 
propiolate (Scheme 3.5). 
TsHN~OTBS 
-
~ 
118 
ethyl propiolate 
N-methylmorpholine 
MeCN, rt, 16h 
98% 
DIBAL-H TBS~··''~ ~ I __ o_c_M_._-?_B_0_c_. 2_h ___ TBS~··''~ 
TsN~OEt ~ I 
II TsN~OH 6 
0 
146 142 
Scheme 3.5 - Synthesis of metathesis precursor 142 
The transformation of the protected amino alcohol 118 to the aza-Michael adduct 
146 was confirmed by the observation of two mutually coupled resonances U = 14.4 Hz) 
at 8 7.69 and 8 5.67 in the 1H NMR spectrum, which corresponded to the newly installed 
trans-alkene in the latter, as well as the disappearance of a doublet at 8 4.92 U = 8.4 Hz) 
which belonged to the amine proton in the former. The 13 C NMR spectrum displayed a new 
peak at 8 167.2 corresponding to the ester carbonyl group and the ESI mass spectrum 
displayed the sodium adduct at m/z 488. 
The reduction of the ester 146 to the allylic alcohol 142 proceeded smoothly in the 
presence of DIBAL-H to provide the desired compound in moderate yield. The 13 C NMR 
spectrum of compound 142 lacked the resonance due to the ester carbonyl (as seen at 
8 167.2 in the previous compound) and the 1H NMR spectrum lacked the resonances 
attributed to the ethyl ester at 8 4.14 and 8 1.25 indicating that the ester functionality had 
been removed. 
The metathesis rearrangement performed on the new substrate 142 fortunately 
provided the desired dihydropyrrole 143 in 630/o yield (Scheme 3.6). 
142 
G-11 (5 mo!%) 
DCE, ll , 1 h, 63% 
_F\_ HO 144 OH 
H OH 
TBSO~ r 
Ts~ ~ -
2 
143 
Scheme 3.6 - Metathesis of enyne 142 to dihydropyrrole 143 
The formation of the dihydropyrrole 143 was confirmed by the absence of the one-
proton triplet at 8 1.81 U = 2.7 Hz) which corresponded to the terminal alkyne proton in 
enyne 142 and the appearance of a two-proton multiplet at 8 6.34 corresponding to the C2 
and Cl" protons in the 1 H NMR spectrum. 
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3.2.1 Oxidation of allylic alcohol moiety 
Following this success, methods were investigated for the manipulation of the allylic 
alcohol side chain to deliver a compound bearing a dimethyl acrylamide side chain as 
observed in porothramycin. The initial strategy involved the oxidation of the allylic alcohol 
143 to the conjugated aldehyde 147 and subsequently to the conjugated acid 148, which 
would hopefully afford the amide 149 when coupled with dimethylamine (Scheme 3.7). 
H 
TBSO 
OH Dess-Martin 
periodinane 
DCM, rt, 1h 
H 
TBS 
O NaCI02 
;, 2-methyl-2-butene H 0 
~~--~---- TBSO 
R 
TsN 
148 (R = OH) ----, 
149 (R = NMe2)•--: 
Scheme 3. 7 -Attempted oxidation of ally lie alcohol 143 to corresponding acid via aldehyde 14 7 
Oxidation of the allylic alcohol 142 to the aldehyde 14 7 proceeded smoothly in the 
presence of Dess-Martin periodinane (DMP) albeit with by-products which were not 
removed by additional purification steps due to possible instability of the aldehyde moiety 
(Scheme 3. 7). The use of sodium hydrogencarbonate as a buffer in the DMP oxidation 
reaction did not deliver the aldehyde 147 in the absence of the aforementioned by-
products and as such was omitted from further reactions. An oxidation of compound 147 
so obtained from the DMP oxidation to the corresponding acid 148 under Pinnick 
conditions failed to deliver the desired product. The use of additives such as hydrogen 
peroxide, as described in a procedure reported by Dalcanale and Montonari,56 also failed 
to give the acid 148 and this synthetic strategy was abandoned. 
Attempts to obtain dimethyl amide 149 from aldehyde 147 using one-pot oxidative 
amidation protocols also failed. 57 While the protocols worked well to transform simple 
benzoic and allylic aldehyde substrates to various tertiary amides, the reactions, which 
employed t-butyl hydroperoxide as an oxidant or were catalysed by palladium, failed to 
transform aldehyde 147 to the desired amide 149.58,59 The review published by. Ekoue-
Kovi and Wolf in 2008 also covered other oxidative methods, however, due to lack of 
material, these reactions were not investigated and efforts were focussed towards the use 
of more traditional oxidation sequences.56,57 
The presence of impurities accompanying the aldehyde 147 obtained from the DMP 
oxidation and the possibility that these by-products were interfering with the subsequent 
oxidation processes could not be discounted. As a result, a cleaner oxidation was required 
and attention was turned towards to the oxidation of allylic alcohols using activated 
manganese dioxide.60 The possibility of extending this protocol to the oxidation of the 
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conjugated aldehyde to esters and amides in the presence of sodium cyanide made this an 
attractive alternative to the previous protocol.61.62 
Thus, the oxidation of the allylic alcohol with activated manganese dioxide, prepared 
using the protocol described by Attenburrow and co-workers, 63 afforded the aldehyde 147 
in the absence of impurities. The 1H NMR spectrum of the crude reaction mixture 
displayed a one proton doublet at 8 9.52 U = 7.8 Hz) and a one-proton doublet of doublets 
at 8 5.85 U = 15.3, 7.8 Hz) corresponding to the aldehyde proton and the proton attached 
to the a-carbon, respectively (Scheme 3.8). 
H 
150 
OH 
CN TBSO 
H 0 
TsN 
CN 
151 
1l HCN 
Mn02 
NaCN, AcOH 
MeOH, rt, 16 h 
MeOHi 
HCN 
H OH 
TB_$0~ r 
Ts~__;--2 
143 
Mn02 
DCM, rt, 1 h H 0 
TBSO~ r 
Ts~__;--2 
147 
45% (2 steps) 
NHMe2, NaCN 
MnO? 
THF/iPrOH 
TBSO 
TBSO 
Scheme 3.8 - Oxidation of al/ylic alcohol 143 with manganese dioxide 
H 0 
OMe 
152 
iPrMgCI 
NHMe2·HCI 
THF, 3 h 
-78 °C, 18% 
H 0 
NMe2 
149 
The oxidation of the aldehyde 147 directly to the dimethyl amide 149 was met with 
difficulties, which were attributed to the purity of the dimethylamine solution employed. 62, 
Due to the lack of material, this strategy was abandoned and the aldehyde 147 was 
oxidised to the methyl ester 152, by way of the formation of the cyanohydrin 150 and acyl 
cyanide 151, after exposure to manganese dioxide, sodium cyanide and methanol to 
deliver the desired compound in a moderate yield over 2 steps (Scheme 3.8).61 The 
installation of the methyl ester was confirmed by the disappearance of the one-proton 
doublet at 8 9.52 U = 7.8 Hz) and the presence of a three-proton singlet at 8 3.72 in the 1H 
NMR spectrum and the observation of ions corresponding to the proton adduct and 
sodium adduct at m/z 452 and 474, respectively, in the ESI mass spectrum. 
An attempt to introduce the dimethyl amide group using isopropylmagnesium 
chloride and dimethylamine hydrochloride delivered the desired compound 149 in a low 
and unoptimised 18DfcJ yield (Scheme 3.8). The 1H NMR spectrum of this compound 
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displayed two three-proton singlets at 8 3.04 and 8 3.00 which were indicative of the 
presence of a dimethyl amide and the ESI mass spectrum displayed ions associated with 
the proton adduct and sodium adduct at m/z 465 and 487, respectively. 
With the completed C-ring and side chain in hand, attempts were made to deprotect 
the fully synthesised C-ring using sodium/naphthalene and samarium diiodide,64 however, 
due to a lack of material and the degradation of the material due to the aforementioned 
reaction conditions, alternate commercially available protecting groups which could be 
removed under mild deprotection protocols were trialled. 
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3.3 Investigation with alternate protecting groups 
3.3.1 Revisiting PMB 
Having concluded that the presence of an allylic alcohol promoted the desired 
metathesis reaction, the previously prepared PMB protected conjugated ester 100 was 
subject to reduction conditions in order to investigate the effect of an electron donating 
protecting group on the reaction. Unfortunately, the reduction of ester 100 to allylic 
alcohol 153 was found to not proceed even after warming of the reaction mixture (Scheme 
3.9). Once again, the electron donating protecting group may be the reason for the 
difficulty in accessing the desired allylic alcohol due to the decreased electrophilicity of 
ester moiety. Further, given the possible instability of the enamine moiety and the 
potential for reduction of the enamine unsaturation, this avenue was not further explored. 
TB~o/''y-'' ~ 
. . PMBN~OAllyl 
0 
DIBAL-H 
DCM, -78~40 °C TBso]··''~ ----------- ~ .... TBS H 
PMBN~OH PMBN 
0 
100 153 154 
Scheme 3.9 -Attempted synthesis of PMB protected metathesis precursor 153 
3.3.2 Alternate electron withdrawing protecting groups - carbamates 
The lack of success when employing PMB indicated that the use of an electron 
withdrawing group was likely more desirable. Thus, the Boe protecting group was trialled. 
The synthesis of the protected amino alcohol 156 proceeded smoothly under 
previously described protocols however, the aza-Michael addition between this compound 
and ethyl propiolate to deliver the conjugated ester 157 was observed to not proceed 
(Scheme 3.10). A literature search revealed that an _aza-Michael addition between a 
carbamate and a propiolate has not been observed and only one reaction of a similar 
nature between an oxazolidinone and ethyl propiolate has been reported.65 
It was postulated that due to the comparatively higher pKa of a proton attached to a 
carbamate (pKa = 24.8 for primary ethyl carbamate) 66 than one attached to a sulfonamide 
(pKa = 16.1 for primary benzenesulfonamide ) 67, the base employed was not sufficiently 
basic for this reaction. As such, the use of other organic bases such as DBU and Hunig's 
base were trialled, however under these conditions, the reaction was also observed to not 
proceed. In light of this, the reaction was also attempted with potassium 
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hexamethyldisilazide (KHMDS) ranging from 0.1-1.0 equivalents in an attempt to 
deprotonate the carbamate before addition of the ethyl propiolate, however, all reactions 
to this end also failed and the employment of a carbamate protecting group was 
abandoned. 
Ph 0 
>=NJotsu 
Ph 
79 
TBSO 
158 
propargyl bromide, 
97, 50% KOH 
PhMe:CHCl3 (7:3) 
-20 °C, 3 d 
Ph 0 
>=NJ t Ph .: 0 Bu 
9~ 
157 
i. 30% wt citric acid 
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ii. Boc20 , NaHC03, 
dioxane/H20 
rt, 16 h 
79% (3 steps) 
98% ee 
ethyl propiolate 
NMM or DBU 
or DIPEA 
0 
BocHNJ t 
. 0Bu 
155 
i. LiAIH4, THF 
rt, 3 h 
ii. TBSCI, imid. 
DMAP, DCM 
rt, 16 h 
80% (2 steps) 
BocHN~OTBS 
-
~ 
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Scheme 3.10 -Attempted synthesis of Boe protected metathesis precursor 
Whilst compound 15 7 has been previously synthesised in the group and subjected 
to the metathesis rearrangement (Section 1.5.2), the route by which compound 15 7 was 
obtained contained low yielding steps.42 The low yield was due to the aza-Michael addition 
of ethyl propiolate and the primary amine derivative of compound 156 which led to the 
formation of E:Z isomers in a ""'1:1 ratio. With the product in hand, the Boe protection to 
give compound 157 only proceeded with the £-isomer, thus resulting in a low yield. 
Although the described synthetic procedure previously used within the group was not 
employed to obtain compound 157, an analogous reaction involving the aza-Michael 
addition of the primary amino ester derivative of compound 155 to ethyl propiolate was 
carried out, however, all efforts to this end were unsuccessful · in delivering the desired 
product. 
3.4 Conclusion 
The new metathesis strategy involving the use of an allylic alcohol group to promote 
the desired metathesis reaction proceeded srnoothly and the investigation into the 
manipulation of the resulting allylic alcohol group to the desired side chain as observed in 
porothramycin (2) has yielded promising results. 
Due to the use of the tosyl protecting group, which has been known to be difficult to 
remove, an investigation into the use of alternate non-sulfonamide protecting groups was 
undertaken. Unfortunately, this proved unsuccessful and as such, attention was turned to 
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the use of a sulfonamide protecting group offering similar electronic properties while also 
carrying the ability to be removed under mild conditions. 
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Chapter 4 Towards the synthesis of 
porothramycin 
The selection of an alternate sulfonamide protecting group led to the choice of 
2-trimethylsilylethanesulfonamide (SES) due to its relatively mild deprotection protocols 
involving removal in the presence of fluoride ions. Although it had been employed 
previously within the group (Section 1.5.2)1 the use of this protecting group during the 
development of a suitable metathesis protocol was not initially pursued as it was not 
readily available. 
4.1 Synthesis 
Before the synthesis of the substrate could begin1 the synthesis of 2-
trimethylsilylethansulfonyl chloride (SESCl) was undertaken. Vinyltrimethylsilane 159 
was either obtained commercially or from the addition of vinyl magnesisum bromide to 
chlorotrimethylsilane.68 With compound 159 in hand1 it then underwent addition of 
sodium hydrogensulfite in the presence of tert-butyl peroxybenzoate to give sulfonate 160 
which was chlorinated with phosphorus pentachloride to give the desired sulfonyl 
chloride 161 in 50°/o yield over two steps (Scheme 4.1).69,70 
" si~ 
/ \ 
159 
t-butyl 
peroxybenzoate 
NaHS03 
MeOH, 50 °C, 3 d 
o e 
,, 0 ® s ..... 
" si~ ,, Na 
,,..... I o 
160 
PCl5 
50% (2 steps) 
Scheme 4.1 - Sy nthesis of SESC! (161) 
q, Cl 
S" 
" si~ ,, 
,,..... I o 
SESCI (161 ) 
The disadvantages of this protecting group included decomposition over time and as 
such/ the reagent was synthesised when needed. Some problems were encountered during 
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the chlorination of the sulfonate with thionyl chloride, as described by Weinreb and co-
workers in 1998,69 and it was found that following an earlier procedure in which Weinreb 
and co-workers employed phosphorus pentachloride was more successful in delivering 
SESCl (161) consistently.7° 
The synthesis once again began with the asymmetric alkylation of glycine imine 79, 
which was deprotected and protected using SESCl (161) to provide protected amino ester 
162 (Scheme 4.2). The ee was determined by analysis of Boe ester 155, which was 
obtained by protecting an aliquot of the compound obtained after diphenylmethylidene 
deprotection with Boe anhydride. This process was deemed necessary as extensive studies 
into separation and identification of the enantiomers of amino ester 162 using chiral HPLC 
failed to provide suitable protocols. This failure may be attributed to the inability of the 
detection devices used to observe the SES protected amino ester 162 in an appropriate UV 
range and to detect any significant rotations due to the lower [a] 0 value for compound 
16_2.{[~]5° +6.1 (c 0.98, CHCh)}, in comparison to Boe protected amino ester 155 {[a]5° 
+33.6 (c 0.63, CHCh)}. 
79 
TBS~ ··''~ 
SESN~OH 
165 
propargyl bromide, 
97 , 50% KOH 
PhMe:CHCl3 (7 :3) 
-20 °c, 3 d 
DIBAL-H 
DCM , -78 "7 0 cc, 
16 h, 89% 
Ph 0 
P)=Nylotsu 
9~ 
164 
i. 30% w/v citric acid O 
THF, rt, 16 h SESHN II 
~otsu 
ii. SESCI (160), 
Et3N, MeCN 
0 cc, 16 h 
62% (3 steps) 
98% ee 
162 
i. LiAIH4, THF 
rt, 3 h, 81 % 
ii. TBDMSCI 
imid , DMAP 
DCM , rt, 16 h 
77% 
ethyl propiolate SESHN~ /"'... 
NMM ~ ·oTBS 
MeCN, rt , 16 h 
92% 
- . 
~ 
163 
Scheme 4.2 - Synthesis of SES protected metathesis precursor 165 
· The ester functionality was reduced and the corresponding primary alcohol was 
protected as the TBS ether 163 (Scheme 4.2). The aza-Michael addition of ethyl propiolate 
proceeded smoothly to deliver the conjugated ester 164. The initial attempt at reduction 
of the ester 164 to the allylic alcohol 165 proceeded smoothly in a moderate 70°/o yield 
however, by allowing the reaction mixture to warm up to O °C, the yield increased to 890/o. 
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4.1.1 Metathesis 
With the allylic alcohol 165 in hand, the compound was subjected to same 
conditions employed for the tosyl derivative - Grubbs' 2nd generation catalyst (G-II) in the 
presence of cis-butene dial (144) - to deliver the dihydropyrrole 166 in 59°/o yield 
(Scheme 4.3). The lH NMR spectrum of this compound displayed a one-proton singlet at 8 
6.21 corresponding to the proton attached to C2. It also exhibited a pair of mutually 
coupled resonances at 8 6.31 U = 15.6 Hz) and 8 5.57 U = 15.6, 5.6 Hz), which are 
attributed to the protons at Cl" and C2" respectively, and indicate that alkene is in a trans-
configuration. In addition, the 1H NMR lacked the triplet at 8 2.02 attributed to the alkynyl 
proton in compound 165. 
G-11 (5 mol%) 
TBSO""''r''~ cis-butene diol (144) OH 
SESN~OH DCE, 90 °C, 1 h 
59% 2 
165 166 
Scheme 4.3 - Metathesis of enyne 165 to dihydropyrrole 166 
Optimisation of the reaction conditions was undertaken to provide a greater yield of 
the desired compound (Table 4.1). The table indicates that by changing the catalyst from 
G-II to HG-II reduced the reaction time significantly and as such, further reactions were 
performed using HG-II as the catalyst. The catalyst loading was- also investigated and it 
was found that increasing the loading gave improved yields, however, further reactions 
were carried out using 5 mol0/o loading as the advantage in using 10 mol0/o loading was not 
great ( entries 2-4 ). 
Entry Catalyst (mol0/o) Additive Time (min) Isolated Yield (O/o) 
1 G-II (5.0) cis-butene dial (5.0 eq) 60 59 
2 HG-II (2.5) cis-butene dial (5.0 eq) 15 55 
3 HG-II (5.0) cis-butene dial (5.0 eq) 15 . 77 
4 HG-II (10.0) cis-butene dial (5.0 eq) 15 82 
5 HG-II (5.0) cis-butene (atmosphere) 15 67 
6 HG-II (5.0) 10 81-quant. 
Table 4.1 - Conditions for optimisation of metathesis of enyne 165 to dihydropyrrole 166 
The use of a cis-butene atmosphere was trialled in an attempt to produce conjugated 
compound 167 bearing the side-chain observed in sibiromycin (3) however, this proved 
unsuccessful and delivered the conjugated alcohol 166 as the sole product ( entry 5) 
(Scheme 4.4). This result prompted the move towards an additive free metathesis which 
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delivered yields ranging from 81 °/o to quantitative during the initial optimisation studies 
( entry 6). 
TBS°]· ''~ 
SESN~ OH 
165 
G-11 (5 mo!%) 
cis-butene 
DCE, 90 °C, 1 h 
H 
TBSO~ /; 
SES~__r' 
167 
(0%) 
H OH 
TBSO~ r 
SES~_;---2 
166 
(67%) 
Scheme 4.4 -Attempted metathesis of enyne 165 to diene 167 with ci s-butene 
Unfortunately1 after optimisation and over the course of the project1 yields ranging 
from 50-60°/o were consistently obtained despite the use of fresh catalyst either with or 
without distilled cis-butene dial. In light of this1 a second attempt at optimisation was 
undertaken employing allyl alcohol as the additive (Table 4.2). The amount of allyl alcohol 
was varied and it was found that the use of 2 equivalents was ideal ( entries 1-4) and the 
_yi~ld obtained was mirrored when HG-II was employed instead of G-11 ( entry 5). 
Entry Catalyst (molO/o) Additive Time (min) Isolated Yield (0/o) 
1 G-11 (5.0) allyl alcohol (1.0 eq) 60 66 
2 G-11 (5.0) allyl alcohol (2.0 eq) 60 75 
3 G-11 (5.0) allyl alcohol (3.0 eq) 60 59 
4 G-11 (5.0) allyl alcohol (5.0 eq) 60 51 
5 HG-II (5.0) allyl alcohol (2.0 eq) 60 71 
Table 4.2 - Conditions for optimisation of metathesis of enyne 165 to dihydropyrrole 166 
4.1.2 Oxidation of allylic alcohol moiety 
- After obtaining the desired dihydropyrrole 1661 attention was turned to the 
oxidation of the allylic alcohol functionality to the methyl ester 169 as described in the 
protocol developed for the tosyl derivative (Section 3.2.1). Following the described 
procedure/ 63 a sluggish conversion to the aldehyde 168 was observed and it was clear that 
the reactivity of the SES derivative was comparatively less than that of the tosyl derivative. 
In light of this/ the reaction was heated to reflux and the aldehyde 168 was obtained in 
60°/o isolated yield (Scheme 4.5) . 
The formation of compound 168 was confirmed by the lH NMR spectrum which 
displaye d a pair of mutually coupled resonances in the form of a distinctive one proton 
doublet at 8 9.54 U = 8.0 Hz) and a doublet of doublets at 8 5.93 U = 15.2, 7.6 Hz) 
corresponding to the protons attached to th e carbonyl and a-carbon respectively. The 13C 
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NMR spectrum also displayed a peak at 8 193.2 corresponding to the newly installed 
aldehyde and the IR spectrum lacked the OH stretch seen at 3431 cm-1 in the precursor. 
H OH Mn02 DCM, rt, 1 h 
TBS 
60% 
166 
H 
168 
Mn02, NaCN 
;,O MeOH , rt, 16 h 0 
169 
Scheme 4.5 -Attempted oxidation of al/ylic alcohol 166 to methyl ester 169 via aldehyde 168 
Unfortunately, repeated attempts at the subsequent oxidation to the ester 169 were 
unsuccessful; once again demonstrating the contrast in reactivity of the SES and tosyl 
derivatives. 
Due to this result, an alternate protocol was sought and the oxidation of the allylic 
alcohol 166 to the corresponding acid 170, by way of the aldehyde 168. Several oxidation 
procedures known to work with allylic alcohols including potassium permanganate and 
silver oxide were attempted, however, the results were inconclusive and often 
decomposition of the starting material was observed (Scheme 4.6). 61,71 Oxidation 
protocols involving acidic reagents such as the Jones' oxidation were not investigated due 
to the acidic nature of the reagent and known difficulties involving in situ deprotection and 
oxidation of TBS ethers.72 The lack of success associated with this strategy led to further 
investigation of the reaction involving manganese dioxide. 
H OH Mn02 DCM , .Li, 1 h 
60% 
166 
H 0 
TBSO~ r 
SES~__j---2 
168 
0 
170 
Scheme 4.6 -Attempted oxidation of allylic alcohol 166 to corresponding acid via aldehyde 168 
Attempts were made towards the direct synthesis of dimethyl amide 171 from the 
aldehyde 168 and initial results delivered the desired compound 171 in moderate yields 
(Scheme 4. 7). However, difficulties experienced in reproducing the result despite 
extensive optimisation - involving the use of fresh manganese dioxide, finely ground 
sodium cyanide, freshly distilled acetic acid and performing the reaction in a variety of 
solvents - and the: deteriotation of the dimethylamine solution over a short period of time 
rendered this approach nonviable. 
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OH Mn02 
DCM, H , 1h 
-----TBS 
H 
168 
NaCN, AcOH 
o then Mn02 
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H 
TBS 
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Scheme 4.7 -Oxidation of allylic alcohol 166 to dimethylamide 171 via aldehyde 168 
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Given the successful oxidation of aldehyde 168 in the presence of dimethylamine, 
albeit irreproducible, the use of ammonia in the oxidation of the compound 168 to the 
primary amide 172 was trialled (Scheme 4.8). The production of the primary amide side-
chain also coincided with the side-chain present in anthramycin (1) and as such would 
allow for the use of this advanced intermediate in the synthesis of such a natural product. 
H 
TBS 
168 
NH3 in iPrOH, 
then NaCN, 
0 then Mn02 h 21-51 % from 166 
or 
NaCN, then 
NH3 in iPrOH, 
then Mn02 
75% from 166 
H 0 
TBSO 
172 
Scheme 4.8 -Attempted oxidation of aldehyde 168 to primary amide 171 
Following a procedure reported by Gilman,62 ammonia was introduced into the 
·system ·by way of a saturated isopropanol solution and initial attempts at the conversion 
consistently delivered the amide 172 in yields ranging frorri 21-51 °/o (Scheme 4.8). 
Attempts to improve the yield by employing an aprotic solvent such as tetrahydrofuran or 
1,4-dioxane were unsuccessful due to the limited solubility of ammonia in such solvents. 
Other protic solvents such as methanol and ethanol were not trialled as they have been 
known to compete with ammonia and form the methyl and ethyl ester products 
respectively. 6t62 
An investigation of manganese dioxide obtained from several preparations was 
undertaken in order to determine the most active form of the oxidant for our desired 
reaction.73 Various procedures, such as those described by Attenburrow and co-workers,63 
Ball and co-workers,74 and Carpino,75 were employed to generate activated manganese 
dioxide and the reaction times and yields obtained in all cases were similar indicating that 
the method by which the manganese dioxide was produced did not have a significant 
influence on the activity. 
The major factor which influenced the activity of the manganese dioxide was time, 
as over the period of months reaction times increased and the equivalents of manganese 
dioxide required to push the reaction to completion also increased indicating a decrease in 
reactivity. As a result, the method reported by Carpino where manganese dioxide is 
obtained by addition of activated charcoal was employed due to ease of preparation and 
purification of the reagent. 
The order of addition of reagents was also investigated so as to determine the ideal 
method of in situ hydrogen cyanide formation which is required to add to the aldehyde to 
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deliver a cyanohydrin species. This cyanohydrin is subsequently oxidised to the acyl 
cyanide and displacement by ammonia to deliver the desired primary amide. During this 
study, it was found that addition of sodium cyanide to isopropanol prior to the 
introduction of ammonia led to an improved 75°/o yield of amide 172 (Scheme 4.8). 
The formation of the primary amide 172 from the aldehyde 168 was confirmed by 
the absence of the one proton doublet at 8 9.54 U = 8.0 Hz) and the observation of a broad 
singlet at 8 5.48 corresponding to the amide protons on the 1H NMR spectrum, whilst the 
ESI+ mass spectrum displayed an ion corresponding to the sodium adduct at m/z 469. 
The primary amide 172 was subsequently methylated to deliver the dimethylamide 
171 in good yield (Scheme 4.9) and the 1H NMR spectrum of this compound showed two 
distinct three-proton singlets at 8 3.01 and 8 3.08 -corresponding to the newly installed 
N-methyl groups. 
0 
TBS 
NaH, Mel 
THF 
85% 
H 
171 
Scheme 4.9- Methylation of primary amide 172 
4.1.3 SES deprotection 
0 
With the C-ring and side-chain synthesised in the form of dimethylamide 171, 
attention was turned towards the global deprotection of the SES sulfonamide and the TBS 
ether. As both protecting groups are silicon based, it was believed that the use of a 
fluoride source such as tetrabutylammonium fluoride (TBAF) or cesium fluoride would 
deliver the unprotected dihydropyrrole 173.76 Unfortunately, under these conditions and 
other conditions reported for the deprotection of the SES protecting group,77-81 the 
removal of the SES protecting group proved unsuccessful and either only TBS 
deprotection or decomposition was observed (Scheme 4.10). 
171 
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Scheme 4.10 -Attempted deprotection of compound 171 
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The use of fluoride sources, namely tetrabutylammonium fluoride (TBAF), 
tris( dimethylamino )sulfonium difluorotrimethyl silicate (T ASF) and cesium fluoride (CsF), 
led to decomposition of the starting material with no observation of any deprotected 
material. 
The use of HF for the deprotection of this material was not trialled as research 
presented by Declerck and co-workers indicated that using HF·pyridine or HF in H20 for 
the deprotection of dihydropyrrole 175 led to no reaction.sz They did report the removal 
of the SES protecting group from compound 175 in the presence of neat HF, however due 
to safety concerns, this particular reaction was not performed (Scheme 4.11) . 
175 
neat HF 
0 °C 
100% 
176 
Scheme 4.11 - SES deprotection using neat HF 
The use of acidic conditions was inspired by the concomitant deprotection of a Boe 
~fria a SES group on the same amine in refluxing 6 N HCl by Decicco and Grover as well was 
the SES deprotection of pipecolic derivatives by Varray and co-workers.s3,B4 Unfortunately, 
the use of acid for the deprotection of compound 171 also led to decomposition (Scheme 
4.1 0). 
In light of this, milder conditions generally associated with the removal of silyl 
ethe.rs such as ammonium fluoride or concentrated HCl in ethanol were trialled and 
yielded only the TBS deprotected compound 17 4 in good yields albeit in the presence of 
some impurities derived from the removed TBS group (Scheme 4.10). Further attempts to 
deprotect this material using the fluoride sources or acid conditions mentioned above 
once again resulted in decomposition.77-so,sz 
Due to the difficulties encountered in the removal of the SES protecting group from 
compound 171, attempts were made towards the removal of the protecting group at an 
earlier stage, such as from allylic alcohol 166 or primary amide 172 (Scheme 4.12) . 
Unfortunately, efforts made towards the removal of the SES protecting group from these 
compounds also resulted in decomposition of the starting materials. 
H 
TBS~ /;R 
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178 (R = CONH2) 
Scheme 4.12 -Attempted deprotection at earlier stages (a llylic alcohol 166 and primary am ide 172) 
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The failure associated with the removal of the protecting group and the ability to 
obtain compound 173 may be due to the resulting amide anion or amine moiety 
participating in unwanted side reactions, such as aza-Michael additions. Thus, further 
investigation into alternate methods for removal of the SES protecting group and the use 
of additives with traditional SES removal conditions was undertaken. 
4.1.3.1 Alternate strategy for SES deprotection 
In the search for alternative deprotection protocols, a procedure reported by Boger 
and co-workers demonstrated that Boe anhydride could be employed to trap the 
deprotected material as the carbamate 180 (Scheme 4.13) .78 The results indicated that 
dilute solutions were ideal and the nitrogen anion derived from the SES deprotection may 
be unstable thus allowing the presence of an electrophile such as the Boe protecting group 
to trap the anion and reduce decomposition of any deprotected material. Although 
possibility of Boe acylation prior to SES removal was not investigated in detail by Boger 
and co-workers, deprotection of 179 in the absence of Boe anhydride led to substantial 
amounts of the corresponding diketopiperazine 181. 
~ .,,NHSES CsF, DMF 
V C02CH3 
179 
~ .,,NHR 
V C02CH3 
180 
0 eq Boe20 95°C, 12 h, 0.6 M R = H 13% 
0 eq Bo~O 95°C, 12 h, 0.01 M R = H 40% 
1 O eq Boe20 95°C, 1 O h, 0.01 M R = Boe 93% 
10 eq Boe20 50°C, 6 h, 0.01 M R = Boe 96% 
0 
~ HN~·,''~ 
~ ,,,~NH V 
0 
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Scheme 4.13 - SES deprotection in the presence of Boe anhydride 
This protocol was also employed by Varray and co-workers for the deprotection of 
dihydropyrrole 182 to give the Boe protected derivative 183 (Scheme 4.14).84 
PEG-SES-NJ 
182 
CsF (10 eq .) 
Boe20 (30 eq. ) 
DMF 
11 0 °C, 12 h 
Boe-NJ 
183 
Scheme 4.14 - SES deprotection of dihydropy rrole in the presence of Boe anhy dride 
Although these conditions did not provide the carbamate 184 when attempted on 
sulfonamide 17 4 (Scheme 4.15) , a strategy involving the trapping of the deprotected 
compound in an intramolecular sense was proposed (Scheme 4.16). By having the A-ring 
installed as an ester 185, it was anticipated that the nitrogen anion so formed under SES 
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deprotection conditions would participate in an intramolecular nucleophilic substitution 
reaction at the ester carbonyl and lead to the formation of the amide 7 5. 
174 
Boc20 , CsF 
DMF, 50 °C 
)( .. HO 
0 
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Scheme 4.15 -Attempted SES deprotection in the presence of Boe anhydride 
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Scheme 4.16 - Proposed intramo/ecular substitution reaction 
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Implementing this strategy required a coupling reaction between the pnmary 
alcohol 17 4 and the azido acid 187 which delivered the ester 185 in quantitative yield 
(Scheme 4.17). The azide 187 was synthesised from 2-amino-3-methoxybenzoic acid 
(186) following a procedure reported by Cavender and Shiner in excellent yield. BS The 
conversion of the azide was confirmed by the presence of an absorbance band at 2114 
cm-1, which is indicative of the presence of an azide, in the IR spectrum. The ESI mass 
spectrum obtained for compound 185 displayed ions associated with the loss of a proton 
and nitrogen at m/z 192 and 164, respectively. 
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Scheme 4.17 - Synthesis of benzoate 185 and subsequent deprotection 
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The successful esterification was confirmed by the presence of an absorbance band 
at 2114 cm-1 in the IR spectrum. The lH NMR of compound 185 displayed a downfield shift 
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for the protons attached to Cl' from 8 3. 79 ppm to 8 4.49 ppm which is consistent which 
the shift expected when converting a primary alcohol to an ester. The sodium adduct was 
also observed in the ESI mass spectrum obtained of the compound. 
Fortunately, subjection of ester 185 to deprotection protocols employing a fluoride 
source did deliver the desired amide 75.64 The formation of this compound was confirmed 
by the disappearance of the resonances associated with the SES protecting group, at 8 
3.09-3.03 (2H), 1.05-1.00 (2H), and 0.06 (9H) ppm, in the 1H NMR as well as the expected 
upfield shift of the resonance corresponding to the protons attached to Cl' from 8 4.49 
ppm to 8 3.91 ppm. The ESI mass spectrum obtained displayed an ion corresponding to 
the sodium adduct of this compound at m/z 394. 
Optimisation of the intramolecular trapping of the SES deprotected molecule was 
undertaken in order to find a suitable fluoride source which can deliver reproducible 
results as well as improved yields. The fluoride sources investigated in this app roach were 
TBAF, TASF and CsF. In small scale reactions, all three fluoride sources were observed to 
deliver the deprotected compound 75. This result was confirmed by the observation of an 
ion corresponding to the sodium adduct at m/z 394 in the ESI mass spectrum in all cases. 
Although all three sources were successful in performing the desired transformation, CsF 
was chosen as the fluoride source with which to proceed as it could be more readily 
obtained and prepared in anhydrous form. s6 
Following the study on the fluoride sources, an investigation into the use of various 
solvents was also undertaken. Most reported deprotection protocols involving CsF have 
been performed in DMF due to the desirable solubility (0.60 mM at 24 °C) of the salt 
allowing for the presence of fluoride ions in solution.76,7s,so,s i,s7 Another advantage of the 
use of DMF is the 'naked anion' effect which allows for greater nucleophilicity of the 
fluoride ions as the solvent co-ordinates to the corresponding cation. Unfortunately, issues 
encountered during the removal of DMF from the final compound led to the trial of DMSO, 
THF and acetronitrile as alternate solvents. 
The use of DMSO in this reaction led to the observation of a faster reaction t ime 
while delivering less than 10°/o yield. It was postulated that the use of this solvent 
increased the 'naked anion' effect and thus a faster reaction time due to an increase in the 
nucleophilicity of the fluoride ions, when compared to DMF. However, the proposed 
increase in reactivity and difficulty in obtaining the solvent free from moisture led to 
degradation of the starting material and/ or product and thus led to a lower yield. Due to 
the polar nature of compound 185, the removal of this solvent from the small scale 
reaction also proved to be difficult leading to the need for extensive purification, which 
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could also lead to further degradation of material and account for the lower yield. As a 
result, further optimisation involving the use of this solvent was not undertaken. 
While employing THF as the solvent for the reaction, the extremely limited solubility 
(0.093 mM at 24 °C) of CsF required 18-crown-6 (18c6) to be used as an additive to aid 
salvation (0.97 mM at 24 °C with 0.10 M of 18c6).87 The use of 18c6 to co-ordinate and 
help solubilise CsF through co-ordination to the cesium cation would also create the naked 
anion effect, however the comparison of such an effect to solvents (DMSO > DMF > 
acetonitrile) in the absence of additives is not known. Unfortunately, after several 
attempts, it was found that 18-crown-6 was inherently difficult to remove from the final 
product and extensive purifications led to a decrease in yield. Thus, further optimisation 
involving this solvent was suspended while an effective solution for the removal of 18-
crown-6 was sought. 
Although CsF is known to have a comparatively lower solubility in acetonitrile (0.25 
rriM at 25 °C) as opposed to DMF,87 it would still allow for a slow introduction of fluoride 
ions into the reaction mixture and allow the expected deprotection to take place. The use 
of acetonitrile would also result in a lower decreased 'naked anion' effect and thus lower 
the nucleophilicity and reactivity of the fluoride ions. The advantages of employing 
acetonitrile over DMF included the ability to obtain the solvent moisture-free and the 
lower boiling point of the solvent which allowed for easier removal of the solvent from the 
reaction mixture without extensive manipulations and extractions. The use of this solvent 
in the .deprotection sequence allowed for a moderate 60°/o isolated yield of the diamide 75 
(Scheme 4.17). 
With the A- and C- rings assembled, attention was turned towards the completion of 
the synthesis by effecting an Staudinger reaction on the aldehyde 188 obtained from 
oxidation of the primary alcohol moiety in compound 75 (Scheme 4.18). 
Staudinger 
0 ------------ • 
~~p~e 
VlyN ~ 0 
0 
75 188 2b 
Scheme 4.18 - Proposed oxidation and Staudinger reaction to form porothramycin B (2b) 
Several oxidation protocols were employed with varying results. The use of Dess-
Martin's reagent allowed for the formation of the aldehyde 188, however, due to the scale 
on which this reaction was performed (typically < 5 mg), the lack of consistent results and 
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the difficulty in removing all residual DMP by-products, even after a reductive work-up, 
led to the search for a protocol that would deliver a cleaner sample of the aldehyde 188. 
The Swern oxidation was also trialled, however, once again, due to the scale of the 
reaction ( < 5 mg) and difficulty in removing residual DMSO from the reaction mixture, it 
was difficult to determine the presence of the aldehyde 188 in the crude reaction mixture 
and this approach was abandoned. 
Finally, the Ley-Griffith oxidation employing tetrapropylammonium perutherate 
(TPAP) and N-methylmorpholine N-oxide (NMO) was attempted and this reaction was 
observed to deliver a cleaner sample of the aldehyde 188 in 930/o yield (Scheme 4.19).88 
Whilst the yield is not an accurate indication of the success of the reaction as there were 
some impurities present, but the contaminats were determined to be only residual TPAP 
and NMO. 
TPAP, NMO, 
OMe OH DCM, OMe 0 polymer- 6¢p~e 6c; H 4AMS oc;~H bound rt, 16 h 3 PPh3 I I 
N 93% No THF/H 20 N o 
0 NMe2 0 NMe2 then 0 NMe2 
75 188 MeOH 2b 
workup 
Scheme 4.19 - Ley-Griffith oxidation of primary alcohol 75 and subsequent Staudinger reaction 
Having obtained several samples of the aldehyde 188, albeit with varying purity, the 
Staudinger aza-Wittig reaction was attempted in the presence of polymer-bound 
triphenylphosphine in various solvents. The reaction was found to only proceed in 
THF /water and attempts to perform this reaction in DCM (to provide the product bearing 
a N10-C11 imine) or methanol [to provide porothramycin B (2b) directly] led to no 
reaction and eventual degradation of starting material over the course of the reaction. The 
product obtained, where THF /water was used as the solvent, would presumably be 
porothramycin A (2a) bearing a hemiaminal thus, in order to obtain the more stable 
porothramycin B (2b), work-up of the reaction involved several rounds of evaporation 
from a methanol solution to deliver the hemiaminal ether. The 1H NMR obtained for this 
compound could not confirm the identity of the natural product due to the small amount 
of material obtained ( < 1 mg) however, the ESI mass spectrum of the sample produced 
displayed ions corresponding to the proton adduct and sodium adduct of the target 
compound, at m/z 358 and 380 respectively. 
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4.2 Conclusion 
The choice of the 2-trimethylsilylethanesulfonyl (SES) protecting group has allowed 
for the observation of traces of a compound bearing the same molecular weight as the 
target compound, porothramycin B (2b). 
Access to the metathesis precursor 165 proceeded smoothly following the synthetic 
sequence developed through Chapters 2 and 3. Asymmetric alkylation of glycine imine 79 
followed by several functional group interconversions yielded protected amino alcohol 
163 which participated readily in an aza-Michael addition reaction to deliver the desired 
precursor 165 in 320/o yield over 7 steps (Scheme 4.20). 
The success of the metathesis rearrangement, first seen in Chapter 3, was 
reproduced with the SES protected derivative 165. However, extensive studies and 
optimisations of this reaction were required to obtain reasonable and consistent yields 
(Scheme 4.20). 
While the methods previously employed for the oxidation of the metathesis product 
1.43 in Chapter 3 could not deliver the same results for compound 166, further 
investigations into the use of manganese dioxide as an oxidant were met with success and 
delivered primary amide 172 (Scheme 4.20). Methylation of the primary amide moiety 
proceeded readily to give the requisite tertiary amide for porothramycin (2) in the form of 
compound 171. It was postulated that the difficulties encountered in the oxidation of 
allylic alcohol 166, in comparison to the tosyl derivative 143, were due to the differing 
electronic properties of the protecting groups, even though both are sulfonamides. 
With the desired C-ring and sidechain in hand, in the form of compound 171, the 
removal of the SES protecting proved unsuccessful using protocols commonly employed 
. . . 
for SES deprotection. The failure observed in the deprotection reaction may be explained 
by the formation of a potentially reactive dihydropyrrole moiety or amide anion, the 
expected product of the deprotection reaction, performing unwanted side reactions and 
leading to degradation of material. 
In order to circumvent the observed degradation of material, the substrate was 
redesigned, so that after SES deprotection of ester 185, the amide anion so formed could 
readily participate in an intramolecular substitution reaction to deliver the diamide 75 
(Scheme 4.20). Although the desired transformation proceeded as expected, extensive 
optimisation of the deprotection was still undertaken in order to determine the ideal 
fluoride source and solvent for the reaction. 
62 
Ph 0 
)=N~otsu 
Pli 
79 
TBso]··''~ 
SESN~OH 
165 
HG-II 
propargyl bromide, 
97, 50% KOH 
PhMe:CHCl3 (7:3) 
-20 °C, 3 d 
DIBAL-H 
DCM, -78 ~ 0 °C, 
16 h, 89% 
allyl alcohol (2 eq.) 
DCE, H 
60% 
Ph 0 
P)=Nylotsu 
9~ 
i. 30% wt citric acid O 
THF, rt, 16 h SESHN II ~~~~~__.. ~otBu 
ii. SESCI (153), 
Et3N, MeCN 
0 °C, 16h 
62% (3 steps) 
98% ee 
-
162 ~ 
i. LiAIH4, THF 
rt, 3 h, 81% 
ii. TBDMSCI 
imid, DMAP 
DCM, rt, 16 h 
77% 
TBso]··''~ 
SESN~OEt 
ethyl propiolate 
NMM SESHN~OTBS 
MeCN, rt, 16 h 
92% 
-
~ 0 
164 163 
H OH 
TBSO~ r 
sEsN_r 
166 
Mn02 
DCM, rt, 1 h H 0 
TBSO~ r 
sEsN_r 
167 
Mn02, NaCN 
NH3, iPrOH 
75% (2 steps) 
H 0 
TBSO~ /0 
sEsN_r NH2 
172 
OMe 
~NH2 
llAcooH 
186 
89% 
OMe 
~N3 
llAcooH 
187 
H 0 
+ HO~ /0 
SESN_r NMe2 
174 
CsF 
MeCN, 50 °C 
60% 
1 
NaH, Mel 
THF 
85% 
cone. HCI 
EtOH, rt H 0 
TBSO~ /0 
SEsN_r NMe2 
75 
TPAP, NMO, 
DCM, 4AMS 
rt, 16 h 
93% 
171 
0 
polymer- &;?H bound PPh3 3 
•-- - ------- I 0 THF/H20 0 N ~ 
then 
N..._ N..._ MeOH 0 / 188 / workup 
Scheme:4.20 - Synthetic sequence for attempted synthesis of porothramycin B (2b) 
With the limited material obtained after the deprotection studies, an investigation 
into the various methods available for oxidation of the primary alcohol moiety to aldehyde 
188 was also undertaken and it was found that the Ley-Griffith oxidation allowed for 
access to cleaner samples of the desired compound. Subjection of the aldehyde 188 to the 
Staudinger aza-Wittig reaction whilst using THF and water as the solvent in the presence 
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of polymer-bound triphenylphosphine suggested the formation of the target natural 
product 2b. 
The numerous difficultie·s encountered in the linear synthetic sequence towards 
porothramycin as well as the need for extensive optimisation of each step resulted in very 
small amounts of material with which to attempt and optimise the final step of the 
sequence. As a result of the insufficient material synthesised, the total synthesis of 
porothramycin B (2b) could not be completed. 
The synthetic sequence described above would deliver porothramycin (2) in 16 
steps which, whilst longer than Langlois' 11 steps synthesis of the sa1ne compound 
(Scheme 1.8), showcases the use of olefin metathesis to create the 2,3-dihydropyrrole 
moiety required for the C-ring. The enyne metathesis displayed in Chapter 3 and 4 is an 
improvement on the attempt to employ RCEYM by the Mori group in their synthesis of 
.anthramycin derivative 65 (Scheme 1.11). Instead of delivering the 2,5-dihydropyrrole 65, 
which required further isomerisation and extension of the side chain to deliver 2,3-
dihydryopyrrole 68, the protocol developed in this thesis allows for the direct synthesis of 
the 2,3-dihydropyrrole, in the form of compound 166, with an appropriate side-chain 
attached for further manipulation. 
Although problems were encountered during oxidation of the allylic alcohol side 
chain on· compound 166 to the desired conjugated tertiary amide, the nature of the side 
chain may allow for further development of analogues, such as those lacking an oxygen in 
the allylic position, as observed in sibiromycin (3), or those bearing alternate heteroatoms 
in the same position. The use of the allylic alcohol residue in metathesis precursor 165 
cannot be avoided as altering this group may lead to loss of reactivity.s4 
While there were also issues involved with the removal of the SES protecting group, 
. - . 
presumably due to reactivity of the dihydropyrrole, they have been resolved through the 
development and implementation of an alternate strategy involving trapping of the 
reactive intermediate intramolecularly. 
. - The combination of these key steps and the investigations carried out for each step 
has allowed for the design of a synthesis incorporating newly developed chemistry which 
may be applied to other PBDs of the same class, such as anthramycin (1) and sibiromycin 
(3) . 
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Chapter 5 Towards the syntheses of other PBDs 
The strategy outlined toward the synthesis of porothramycin B (2b) lends itself to 
the synthesis of other PBDs including anthramycin (1) and sibiromycin (3). During the 
course of this work, several alternate targets relating to these two natural products were 
briefly investigated as discussed in this Chapter. 
Both of these natural products display biologically significant activity (Section 1.1.2), 
with sibiromycin exhibiting the highest DNA binding affinity of the naturally isolated PBDs 
and ICso's in the picomolar range for various cell lines. Despite both compounds bearing 
the C9 hydroxyl group attributed to cardiotoxicity, the syntheses of these natural products 
would allow for development of analogues lacking the unfavourable hydroxyl group. 
5.1 Towards the synthesis of anthramycin 
The proposed synthesis for anthramycin (1) would involve the coupling of azido 
acid 190, which can be obtained from nitro benzoic acid 189, to the previously 
synthesised primary amide 172, obtained from the metathesis and oxidation sequence as 
seen in Chapter 4 (Scheme 5.1). This would be followed by implementation of the 
deprotection strategy developed in Chapter 4 on ester 191. The completion of the 
--
synthesis would proceed in a similar fashion to that described for porothramycin (2), an 
oxidation of primary alcohol 192 followed by a Staudinger reaction to deliver anthramycin 
methyl ether (lb). 
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Scheme 5.1 - Proposed synthesis for anthramycin (lb) 
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5.1.1 Attempts at synthesising azido acid for anthramycin 
Several attempts were made towards to synthesis of azido acid 190 from 3-hydroxy-
4-methyl-2-nitrobenzoic acid (189). Reduction of the nitro benzoic acid 189 to the 
corresponding anthranilic acid 193 proceeded smoothly and provided the desired 
compound in good yields (Scheme 5.2). Unfortunately, attempts to convert compound 193 
to the azido derivative 190 were met with failure when employing the conditions 
described for the synthesis of azido acid 187. The reactions performed consistently 
provided a red precipitate which may be attributed to the co-ordination of copper to the 
substrate. An attempt to perform this reaction with the phenol protected as the TBS ether 
194 also failed and again led to the observation of a red precipitate. 
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Scheme 5.2 -Attempted synthesis of azido acid 190 
Due to the unsuccessful attempts at converting amine 193 to azide 190, a more 
traditional method, employing sodium nitrate and sodium azide, was attempted. In order 
to avoid any complications involving the acid moiety, it was converted to the methyl ester 
after reduction of the nitro moiety to give amino ester 196. The conversion of this 
compound to the corresponding azide 197 proceeded smoothly in good yields. 
Unfortunately, attempts to reveal the acid by hydrolysis of the ester in the presence 
of lithium hydroxide did not deliver the desired compound 190. Further optimisation and 
investigation into the hydrolysis of the ester will need to be undertaken to provide the 
required acid derivative for coupling to amide 172 and completion of this synthesis. 
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5.2 Proposed synthesis for sibiromycin 
The proposed synthesis for sibiromycin (3) would involve the coupling of azido acid 
199, which may be synthesised from benzoic acid 198, to the deoxygenated derivative 
167 of the metathesis product 166 (Scheme 5.3). 
The synthesis of compound 167 was briefly attempted during the investigation and 
optimisation of the metathesis reaction in Chapter 4 (Section 1.1.1, Scheme 4.4). Although 
the reaction did provide an insight into the metathesis rearrangement, the disappointing 
result in relation to the synthesis of compound 167 meant that an alternate route was 
required. The allylic oxygen may be removed by converting the alcohol to a good leaving 
group by the addition of a mesylate or sulfonate group followed by elimination by a 
hydride souce such as lithium aluminium hydride or Super Hydride®.B9,9o 
The implementation of the deprotection strategy developed in Chapter 4 on ester 
200 would deliver the diamide 201 and the completion of the synthesis would proceed in 
a similar fashion to that described for porothramycin (2), an oxidation of primary alcohol 
followed by a Staudinger reaction to deliver sibiromycin (3). 
The synthesis and introduction of sibirosamine, which has been previously 
synthesised a number of times, is not discussed as this is beyond the scope of the 
strategy.91-95 
OH OH 
~ <,,,____~ ~N3 + H H OH TBSO~ ff ~->TBSO~ ~ 
HO~COOH RO~COOH sEsN~ sEs~__;-----2 
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Scheme 5.3 - Proposed synthesis of sibiromycin (3) 
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Chapter 6 Experimental 
6.1 General Experimental 
Starting materials and reagents were obtained from the Sigma-Aldrich, Merck, TCI 
or Lancaster Chemical Companies and used as supplied or, occasionally, recrystallised or 
distilled. Inorganic salts were·purchased from the Sigma-Aldrich, Alfa Aesar, AJAX, BDH or 
Unilab Chemical Companies. 
THF, DMF, dichloromethane, acetonitrile and toluene were dried using a Glass 
Contour™ solvent purification system that is based upon a technology originally described 
by Grubbs et al.96 Solvents were collected from the purification system as required. 
Glassware was rinsed with acetone, dried then soaked in a base bath (Pyroneg® in 
water) before being rinsed with distilled water and oven-dried at 120 °C. Assembled 
apparatus was evacuated ( <0.1 mm Hg) and flushed three times with dry nitrogen prior to 
use. Reaction mixtures were manipulated under nitrogen using standard Schlenk 
techniques. 
Ambient temperature was assumed to be ca. 18 °C. Temperatures higher than 
ambient were attained using oil baths heated on a thermostated-hot-plate stirrer. To attain 
temperatures lower than ambient for short periods of time, appropriate cooling baths 
were used (ice/water slurry, 0 °C; dry ice/acetone, -78 °C). To maintain temperatures 
lower than ambient for long periods of time, the Operon immersion cooler, IMC-90, was 
employed. 
Organic solutions (extracts) obtained from the work-up of reaction mixtures were 
dried vvith anhydrous sodium sulfate (N a2S04) or magnesium sulfate (MgS04) before being 
filtered and concentrated under reduced pressure on a rotary evaporator with a water 
bath temperature generally not exceeding 40 °C. 
Analytical thin layer chromatography (TLC) was performed on aluminium-backed 
0.2 mm thick silica gel 60 F2s4 plates as supplied by Merck Eluted plates were visualised 
-
using a 254 nm UV lamp and/or by treatment with a suitable dip followed by heating. 
These dips included: a) potassium permanganate : potassium carbonate : 5°/o sodium 
hydroxide aqueous solution : water (3 g : 20 g : 5 mL : 300 mL); b) p-anisaldehyde : 
sulfuric acid (cone.) : acetic acid : ethanol (0.7 ml : 9.5 mL : 2.7 mL : 200 mL) ; and c) 
ninhydrin: acetic acid: ethanol (0.3 g: 3 mL: 100 mL) 
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Melting points were measured on a Stanford Research Systems Optimelt -
Automated Melting Point System and are uncorrected. 
Unless specified otherwise, proton (1H) and carbon (13C) NMR spectra were 
recorded at 20 °Con either a Varian Mercury 300 spectrometer (operating at 300 MHz for 
proton and 75 MHz for carbon nuclei) or a Varian MR400 spectrometer (operating at 400 
MHz for p roton and 100 MHz carbon nuclei) using CDCh stored over K2C03. For l H NMR, 
signals arising from the residual protio-forms of the solvent were used as the internal 
standard.97 Chemical shifts are recorded as 8 values in parts per million (ppm). lH NMR 
data are r ecorded as follows: chemical shift (8) [multiplicity, coupling constant(s) J (Hz), 
relative integral] where multiplicity is defined as: s = singlet; d = doublet; t = triplet; q = 
quartet; m = multiplet or combinations of the above. For 13C NMR spectra, the chemical 
shifts are referenced against with the central peak (8 77.16) of the CDCh "triplet/). BC NMR 
data are r ecorded as follows: chemical shift (8). 
Infrared spectra (v max) were recorded on a Perkin-Elmer 1800 Series FTIR 
Spectr ometer. Samples were analysed as KBr discs (for solids) or as thin films on KBr 
plates (for liquids/ oils). 
Mass spectrometry was performed by the Australian National Universit:ys Mass 
Spectrometric Services Unit located in the Research School of Chemistry, Canberra, 
Australia. Low and high resolution electrospray (ES) mass spectra were recorded on a 
Micromass.:.Waters LC-ZMD single quadrupole liquid chromatograph-MS or a VG Quattro II 
triple quadrupole MS instrument operating in positive or negative ionisation mode. High 
performance liquid chromatography (HPLC) was performed on a Waters system 
consisting of a 600E quaternary pump and 2996 diode detector system. 
Optical r otations were measured between 17 to 20 °C on a Perkin-Elmer 241 
polarimeter at the sodium-D line (A = 589 nm) and the concentrations (c) (g/100 mL) 
indicated using spectroscopic grade chloroform (CHCh ) as solvent. The measurements 
were carried out in a cell with a path length (l) of 1 dm. Specific rotations [ a] o vvere 
calculated using the equation [a] o = (100xa)/(cxl) and are given in deg.dm-1.cm3.g-1. 
Flash chromatography was performed using analytical grade solvents and silica gel 
60 (230 - 400 mesh, 0.04 0 - 0.0063 mm) as supplied by Merck.98 
Enantiomeric excess (e.e. ) for compounds obtained after asymmetric alkylation 
were obtained by chiral HP LC analysis of the Boe derivative 155 on a Chiralcel OD-H (250 
x 4.6 mm) column with 1 °/o IPA in hexane (0 .5 mL/ min) as eluent (minor @ 12.9 min, 
major@ 14.1 min) with detection at 210 nm. 
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6.2 Experimental procedures for chapter 2 
(-)-Hydrocinchonidine (103)99 
Following a procedure reported by Lee and co-workers, a solution of (-)-
cinchonidine (3.26 g, 11.1 mmol) in methanol (100 mL) was added 10°/o Pd-C (652 mg, 
200/o w/w) at rt. The reaction mixture was stirred under a hydrogen atmosphere for 20 h 
at this temperature then filtered through a pad of Celite™ and washed with methanol (2 x 
SO mL). The filtrate was concentrated under reduced pressure then suspended in hexane 
(200 mL) and stirred for 1 h at rt. The solids were collected and dried under reduced 
pressure to afford 103 (2.48 g, 76°/o) as a white solid. m.p. 224-237 °C (lit.100 m.p. 236-237 
°C); [aJ5° -87.1 (c 0.396, (H30H) [lit.100 [aJ5° -100.0 (c 0.386, CH30H)]; IR (film) 3068 
(OH), 2943, 2924, 2866 (C-H), 1750, 1733, 1589, 1567, 1507 (C=C); 1H NMR (400 MHz, 
CDCh) 8 8.87 (1H, d,] = 4.4 Hz), 8.12 (1H, d,J = 8.4 Hz), 8.03 (1H, d,] = 8.4 Hz), 7.69 (1H, t,j 
= 7.6 Hz), 7.58 (1H, d,J = 4.4 Hz), 7.50 (1H, t,] = 7.2 Hz), 5.64 (1H, d,J = 4.4 Hz), 3.38 (1H, 
m), 3.14 (1H, m), 3.05 (1H, dd,] = 13.2, 10.0 Hz), 2.62 (1H, m), 2.38 (1H, m), 1.86-1.62 (3H, 
--
m ), 1.52 (1H, m), 1.42 (2H, m), 1.25 (2H, m), 0.81 (3H, t,] = 7.2 Hz); 13( NMR (100 MHz, 
CDCh) 8 150.4, 148.4, 130.5, 129.2, 126.8, 125.9, 123.2, 118.3, 72.4, 60.3, 58.8, 43.4, 37.7, 
28.5, 27.8, 25.7, 21.8, 12.2; MS (ESI+) m/z 297 ([M + H]+, 100°/o). 
N-(2 '-Cyanobenzyl)hydrocinchonidium bromide (104 )46 
8 Br 
A mixture:of compound 103 (5.05 g, 17.0 mmol) and 2-cyanobenzyl bromide (3 .67 
g, 18.7 mmol) in a mixture of ethanol (12.5 mL), DMF (15 mL) and chloroform (5 mL) was 
stirred at 100 °C for 4 h. Upon cooling to room temperature, the reaction mixture was 
diluted with methanol (60 mL) and then added dropwise to diethyl ether (600 mL) with 
stirring. The solid precipitate was filtered and washed with diethyl ether (600 mL). The 
crude solid was then recrystallised from methanol/ ether to afford target compound 104 
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(5.71 g, 68°/o) as a light pink solid. m.p. 166 °C (lit.46 m.p. 151 °C); [a]5° -132 (c 0.310, 
CH30H) [lit.46 [a]55 -140 (c 0.555, CH30H)]; IR (film) 3128 (OH), 2958, 2824 (C-H), 2226 
(C NJ, 1701, 1616, 1591, 1570; 1531, 1508 (C=C); 1H NMR (300 MHz, CDCh) 8 8.95 (1H, 
d,} = 4.5 Hz), 8.61 (1H, d,} = 7.8 Hz), 8.12 (1H, dd,} = 8.1, 1.4 Hz), 8.05 (1H, d, j = 8.1 Hz), 
7.90 (1H, d,J = 4.5 Hz), 7.84-7.76 (2H, m), 7.71-7.61 (3H, m), 6.84 (1H, d,J = 5.4 Hz), 6.61 
(1H, d,J = 12.3 Hz), 6.48 (1H, d,J = 6.3 Hz), 5.15 (1H, m), 4.92 (1H, d,J = 8.1 Hz), 3.86 (1H, t, 
} = 9.0 Hz), 3.24 (2H, d,] = 7.8 Hz), 3.08 (1H, m), 2.41-2.16 (2H, m), 2.02 (1H, d,] = 3.0 Hz), 
1.83-1.67 (2H, m), 1.45-1.18 (3H, m), 0.77 (3H, t,] = 7.5 Hz); MS (ESI+) m/z 412 ([M - Br] +, 
100o/o). 
N-(2' -Cyanobenzyl)- 9-( 0-allyl)hydrocinchonidium bromide (97)46 
Br e 
A suspension of 104 (5.53 g, 11.2 mmol) in dichloromethane (3.5 mL) was added 
allyl bromide (2.77 mL, 33.7 mmol) and 50°/o aqueous KOH (5.53 mL, 55.8 mmol) and 
stirred vigorously for 4 h at rt. The mixture was then diluted with water (10 mL) and 
extracted with dichloromethane (3 x 30 mL). The combined organic extracts were dried 
over MgS04, filtered and concentrated under reduced pressure. The resulting crude solid 
was recrystallised from dicholormethane/hexane to afford 97 (5.09 g, 85%) as an orange 
solid. m.p. 157 °C (lit. m.p. 165 °C); [a]5° -124 (c 0.666, CH30H) [lit.46 [a]5° ~154 (c 0.54, 
CH30H)]; IR (film) 3392 (Ar ring), 2957, 2875 (C-H), 2223, (C N), 1647, 1589, 1570, 1508 
(C=C); 1H NMR (300 MHz, DMS0-d6) 8 9.02 (1H, d,] = 4.5 Hz), 8.34 (1H, d,J = 8.4 Hz), 8.21-
8.06 (2H, m), 7.97 (1H, d, J = 7.8 Hz), 7.92-7.73 (m, 4H), 7.70 (1H, d,] = 4.5 Hz), 6.51 (1H, 
s), 6.13 (1H, ddd,] = 22.8, 10.8, 5.4 Hz), 5.42 (1H, d,] = 17.4 Hz), 5.34 (1H, d,} = 12.9 Hz), 
5.26 (1H, d,] = 10.5 Hz), 5.15 (1H, d,} = 12.9 Hz), 4.37 (1H, dd,J = 11.7, 5.1 Hz), 4.23 (1H, 
m), 4.11 (1H, t] = 9.0Hz), 3.97 (1H, dd,} = 12.3, 5.7 Hz), 3.66 (1H, d,J = 10.8 Hz), 3.44 (1H, 
d,} = 11.1 Hz) , 3.32-3.21 (2H, m), 2.25 (1H, m), 2.13-2.02 (1H, m), 1.84-1.68 (2H, m), 1.53-
1.36 (1H, m), 1.18-1.12 (2H, m), 0.70 (3H, t,] = 7.2 Hz) ; 13C NMR (100 MHz, DMS0-d6) 
8 150.1, 147.9, 140.8, 135.7, 134.2, 133.7, 133.6, 131.1, 130.5, 129.8, 129.5, 127.2, 125.0, 
123.6, 119.6, 117.8, 117.7, 115.6, 69.3, 67.7, 61.6, 61.0, 51.2, 35.0, 30.8, 25.3, 24.9, 23.4, 
20.7, 11.1; MS (ESI+) m/z 452 ([M - Br] +, 100°/o). 
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tert-Butyl N-( diphenylmethyl-10-ene )glycinate (79) 101 
A solution of tert-butyl bromoacetate (8.56 mL, 58.0 mmol) in acetonitrile (60 mL) 
was treated with benzophenone 1m1ne (8.72 mL, 52.1 mmol) and N,N-
diisopropylethylamine (10.1 mL, 58.0 mmol) and stirred at 70 °C for 14 h. The reaction 
mixture was allowed to cool to room temperature and concentrated under reduced 
pressure. The residue was partitioned between water (SO mL) and dichloromethane (SO 
mL), and the aqueous layer was extracted with dichloromethane (2 x 50 mL). The 
combined organic layers were dried over MgS04, filtered then concentrated. The crude 
mixture was crystallised using ethanol and collected. The filtrate was concentrated and 
crystallised from ethanol/petroleum ether in another two cycles to give a total yield of 
11.9 g (770/o) of imine 79 as a white powder. m.p. 111-112 °C (lit.41 m.p. 111-115 °C); Rt 
0.27 (100/o ethyl acetate in hexane);41 IR (film) 1740 (C=O); 1ff NMR (400 MHz, CDCh) 
8 7.67-7.65 (2H, m, phenyl-HJ, 7.48-7.30 (6H, m, phenyl-HJ, 7.20-7.17 (2H, m, phenyl-HJ, 
4.12 (2H, s, CH2), 1.46 (9H, s, C(CH3)3); 13C NMR (100 MHz, CDCh) 8 171.6, 169.9, 139.5, 
136.3, 130.5, 128.9, 128.9, 128.7, 128.2, 127.8, 81.2, 56.5, 28.2; MS (ESI+) m/z 296 ([M + 
H]+, 30%); 318 ([M + Na]+, 60°/o). 
(S)-tert-Butyl 2-( diphenylmethyl-10-ene )pent-4-ynoate (98)46 
Ph 0 
P)==N0otsu 
~ 
A solution of imine 79 (3.54 g, 11.98 mmol) and phase transfer catalyst 97 (0.638 g, 
1.198 mmol) in toluene/chloroform (7:3, 63 mL) was added propargyl bromide (9 mL, 
60.5 mmol). The mixture was cooled to -20 °C and aqueous potassium hydroxide (50% 
w /v, 4.5 mL, 40.1 mmol) was added. The reaction mixture was stirred at -20 °C for 2 d then 
warmed to room temperature and concentrated. The residue was partitioned between 
diethyl ether (7_5 mL) and water (75 mL) and the aqueous layer was extracted with 
dichloromethane (3 x 75 mL). The combined organic layers were dried with MgS04, 
filtered and concentrated under reduced pressure to afford imine 98 in a crude mixture as 
a light brown oil. The crude mixture was used in the next step without purification. 
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(S)-tert-Butyl 2-( 4-methoxybenzamido )pent-4-ynoate (105) 
A solution of imine 98 (20.0 mmol) in tetrahydrofuran (150 mL) was added aqueous 
citric acid (30°/o w /v, 46.1 mL, 60.0 mmol), and the mixture was stirred at rt for 20 h. The 
reaction mixture was then concentrated under reduced pressure, diluted with diethyl 
ether (100 mL) and extracted twice with hydrochloric acid (1M, 3 x 100 mL). The 
combined aqueous layers were basified to pH "'8-9 with solid sodium bicarbonate and 
extracted with ethyl acetate (3 x 100 mL). The combined organic layers were dried with 
MgS04, filtered and concentrated under reduced pressure to afford a light brown oil. 
To a solution of the above oil in dichloromethane (100 mL) was added p-anisoyl 
- . 
chloride ( 4.1 mL, 30.3 mmol) and triethylamine ( 4.2 mL, 30.1 mmol) at rt and the reaction 
was stirred for 16 h. The reaction mixture was added water (SO mL) and separated. The 
aqueous layer was extracted with dichloromethane (3 x 75 mL). The combined organic 
layers were dried with MgS04, filtered and concentrated under reduced pressure to afford 
a light brown oil. The crude mixture was purified by flash chromatography (gradient 
elution of 5-10°/o ethyl acetate in hexane) to yield ester 105 (3.62 g, 59°/o, 950/o ee) from 
imine 98 as a pale yellow oil. [aJ5° +67.7 (c 1.80, CHCb); Rf 0.06 (10% ethyl acetate in 
hexane); IR (film) 3429 (N-H), 3297 (CC-H), 3003, 2978, 2935, 2840 (C-H), 2122 (C- CH), 
1731, 1644 (C=O), 1606, 1578, 1533, 1503 (C=C); 1ff NMR ( 400 MHz, CDCb) 8 7.80 (2H, d, 
J = 8.4 Hz, Ar-H), 6.93 (3H, d,] = 8.4 Hz, Ar-H & NH), 4.79 (1H, m, H2), 3.84 (3H, s, OMe), 
2.86 (2H, m, H3), 2.03 (1H, s, Hs) 1.51 (9H, s, C(CH3)3); 13C NMR (100 MHz, CDCb) 8 169.8, 
166.4, 162.5, 129.0, 126.3, 113.8, 83.0, 78.9, 71.4, 55.5, 51.4, 28.1, 22.9; MS (ESI+) m/z 304 
([M + Na]+, 5%), 336 ([M + Na]+, 100°/o), 342 ([M + K]+, 30°/o); HRMS (ESI+) calcd for 
( 17H21 N04Na: 326.1368, found 326.1360, calcd for ( 17H21 N04K: 342.1108, found 342.1103. 
( S)-1-( tert-Butyldimethylsilyloxy)-N-( 4-methoxybenzyl)pent-4-yn-2-ylamine (99) 
1 
PMBHN ~ OTBS 
3~ 
5 
To a solution of ester 105 (3.62 g, 11.9 mmol) in diethyl ether (250 mL) was added 
lithium aluminium hydride (1.36 g, 35.8 mmol) at O °C and the reaction stirred at rt for 3 h. 
The reaction mixture was then cooled to O °C and diluted with diethyl ether (125 mL), 
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treated with water (1.5 mL), NaOH (3M, 1.5 mL) and water (5 mL), and added MgS04. The 
mixture was stirred for a further 15 min, then filtered through a pad of Celite™ and 
concentrated under reduced pressure to give a yellow oil. The crude alcohol was used in 
the next step without further purification. 1H NMR (300 MHz, CDCh) 8 7.27-7.23 (2H, m, 
Ar-H), 6.89-6.85 (2H, m, Ar-H), 3.84-3.68 (2H, m, Ar-CH2), 3.80 (3H, s, OCH3), 3.66 (1H, dd, 
] = 10.8, 4.2 Hz, H1a), 3.46 (1H, dd,] = 10.8, 6.6 Hz, H1b), 2.69 (1H, qd,] = 6.0, 4.5 Hz, H2), 
2.49-2.32 (2H, m, H3), 2.17 (2H, bs, NH & OH), 2.03 (1H, t,] = 2.7 Hz, H5); 13C NMR (75 MHz, 
CDCh) 8 158.8, 131.9, 129.4, 113.9, 80.8, 70.9, 62.9, 56.5, 55.3, 50.4, 20.9. 
To a solution of the above alcohol (11.9 mmol) in dichloromethane (100 mL) was 
added tert-butyldimethylsilyl chloride (2.71 g, 18.0 mmol), imidazole (1.23 g, 18.0 mmol) 
and DMAP (73.3 mg, 0.6 mmol) and the reaction was stirred at rt for 16 h. The reaction 
mixture was added water (100 mL) and extracted with dichloromethane (2 x 100 mL). 
The combined organic layers were dried with MgS04, filtered and concentrated under 
reduced pressure. The crude mixture was purified by flash chromatography (gradient 
elution of 5-100/o ethyl acetate in hexane) to yield silyl ether 99 (2.85 g, 72°/o) as a yellow 
oil. [aJ5° +8.5 (c 1.65, CHCh); Rr 0.34 (10°/o ethyl acetate in hexane); IR (film) 3635 (N-H), 
3309 (CC-H), 3030, 2998, 2929, 2856 (C-H), 2117 (C CH), 1612, 1585, 1512 (C=C); lff 
NMR (300 MHz, CDCh) 8 7.26-7.23 (2H, m, Ar-H), 6.87-6.84 (2H, m, Ar-H), 3.84-3.69 (2H, 
--
m, Ar-CH2), 3.78 (3H, s, OCH3), 3.68-3.62 (2H, m, H1), 2.86-2.80 (1H, m, H2), 2.41-2.37 (2H, 
m, H2),2.03 (1H, bs, NH), 1.98 (1H, t, J = 2.7 Hz, Hs), 0.89 (9H, s, C(CH3)3), 0.06 (6H, s, 
SiCH3); 13C NMR (75 MHz, CDCh) 8 158.7, 132.4, 129.3, 113.8, 81.6, 70.1, 64.0, 57.1, 55.3, 
50.7, 26.0, 20.8, 18.3, -5.3; MS (ESI+) m/z 334 ([M + H]+, 100°/o); HRMS (ESI+) calcd for 
C19H32 N02Si: 334.2202, found 334.2207. 
Allyl propiolate102 
Following a procedure reported by Balas and Longwost, 102 a solution of propiolic 
acid (3.56 g, 50.8 mmol) and allyl alcohol (4.7 mL, 94.8 mmol) in THF (100 mL) was added 
a solution of DMAP (423 mg, 3.46 mmol) and DCC (10.62 g, 51.5 mmol) in THF (24 mL) at 
-20 °c. The reaction mixture was allowed to warm to room temperature and stirred at this 
temperature for 14 h. The reaction mixture was filtered and the filtrate was washed with 
aq. HCl (1M, 100 mL), and brine (100 mL). The organic layer was then dried with MgS04, 
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filtered and concentrated under reduced pressure. Distillation of the crude mixture 
furnished allyl propiolate as a clear, colourless oil (3.24 g, 61 °/o). The spectroscopic data 
obtained for this compound correlated with those previously reported.102 
(S,E)-Prop-1-en-3-yl 3-(N-(1-( tert-butyldimethylsilyloxy)pent-4-yn-2-yl)-N-( 4-
methoxybenzyl)amino )propenoate (100) 
1 3 
~,,~ .... 
TBSO ( ~ 5 
6
, 
PMBN ~ O~ . 
1' - 11 S' 7 
0 
To a solution of silyl ether 99 (518 mg, 1.55 mmol) in acetonitrile (20 mL) was 
added allyl propiolate (200 mg, 1.82 mmol) and the reaction was allowed to stir at reflux 
for 16 h. The reaction mixture was cooled to rt and concentrated under reduced pressure. 
The crude mixture was purified by flash chromatography (10°/o ethyl acetate in hexane) to 
yield conjugated ester 100 (680 mg, 99°/o) as a pale yellow oil. [a]?>° -25.0 (c 1.11, CHCb); 
Rr 0.17 (10°/o ethyl acetate in hexane); IR (film) 3293 (CC-H), 3083, 2953, 2930, 2857 
(C-H), 2121 (C CH), 1690 (C=O), 1647, 1607, 1513 (C=C); tff NMR (300 MHz, CDCb) 
8 7.70 (1H, d,] = 13.2 Hz, H21), 7.18-7.15 (2H, m, Ar-H), 6.85-6.82 (2H, m, Ar-H), 5.94 (1H, 
ddt,] = 17.1, 10.2, 5.7 Hz, H6'), 5.28 (1H, app. dq,] = 17.4, 1.5 Hz, H7 1), 5.28 (1H, app. dq, J = 
10.5, 1.5 Hz, H7 1), 4. 71 (1H, d,] = 13.2 Hz, H1 1), 4.56 (2H, dt,] = 5. 7, 1.5 Hz, Hs'), 4.34 (2H, s, 
Ar-H), 3.79 (3H, s, OCH3), 3.73-3.71 (2H, m, H1), 3.54-3.46 (1H, m, Hz), 2.58-2.40 (2H, m, 
H3), 2.03 (1H, t, J = 2.8 Hz, Hs), 0.87 (9H, s, C(CH3)3), 0.022 (3H, s, SiCH3), 0.017 (3H, s, 
SiCH3), 0.04 (9H, s, Si(CH3)3); 13C NMR (75 MHz, CDCb) 8 169.3, 159.0, 150.9(bs), 133.6, 
128.4(bs), 117.3, 114.2, 86.2(bs), 80.4, 71.2, 64.0, 63.5(bs), 55.4, 52.l(bs), 25.9, 20.4(bs), 
18.3, -5.4, -5.5 [signals marked with (bs) indicate that the signal was a broad singlet]; MS 
(ESI+) m/z 444 ([M + H]+, 1000/o), 466 ([M + Na]+, 70°/o); HRMS (ESI+) calcd for 
C2s H3sN04Si: 444.2570, found 444.2570, C2s H37NQ4SiNa: 466.2390, found 466.2389. 
(S)-tert-Butyl 2-( 4-methylbenzenesulfonamido )pent-4-ynoate (117) 
0 
TsHN ~ 1 
. OBu 
3~ 
5 
A solution of imine 98 (7.99 mmol) in tetrahydrofuran (70 mL) was added aqueous 
citric acid (30°/o w /v, 15.35 mL, 24.0 mmol), and the mixture was stirred at rt for 20 h. The 
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reaction mixture was then concentrated under reduced pressure, diluted with diethyl 
ether (SO mL) and extracted with hydrochloric acid (1M, 3 x 50 mL). The combined 
aqueous layers were basified to pH ""'8-9 with solid sodium bicarbonate and extracted 
with ethyl acetate (3 x 70 mL). The combined organic layers were dried with MgS04, 
filtered and concentrated under reduced pressure to afford a light brown oil. 
To a solution of the above oil in dichloromethane (25 mL) was added p-
toluenesulfonyl chloride (1.68 g, 8.81 mmol) and triethylamine (3.40 mL, 24.2 mmol) at rt 
and the reaction was stirred for 16 h. The reaction mixture was added to water (25 mL) 
and was extracted with dichloromethane (2 x 50 mL). The combined organic layers were 
dried with MgS04, filtered and concentrated under reduced pressure to afford a light 
brown oil. The crude mixture was purified by flash chromatography (gradient elution of 5-
100/o ethyl acetate in hexane) to yield ester 117 (1.84 g, 71°/o, 95°/o ee) from imine 98 as a 
white solid (m.p. 75 °C); [aJ5° +6.7 (c 1.00, CHCh); Rr 0.07 (10% ethyl acetate in hexane); 
IR (film) 3285 (CC-H), 2980, 2931 (C-H), 2123 (C-CH), 1730 (C=O), 1598 (C=C); 1H NMR 
(400 MHz, CDCh) 8 7.74 (2H, d,J = 8.4 Hz, Ar-H), 7.29 (2H, d,] = 8.0 Hz, Ar-H), 5.39 (1H, d,] 
= 8.8 Hz, NH), 3.97 (1H, m, Hz), 2.65 (2H, m, H3), 2.41 (3H, s, Ar-Me), 2.01 (1H, t,] = 2.8 Hz, 
Hs), 1.32 (9H, s, C(CH3)3); 13C NMR (100 MHz, CDCh) 8 168.4, 143.6, 136.9, 129.6, 127.2, 
83.1, 77.8, 72.1, 54.3, 27.6, 24.3, 21.4; MS (ESI+) m/z 362 ([M + K]+, 100°/o), 346 ([M + Na]+, 
80°/o); HRMS (ESI+) calcd for C16H21N04SNa: 346.1089, found 346.1088, calcd for 
(S)-N-(1-(tert-Butyldimethylsilyloxy)pent-4-yn-2-yl)-4-methylbenzenesulfonamide 
(118) 
TsHN _ 2 ~ 
~ 'OTBS 
3~ 
5 
To a solution of ester 117 (1.84 g, 5.69 mmol) in tetrahydrofuran (100 mL) was 
added lithium aluminium hydride (0.646 g, 17.0 mmol) at O °C and the reaction stirred at 
rt for 1 h. The reaction mixture was then cooled to O °C and diluted with diethyl ether (125 
mL), treated with water (0.6 mL), NaOH (3M, 0.6 mL) and water (1.8 mL), and dried with 
MgS04. The mixture was then stirred for a further 15 min and filtered through a pad of 
Celite™, then concentrated under reduced pressure. The crude mixture was purified by 
flash chromatography (300/o ethyl acetate in hexane) to yield the corresponding alcohol 
(1.25 g, 87°/o) as a clear, colourless oil. [a]5° -51.8 (c 1.30, CHCh); Rr 0.12 (30% ethyl 
acetate in hexane); IR (film) 3485 (0-H), 3287 (CC-H), 2961, 2921, 2883 (C-H), 2120 
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(C- CH), 1597 (C=C); 1H NMR (400 MHz, CDCh) 8 7.77 (2H, d,] = 8.0 Hz, Ar-H), 7.29 (2H, d, 
] = 8.4 Hz, Ar-H), 5.46 (lH, d,] = 8.4 Hz, NH), 3.65 (2H, m, H1), 3.40 (lH, m, H2), 2.63 (lH, m, 
OH), 2.41 (3H, s, Ar-Me), 2.26 (2H, m, H3), 1.95 (lH, t,] = 2.8 Hz, Hs); 13C NMR (100 MHz, 
CDCh) 8 143.8, 137.4, 129.9, 127.2, 79.5, 71.6, 63.4, 53.5, 21.6; MS (ESI+) m/z 254 ([M + 
H] +, 100/o), 276 ([M + Na]+, 45%), 292 ([M + K]+, 35%); HRMS (ESI+) calcd for C12H16NQ3S: 
254.0851, found 254.0851, calcd for C12H1sN03SNa: 276.0670, found 276.0670, calcd for 
C12 H1s N03SK: 292.0410, found 292.0410. 
To a solution of the above alcohol (1.25 g, 4.93 mmol) in dichloromethane (100 mL) 
was added tert-butyldimethylsilyl chloride (1.12 g, 7.43 mmol), imidazole (0.505 g, 7.41 
mmol) and DMAP (30 mg, 0.246 mmol) and the reaction was stirred at rt for 16 h. The 
reaction mixture was added water (SO mL) and extracted with dichloromethane (2 x 50 
mL). The combined organic layers were dried with MgS04, filtered and concentrated under 
reduced ·pressure. The crude mixture was purified by flash chromatography (gradient 
elution of 5-10°/o ethyl acetate in hexane) to yield silyl ether 118 (1.61 g, 89%) as a clear, 
colourless oil. [a]5° -4.9 (c 0.448, CHCh); Rt 0.16 (10% ethyl acetate in hexane); IR (film) 
3291 (CC-H), 3065, 2954, 2929, 2884, 2857 (C-H), 2121 (C-CH), 1644, 1599 (C=C); 1H 
NMR (400 MHz, CDCh) o 7.76 (2H, d,] = 8.4 Hz, Ar-H), 7.30 (2H, d,] = 8.0 Hz, Ar-H), 4.92 
(lH, d,] = 8.4 Hz, NH), 3.66 (lH, dd,] = 10.0, 3.6 Hz, H1a), 3.45 (lH, dd,] = 10.0, 5.2 Hz, H1b), 
3.42 .:3.34 (1H, m, H2), 2.47 (1H, ddd,J = 16.8, 4.4, 2.8 Hz, H3a), 2.42 (3H, s, OCH3), 2.31 (1H, 
ddd,] = 16.8, 8.0, 2.8 Hz, H3b), 1.93 (1H, t,] = 2.8 Hz, Hs), 0.84 (9H, s, C(CH3)3)1 0.00 (3H, s, 
SiCH3), -0.01 (3H, s, SiCH3); 13( NMR (100 MHz, CDCh) 8 143.6, 137.8, 129.9, 127.2, 79.8, 
71.1, 62:9, 53.3, 25.9, 21.6, 18.3, -5.4 (2C); MS (ESI+) m/z 368 ([M + H]+, 20%), 390 ([M + 
Na] +, 100%); HRMS (ESI+) calcd for CrnH30N03SSi: 368.1718, found 368.1725, calcd for 
C1sH29 NQ3SSiNa: 390.1535, found 390.1529. 
(S,E)-Prop-1-en-3-yl 3-(N-(1-( tert-butyldimethylsilyloxy)pent-4-yn-2-yl)-4-
methylbenzenesulfonamido )propenoate (119) 
1 3 
~ ,'"-..__, 
TBSO ( ~ 5 s· 
TsN ~ O~ . 
1· - II ~ 7 
0 
To a solution of silyl ether 118 (99.9 mg, 0.27 mmol) in acetonitrile (2 mL) was 
added allyl propiolate (38.9 mg, 0.35 mmol) and N-methylmorpholine (35.7 mg, 0.35 
mmol) and the reaction was allowed to stir at rt for 16 h. The reaction mixture was then 
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concentrated under reduced pressure and the crude residue was purified by flash 
chromatography (5-lOo/o ethyl acetate in hexane) to yield conjugated ester 119 (128.6 g, 
99%) as a pale yellow oil. [ a Jii0 + 15.8 ( c 0.46, CH Ch); Rf 0.49 (30°/o ethyl acetate in 
hexane); IR (film) 3293 (CC-H), 3067, 2953, 2929, 2884, 2857 (C-H), 2123 (C C), 1713 
(C=O), 1624, 1598 (C=C); 1H NMR ( 400 MHz, CDCh) 8 7.76 (2H, d,] = 8.1 Hz, Ar-H), 7.70 
(2H, d,] = 14.4 Hz, H2 1), 7.29 (1H, d,] = 8.1 Hz, Ar-H), 5.96-5.83 (1H, m, H6'), 5.67 (1H, d,] = 
14.4 Hz, H1 1), 5.27 (1H, d,] = 17.1 Hz, H7'a), 5.18 (1H, d,J = 10.5 Hz, H7'b), 4.58 (2H, d,J = 5.7 
Hz, Hs 1), 4.45-4.36 (1H, m, H2), 3.88-3.78(1H, m, H1), 3.19 (2H, m, CH2S02), 2.67 (1H, ddd,] 
= 17.1, 7.5, 2.4 Hz, H3a), 2.50 (1H, ddd, J = 17.1, 7.5, 2.4 Hz, H3b), 2.40 (3H, s, Ar-CH3), 1.85 
(1H, t,] = 2.8 Hz, Hs), 0.82 (9H, s, C(CH3)3), -0.007 (3H, s, SiCH3), -0.012 (3H, s, SiCH3); 13( 
NMR (100 MHz, CDCh) 8 166.9, 144.9, 140.4, 135.6, 132.6, 129.9, 129.7, 117.9, 100.5, 79.4, 
71.3, 64.8, 63.0, 59.7, 25.8, 21.6, 19.5, 18.2, -5.56, -5-.62; MS (ESI+) m/z 500 ([M + Na]+, 
100%), 478 ([M + H]+, 12%); HRMS (ESI+) calcd for C24H36NOsSSi: 478.2083, found 
4 78.2086, C24H3sNOsSSiNa: 500.1903, found 500.1903. 
(S,E)-N-(3-(Prop-1-en-3-yloxy)prop-1-enyl)-N-(1-( tert-butyldimethylsilyloxy)pent-
4-yn-2-yl)-4-methylbenzenesulfonamide (122) 
1 3 
~ ,,~, 
TBSO ( ~ 5 s· 
TsN~O~ 
1' 3' 5' 7' 
To a solution of conjugated ester 119 (39.6 mg, 0.08 mmol) in dichloromethane (0.5 
mL) was added a solution of diisobutylaluminium hydride in hexanes (1.0M, 249 µL, 0.25 
mmol) at -78 °C and allowed to stir at this temperature for 2 h. The reaction mixture was 
then diluted with dichloromethane (5 mL), treated with water (0.1 mL), NaOH (3M, 0.1 
mL) and water (0.5 mL) and dried with MgS04. The mixture was then stirred for a further 
15 min and filtered through a pad of Celite™, then concentrated and dried under reduced 
pressure. The crude product was used in the next step without further purification 
To a solution of the crude mixture in acetonitrile (0.5 mL) was added sodium 
hydride (60% w /w, 9.5 mg, 0.24 mmol) at O °C and the mixture was allowed to stir for 5 
mins. Allyl bromide (72 µL, 0.83 mmol} was then added and the reaction was allowed to 
stir at rt until starting material was consumed. The reaction was quenched with a few 
drops of methanol and concentrated under reduced pressure and the resulting crude 
mixture was partitioned between ethyl acetate (5 mL) and water (5 mL). The aqueous 
layer was washed with ethyl acetate (2 x 5 mL) and the combined organic layers were 
dried with MgS04, filtered and concentrated under reduced pressure. The resulting crude 
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mixture was purified by column chromatography (10°/o ethyl acetate in hexane) to yield 
ether 122 as a yellow oil in 73°/o yield from starting ester 119. [a]l/ +2.8 (c 0.25, CHCh); 
Rr 0.21 (10°/o ethyl acetate in .hexane); IR (film) 3285 (CC-H), 2926, 2854 (C-H), 2120 
(C C), 1653 (C=C); 1H NMR (300 MHz, CDCh) 8 7.74 (2H, d,J = 8.4 Hz, Ar-H), 7.26 (2H, d, j 
= 8.1 Hz, Ar-H), 6.28 (1H, dt,j = 14.1, 1.2 H11), 5.86 (1H, ddt,j = 17.4, 10.5, 5.7 Hz, H6,), 5.59 
(1H, dt,j = 14.1, 6.6 Hz, H21) , 5.23 (1H, ddd,J = 17.1, 3.3, 1.5 Hz, H7'a), 5.16 (1H, ddd,j = 10.5, 
3.0, 1.5 Hz, H7'b), 4.04 (1H, tt,j = 7.5, 5.7 Hz, H2), 3.94 (2H, dd,j = 6.3, 1.2 Hz, 8 31), 3.88 (2H, 
dt,j = 5.7, 1.5 Hz, Hs 1) , 3.83-3.72 (2H, m, H1), 2.61 (1H, ddd,J = 17.1, 7.2, 2.7 Hz, H3a), 2.50-
2.40 (1H, m H3b), 2.40 (3H, s, Ar-CH3), 1.84 (1H, t, J = 2.7 Hz, Hs), 0.84 (9H, s, C(CH3)3) 0.01 
(3H, s, SiCH3) 0.00 (3H, s, SiCH3); 13C NMR (75 MHz, CDCh) 8 143.7, 137.8, 134.7, 129.6, 
127.7, 127.0, 118.8, 117.2, 80.5, 70.7, 70.6, 69.0, 63.4, 59.3, 25.9, 21.7, 19.8, 18.3, -5 .5; MS 
(ESI+) m/z 486 ([M + Na] +, 100°/o), 502 ([M + K]+, 30°/o); HRMS (ESI+) m/z calcd for 
C24H37NQ4SSiNa: 486.2110, found 486.2109, C24H37 NQ4SSiK: 502.1850, found 502.1853. 
The following compounds could not be fully characterised due to the limited 
amount·of material obtained. 
(S,E)-allyl 3-(N-(1-(tert-butyldimethylsilyloxy)-4-methylenehex-5-en-2-yl)-4-
methylphenylsulfonamido )acrylate (121) 
l
.·r , 
TBSO ·'' 
6' 
TsN~O~ . 
1· - 11 s· 7 
0 
A solution of enyne 121 (10.9 mg, 23 µmol) in dichloromethane (2.5 mL) was 
fr eeze-dried-thawed under an ethylene atmosphere then added Hoveyda-Grubbs catalyst 
(1 .4 mg, 2.2 µmol). The reaction was heated to reflux and allowed to stir at this 
temperature for 1 h. After this time, the crude reaction mixture was concentrated and 
purified by preperative thin layer chromatography (eluent 30°/o ethyl acetate in hexane). A 
yi eld was not obtained for this reaction, however the title compound was tentatively 
identified using 1H NMR (300 MHz, CDCh) 8 7.80 (1H, d, j = 14.4 Hz, H2'), 7.72 (2H, d, j = 
8.5 Hz, Ar-H) , 7.29 (2H, d, j = 7.9 Hz, Ar-H), 6.20 (1H, dd, j = 17.7, 10.8 Hz, Hs), 5.95 (1H, 
ddt, j = 17.1, 10.2, 5.7 Hz, H6,), 5.64 (1H, d,j = 14.3 Hz, H11), 5.35 - 5.21 (2H, m, H7'), 5.21 
(1H, d, j = 17.7 Hz, H6a), 5.08 (d, j = 10.8 Hz, H6b), 4.93 (1H, d,j = 3.5 Hz, H111), 4.63 (2H, d,J = 
5.6 Hz, Hs'), 4.40 (1H, m, H2), 3.82 - 3.66 (2H, m, H1), 2. 77 (1H, dd, j = 14.4, 6.8 Hz, H3a), 
2.57 (1H, dd, J = 13.5, 8.1 Hz, H3b), 2.43 (3H, s, Ar-Me), peaks below 2 ppm were omitted 
due to presence of water, grease and silicon grease impurities. 
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6.3 Experimental procedures for chapter 3 
(S,E)-Ethyl 3-(N-(1-(tert-butyldimethylsilyloxy)pent-4-yn-2-yl)-4-
methylbenzenesulfonamido )propenoate (146) 
1 3 
TBSO~·'''~ I ~ 5 
TsN~OEt 
1' - II 
0 
To a solution of silyl ether 118 (810 mg, 2.20 mmol) in acetonitrile (16 mL) was 
added ethyl propiolate (281 mg, 2.86 mmol) and N-methylmorpholine (290 mg, 2.86 
mmol) and the reaction mixture was allowed to stir at rt for 16 h. The reaction mixture 
was concentrated under reduced pressure. The crude mixture was purified by flash 
chromatography (10o/o ethyl acetate in hexane) to yield conjugated ester 146 (1.005 g, 
98%) as a pale yellow oil. [aJ5° +16.3 (c 1.10, CHCh); Rr 0.49 (30°/o ethyl acetate in 
hexane); IR (film) 3291 (CC-HJ, 3066, 2955, 2930, 2884, 2857 (C-H), 2123 (C CJ, 1712 
(C=O), 1623, 1599 (C=C); 1H NMR (300 MHz, CDCh) 8 7.78 (1H, d, J = 8.4 Hz, Ar-HJ, 7.69 
(1H, d,] = 14.4 Hz, H2 1), 7.31 (1H, d, J = 8.4 Hz, Ar-HJ, 5.67 (1H, d,J = 14.4 Hz, H11) , 4.47-4.38 
(1H, m, H2), 4.14 (2H, q,] = 7.2 Hz, CH2CH3), 3.90-3.80 (2H, m, H1), 2. 70 (1H, ddd,] = 17.1, 
7.5, 2.7 Hz, H3a), 2.70 (1H, ddd,J = 17.1, 7.5, 2.7 Hz, H3b), 2.41 (3H, s, Ar-Me), 1.89 (1H, t,] = 
2. 7 Hz, Hs), 1.25 (3H, t,] = 7.2 Hz, CH2CH3), 0.84 (9H, s, C(CH3)3), 0.02 (3H, s, SiCH3), 0.01 
(3H, s, SiCH3); 13C NMR (75 MHz, CDCh) 8 167.2, 144.8, 139.9, i35.6, 129.8, 127.6, 101.0, 
79.3, 71.2, 63.0, 60.0, 59.6, 25.7, 21.5, 19.4, 18.1, 14.3, -5.65, -5.70; MS (ESI+) m/z 488 ([M 
+ Na]+, 100%), 466 ([M + HJ+, 12°/o); HRMS (ESI+) calcd for ( 23 H36NOsSSi: 466.2083, found 
466.2092, C23 H3sNOsSSiNa: 488.1903, found 488.1900. 
(S,E)-N-(1-( tert-Butyldimethylsilyloxy)pent-4-yn-2-yl)-N-(3-hydroxyprop-1-enyl)-4-
methylbenzenesulfonamide (142) 
1 3 
TBSO~·'''~ I ~ 5 
TsN~ OH 
1' 3' 
To a solution of conjugated ester 146 (511 mg, 1.10 mmol) in dichloromethane 
(7 mL) was added a solution of diisobutylaluminium hydride in hexanes (1.0 M, 4.39 mL, 
4.39 mmol) at -78 °C and stirred for 2 h. The reaction mixture was then diluted with 
dichloromethane (25 mL), treated with water (0.5 mL), NaOH (3 M, 0.5 mL) and water 
(1.5 mL) and dried with MgS04. The mixture was stirred for a further 15 min and filtered 
through a pad of Celite™, then concentrated under reduced pressure. The crude mixture 
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was purified by flash chromatography (20°/o ethyl acetate in hexane) to yield allylic 
alcohol 142 (392 mg, 84°/o) as a pale yellow oil. [aJ5° +1.2 (c 0.84, CHCb); Rr 0.18 (300/0 
ethyl acetate in hexane); IR (film) 3435 (0-H), 2956, 2926, 2850 (C-H), 2103 (C C), 1644 
(C=C); 1H NMR (300 MHz, CDCb) 8 7.69 (2H, d,J = 8.1 Hz, Ar-H), 7.22 (2H, d,J = 8.1 Hz, Ar-
H), 6.20 (1H, d,J = 13.8, H1,), 5.67 (1H, dt,] = 14.1, 6.3 Hz, H2,), 4.27-4.18 (1H, m, H2), 4.04 
(2H, d,J = 6.0 Hz, H3'), 3.75-3.64 (2H, m, H1), 2.58-2.39 (3H, m, H3, OH), 2.35 (3H, s, Ar-CH3), 
1.81 (1H, t,j = 2.4 Hz, Hs) 0.79 (9H, s, C(CH3)3) 0.044 (3H, s, SiCH3) 0.049 (3H, s, SiCH3); 13( 
NMR (75 MHz, CDCb) 8 143.6, 137.0, 129.5, 127.4, 125.5, 123.0, 80.3, 70.7, 63.2, 61.7, 59.2, 
25.7, 21.5, 19.6, 18.1, -5.61, -5.63; MS (ESI+) m/z 446 ([M + Na]+, 100%); HRMS (ESI+) 
m/z calcd for C21H33N04SSiNa: 446.1797, found 446.1802. 
(S,E)-3-(5-((tert-ButyldimethylsHyloxy)methyl)-1-tosyl-4,5-dihydro-1H-pyrrol-3-yl) 
prop-2-en-1-ol (143) 
OH 
. TBS 3" 
2 
A solution of allylic alcohol 142 (22.9 mg, 54.1 µmol) and cis-butene dial 
(14 µL, 170.0 µmol) in dichloroethane (1 mL) under an argon atmosphere was freezed-
thawed-dried and Grubbs 2nd generation catalyst (2.3 mg, 2.7 µmol) added. The reaction 
mixture was heated to 90 °C and allowed to stir at this temperature for 1 h under an argon 
atomosphere. The reaction mixture . was cooled to rt then adsorbed on to silica and 
purified· by flash chromatography (20% ethyl acetate in hexane) to yield dihydropyrrole 
143 (14.0 mg, 63.2°/o) as a yellow oil. [aJ5° -144.1 (c 0.57, CHCb); Rr 0.24 (30°/o ethyl 
acetate in hexane); IR (film) 3421 (0-H), 2952, 2928, 2853 (C-H), 1654, 1647, 1636 (C=C); 
1H NMR (300 MHz, CDCb) 8 7.64 (2H, d, j = 8.1 Hz, Ar-H), 7.29 (2H, d, j = 7.8 Hz, Ar-H), 
6.3·6-6.31 (2H, m, H2 & H1"), 5.52 (1H, dt, j = 15.6, 6.0 Hz, H2°), 4.17 (2H, d, j = 5. 7 Hz, H3"), 
3.89 (1H, dd, j = 9.9, 3.9 Hz, H1'a), 3.77 (1H, m, Hs), 3.65 (1H, dd, j = 9.6, 7.8 Hz, H1·b), 2.68-
2.49 (2H, m, H4), 2.43 (1H, s, OH), 2.41 (3H, s, Ar-CH3), 0.87 (9H, s, C(CH3)3), 0.07 (6H, s, 
SiCH3); 13C NMR (75 MHz, CDCb) 8 144.0, 133.5, 129.8, 128.6, 128.0, 127.4, 124.6, 124.3, 
65.3, 63.2, 61.0, 32.5, 25.9, 21.6, 18.2, -5.3 ; MS (ESI+) m/z 446 ([M + Na] +, 100°/o); HRMS 
(ESI+) m/z calcd for C21 H33 N04SSiNa: 446.1797, found 446.1798. 
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(S,.E)-3-(5-((tert-Butyldimethylsilyloxy)methyl)-1-tosyl-4,5-dihydro-1H-pyrrol-3-yl) 
propenal (147) 
0 ~ 1H 
TBSO Ts~5J-";· · 
2 
A solution of allylic alcohol 143 (22.0 mg, 52 µmol) in dichloromethane (3 mL) was 
added activated manganese dioxide (90 mg, 1.04 mmol) at room temperature. The 
reaction mixture was allowed to stir at this temperature for 1 h. The reaction mixture was 
then filtered through a pad of Celite™ and the filtrate was concentrated under reduced 
pressure to yield crude aldehyde 147 as a clear, colourless oil. The crude mixture was 
used in the next reaction without further purification. 1H NMR (300 MHz, CDCh) 8 9.52 
(1H, d,] = 7.8 Hz, H3 11), 7.67 (2H, d,] = 8.4 Hz, Ar-H), 7.34 (2H, d,] = 8.4 Hz, Ar-H), 7.21 (1H, 
d,] = 15.3 Hz, H1 11), 6.91 (1H, s, H2), 5.85 (1H, dd,] = 15.3, 7.8 Hz, H211 ) , 3.94 (1H, m, Hs), 3.86 
(1H, dd,] = 10.2, 3.3 Hz, H1 1a), 3.79 (1H, dd,] = 10.2, 6.3 Hz, H1 1b), 2.66 (2H, m, H4), 2.44 (3H, 
s, Ar-CH3), 0.85 (9H, s, C(CH3)3), 0.06 (6H, s, SiCH3); MS (ESI+) m/z 460 ([M + K]+, 1000/o), 
444 ([M + Na]+, 100°/o); HRMS (ESI+) m/z calcd for C21H31N04SSiNa: 444.1641, found 
444.1643; the full characterisation of this compound was not carried out due to the limited 
material available and possible instability. 
( S,.E)-Methyl 3-(5-((tert-butyldimethylsilyloxy)methyl)-1-tosyl-4,5-dihydro-1H-
pyrrol-3-yl)propenoate (150) 
H 0 
TBSO~ 1H 
Ts~5r· OMe 
2 
A solution of aldehyde 147 (52 µmol) in methanol (3 mL) was added sodium 
cyanide (12.7 mg, 0.26 mmol) and a drop of glacial acetic acid at room temperature and 
the reaction was allowed to stir for 15 mins. Activated manganese dioxide (82 mg, 0.94 
mmol) was then added at rt and the reaction mixture was allowed to stir at this 
temperature for 1 h. The reaction mixture was then filtered through a pad of Celite™ and 
washed with methanol (10 mL). The filtrate was concentrated under reduced pressure 
and the resulting crude material was purified by flash chromatography to yield methyl 
ester 150 (10.6 mg, 45%) as a yellow oil. [aJ5° -159.1 (c 0.09, CHCh); Rr 0.14 (10°/o ethyl 
acetate in hexane); IR (film) 2949, 2928, 2852 (C-H), 1716 (C=O), 1623, 1596 (C=C); 1u 
NMR (300 MHz, CDCh) 8 7.65 (2H, d, ] = 8.4 Hz, Ar-H), 7.38 (1H, d,] = 15.3 Hz, H111 ) , 7.32 
(2H, d,] = 8.4 Hz, Ar-H), 6.74 (1H, s, H2), 5.55 (1H, d,] = 15.3 Hz, H211), 3.89-3 .85 (2H, m, 
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H1 1)i 3.77-3.71 (1H, m, Hs), 3.73 (1H, s, OCH3J, 2.67-2.51 (2H, m, H4), 2.43 (1H, s, Ar-CH3J, 
0.86 (9H, s, C(CH3)3J, 0.07 (6H, s, SiCH3J; 13C NMR (100 MHz, CDCbJ 8 167.6, 144.5, 138.0, 
135.8, 134.0, 130.1, 127.4, 122.5, 116.6, 65.1, 61.9, 51.7, 32.0, 25.9, 21.8, 18.3, -5.2; MS 
(ESI+) m/z 452 ([M + H]+, 45°/0)1 474 ([M + Na]+, 100°/o); HRMS (ESI+) m/z calcd for 
C22 H34NOsSSi: 452.1927, found 452.1938, calcd for C22 H33 NOsSSiNa: 4 74.1746, found 
474.1755. 
(S,.E)-3-(5-((tert-Butyldimethylsilyloxy)methyl)-1-tosyl-4,5-dihydro-1H-pyrrol-3-
yl)-N,N-dimethylpropenamide (149) 
H 0 
TBSO~ 1H 
Ts~s~. NMe2 
2 
To a solution of ester 150 (10.6 mg1 23 µmol) and dimethylamine hydrochloride 
(3.8 mg1 4 7 µmol) in THF (2 mL) was added dropwise isopropylmagnesium chloride 
(_2 M in THF1 59 µL1 117 µmol) over 1 min at -78 °C. The reaction mixture was allowed to 
stir· at this temperature for 3 h. The reaction mixture was then treated with phosphate 
buffer (pH = 41 5 mLJ and extracted with ethyl acetate (3 x 5 mLJ. The combined organic 
extracts were dried with MgS041 filtered and concentrated under reduced pressure. The 
crude material was purified by flash chromatography (5 0°/o ethyl acetate in hexane J to 
yield dimethylamide 149 (2.0 mg, 18%) as a yellow oil. 1H NMR (300 MHz, CDCbJ 8 7.65 
(2H, d, J = 8.4 Hz1 Ar-HJ, 7.36 (1H1 d1 ] = 15.0 Hz, H1")1 7.31 (2H, d,] = 8.1 Hz, Ar-H), 6.68 
(1H, s, H2 11), 5.96 (1H, d,] = 15.0 Hz1 HZ"), 3.92-3.71 (3H, m, H1· & Hs), 3.04 (1H, s, NCH3J, 
3.00 (1H, s, NCH3)1 2.66-2.52 (2H1 m 1 H4)1 2.42 (1H1 s, Ar-CH3J, 0.87 (9H, s, C(CH3)3J, 0.08 
(6H, s, SiCH3J; the full characterisation of this compound was not carried out due to the 
limited material available. 
(S)-tert-Butyl 2-( tert-butoxycarbonylamino )pent-4-ynoate (15 5) 
0 
BocHN~ t 
. 0 Bu 
3 ~ 
5 
To a solution of imine 98 ( 4.01 mmolJ in tetrahydrofuran (35 mLJ was added 
aqueous citric acid (30°/o w /v, 7.7 mL, 12.0 mmolJ, and the mixture was stirred at rt for 20 
h. The reaction mixture was then concentrated under reduced pressure, diluted with 
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diethyl ether (25 mL) and extracted twice with hydrochloric acid (1 M, 3 x 25 mL). The 
combined aqueous layers were basified to pH ""'8-9 with solid sodium bicarbonate and 
extracted with ethyl acetate (3 x 50 mL). The combined organic layers were dried with 
MgS04, filtered and concentrated under reduced pressure to afford a light brown oil. 
To a solution of the above oil in dioxane:water (1:1, 30 mL) was added Boe 
anhydride (1.75 g, 8.02 mmol) and sodium bicarbonate (1.01 g, 12.03 mmol) at rt and the 
reaction was allowed to stir for 16 h. The reaction mixture was then concentrated under 
reduced pressure and extracted with ethyl acetate (3 x 25 mL). The combined organic 
layers were dried with MgS04, filtered and concentrated under reduced pressure to afford 
a brown oil. The crude mixture was purified by flash chromatography (gradient elution of 
S-10010 ethyl acetate in hexane) to yield ester 117 (857.1 mg, 79°/o, 950/o ee) from imine 98 
as a white solid (m.p. 61-62 °C). [a Jr>° +33.6 (c 0.63, CHCh); Rf 0.41 (10°/o ethyl acetate in 
hexane); IR (film) 3748 (NH), 3312 (CC-H), 2979, 2933 (C-H), 2123 (C-CH), 1735, 1717 
(C=O); 1H NMR (400 MHz, CDCh) 8 5.34 (1H, d,] = 6.8 Hz, NH), 4.36-4.32 (1H, m, Hz), 2.75-
2.66 (2H, m, H3), 2.01 (1H, s, Hs), 1.48 (9H, s, C(CH3)3), 1.45 (9H, s, C(CH3)3); 13C NMR (100 
MHz, CDCh) 8 169.8, 163.1, 82.6, 80.1, 79.0, 71.4, 52.4, 28.5, 28.1, 23.2; MS (ESI+) m/z 292 
([M + Na]+, 50%); HRMS (ESI+) calcd for C14H24N04: 270.1705, found 270.1703, calcd for 
C14H23NQ4Na: 292.1525, found 292.1525. 
(S)-tert-Butyl 1-(tert-butyldimethylsilyloxy)pent-4-yn-2-ylcarbamate (156) 
1 BocHN~ 2 /'.... 
"'-:" 'OTBS 
3 ~ 
5 
To a solution of ester 155 (305.5 mg, 1.13 mmol) in tetrahydrofuran (20 mL) was 
added lithium aluminium hydride (17 4 mg, 4.58 mmol) at O °C and the reaction was 
warmed to rt and stirred for 3 h. The reaction mixture was then cooled to O °C and diluted 
with diethyl ether (75 mL), treated with water (0.2 mL), NaOH (3 M, 0.2 mL) and water 
(0.6 mL), and dried with MgS04. The mixture was then stirred for a further 15 min and 
filtered through a pad of Celite™, then concentrated under reduced pressure. The crude 
mixture was used in the next reaction without further purification. 
A solution of the above crude mixture in dichloromethane (10 mL) was added tert-
butyldimethylsilyl chloride (230.6 mg, 1.53 mmol), imidazole (104.2 mg, 1.53 mmol) and 
DMAP (12.5 mg, 0.10 mmol) and the reaction was stirred at rt for 16 h. The reaction 
mixture was added water (10 mL) and extracted with dichloromethane (2 x 20 mL). The 
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combined organic layers were dried with MgS04, filtered and concentrated under reduced 
pressure. The crude mixture was purified by flash chromatography (gradient elution of 5-
100/o ethyl acetate in hexane) to yield silyl ether 156 (284.5 mg, 80°/o from ester 155) as a 
clear, colourless oil. [aJ5° -1.7 (c 0.294, CHCh); IR (film) 3312 (CC-H), 2955, 2929, 2857 
(C-H), 2121 (C CH), 1718 (C=O); 1H NMR ( 400 MHz, CDCh) 8 4.82 (1H, d, J = 5.6 Hz, NH), 
3.76 (2H, dd,] = 10.0, 3.2 Hz, H1), 3.60 (1H, dd,] = 10.0, 5.6 Hz, Hz), 2.51-2.37 (2H, m, H3), 
1.96 (1H, t,] = 2.8 Hz, Hs), 1.44 (9H, s, C(CH3)3), 0.89 (9H, s, C(CH3)3), 0.07 (6H, s, Si(CH3)2); 
13C NMR (100 MHz, CDCh) 8 155.4, 80.8, 79.6, 70.4, 63.1, 50.5, 28.5, 26.0, 21.1, 18.4, -5.3; 
MS (ESI+) m/z 336 ([M + Na]+, 80o/o); HRMS (ESI+) calcd for C16H32 N03Si: 314.2151, found 
314.2149, calcd for C16H31N03SiNa: 336.1971, found 336.1958, calcd for C16H31 N03SiK: 
352.1710, found 352.1711. 
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6.4 Experimental procedures for chapter 4 
Sodium 2-(trimethylsilyl)ethanesulfonate (160) 69 
Following a procedure reported by Weinreb and co-workers,69 a solution of vinyl 
trimethylsilane (9.35 mL, 64.3 mmol) in methanol (100 mL) was added dropwise tert-
butyl peroxybenzoate (245 µL, 1.29 mmol) and a solution of sodium hydrogen sulphite 
(13.4 g, 129 mmol) in water (100 mL) at rt. The reaction mixture was warmed to 50 °C and 
stirred for 48 h. The reaction was cooled to rt and added methanol (50 mL) and 
concentrated under reduced pressure. In order to r~move water from the solution, the 
resultant mixture diluted with methanol (100 mL) ·and concentrated under reduced 
pressure. This was repeated a further two times to yield a white solid. Methanol (200 mL) 
was added and the suspension was stirred vigorously for 15 min. The mixture was filtered 
through a pad of Celite™, and the collected solids were again taken up into methanol 
(100mL). This was repeated a further two times and the combined filtrate was 
concentrated under reduced pressure to yield a white solid. The solid was further dried in 
the oven at 110 °C overnight to yield sulfonate 160 as a white solid (11.7 g, 890/o). The 
spectroscopic data obtained for this compound correlated with that previously reported.69 
2-(Trimethylsilyl) ethanesulfonyl chloride ( 161) 69 
Following a procedure reported by Weinreb and co-workers,7o a suspension of 
sulfonate 160 (11.7 g, 57.2 mmol) in dichloromethane (200 mL) was added phosphorus 
pentachloride (35.7 g, 172 mmol) in lg portions over 10 mins at O 0 C. The reaction was 
allowed to stir at this temperature for 90 min. The reaction was quenched by pouring over 
ice (150 mL) and the resulting mixture was allowed to stir for a further 30 min. The 
reaction mixture was separated and the aqueous layer was extracted with 
dichloromethane (3 x 150 mL). The combined organic layers were washed with saturated 
sodium bicarbonate (3 x 150 mL) and brine (150 mL). The organic phase was dried over 
MgS04, filtered and concentrated under reduced pressure to yield a pale brown oil. The 
crude mixture was purified by flash chromatography (100% hexane) to yield sulfonyl 
chloride 161 as a pale brown oil (6.9 g, 60%). The spectroscopic data obtained for this 
compound correlated with that previously reported.69 
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(S)-tert-Butyl 2-(2-(trimethylsilyl)ethylsulfonamido)pent-4-ynoate (162) 
0 
SESHN ~ t 
. 0Bu 
3~ 
5 
To a solution of imine 98 (11.98 mmolJ in tetrahydrofuran (100 mLJ was added 
aqueous citric acid (30°/o w /vi 23.0 mL1 35.9 mmol)1 and the mixture was stirred at rt for 
20 h. The reaction mixture was then concentrated under reduced pressure1 diluted with 
diethyl ether (75 mLJ and extracted twice with hydrochloric acid (1M1 3 x 75 mL). The 
combined aqueous layers were basified to pH ......,8-9 with solid sodium bicarbonate and 
extracted with ethyl acetate (6 x 100 mL). The combined organic layers were dried with 
MgS041 filtered and concentrated under reduced pressure to afford a light brown oil. 
To a solution of the above oil in acetonitrile (25 mLJ was added triethylamine (5.05 
mL/ 35.9 mmolJ then 2-(trimethylsilyl)ethanesulfonyl chloride (3.13 g1 15.57 mmol) at 0 
°C and the reaction was stirred for 16 h. The reaction mixture was concentrated under 
reduced pressure and extracted with ethyl acetate (3 x SO mLJ. The combined organic 
layers were dried with MgS041 filtered and concentrated under reduced pressure to afford 
a light brown oil. The crude mixture was purified by flash chromatography (gradient 
elution of S-10o/o ethyl aceta_te in hexane) to yield ester 162 (2.46 g1 62%1 98°/o ee) from 
imine 98 as a pale yellow oil. Rr 0.19 (10% ethyl acetate in hexane); [aJ5° +6.1 (c 0.981 
CHCb J; IR (film) 3278 (N-HJ1 29781 29551 29301 2854 (C-HJ1 2124 (C CH)1 1734 (C=OJ; 1H 
NMR (400 MHz1 CDCbJ 8 5.21 (1H1 d1 ] = 8.8 Hz1 NH)1 4.13 (1H1 dt] = 8.81 4.8 Hz1 H2)1 2.92 
(2H1 ml CH2S02)i 2.72 (1H1 ml H3a)1 2.64 (1H1 ml H3b)i 2.04 (1H1 ti]= 2.8 Hz1 Hs)1 1.44 (9H1 S1 
C(CH3)3)1 1.04 (2H1 m 1 CH 2Si)1 -0.05 (9H1 s1 Si(CH3)3); 13 C NMR (100 MHz1 CDCb) cS 169.21 
83 .2, 78.4, 72.t 54.71 50.3, 27.8, 24.41 10.3/ -2.1; MS (ESI+ J m/z 356 ([M + Na] \ 100°/oJ; 
HRMS (ESI+) calcd for C14Hn N04SSiNa: 356.1328/ found 356.1331 
(S)-N-(1-Hydroxypent-4-yn-2-yl)-2-(trimethylsilyl)ethanesulfonamide (202) 
1 SESHN ~ 
. OH 
J~ 
5 
To a solution of ester 162 (3.03 g1 9.08 mmolJ in diethyl ether (125 mL) was added 
lithium aluminium hydride (1.03 g1 27.3 mmolJ at O °C and the reaction stirred at rt for 3 h. 
The r eaction mixtu re w as then cooled to O °C and diluted with diethyl ether (125 mLJJ 
treated with w ater (1 mL)i NaOH (3M, 1 mL) and water (3 mLJ, and dried with MgS04. The 
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mixture was stirred for a further 15 min and filtered through a pad of CeliteM, then 
concentrated under reduced pressure. The crude mixture was purified by flash 
chromatography (30°/o ethyl acetate in hexane) to yield alcohol 202 (1.93 g, 81 o/o) as a 
pale yellow oil. Rf 0.22 (30°/o ethyl acetate in hexane); [aJ5° +15.2 (c 0.45, CH Ch); IR (film) 
3489 (0-H), 3287 (N-H), 2953, 2924, 2854 (C-H), 2120 (C- CH); 1H NMR (400 MHz, CDCh) 
8 5.14 (1H, d,] = 8.8 Hz, NH), 3.73 (2H, m, H1), 3.59 (1H, m, H2), 3.01 (2H, m, CH 2S02), 2.95 
(1H, m, OH), 2.54 (1H, m, H3a), 2.52 (1H, m, H3b), 2.06 (1H, t, J = 2.8 Hz, Hs), 1.06 (2H, m, 
CH2Si), 0.05 (9H, s, Si(CH3)3); 13C NMR (100 MHz, CDCh) 8 80.0, 71.6, 64.6, 54.0, 50.3, 22.6, 
10.7, -1.8; MS (ESI+) m/z 286 ([M + Na]+, 100%); HRMS (ESI+) calcd for C10H21N03SSiNa: 
286.0909, found 286.0906 
( S)-N-( 1-( tert-Butyldimethylsilyloxy) pent-4-yn-2-yl)-2-
( trimethylsilyl) ethanesulf onamide (163) 
1 
SESHN~OTBS 
3 ~ 
5 
To a solution of alcohol 202 (1,24 g, 4.90 mmol) in dichloromethane (100 mL) was 
added tert-butyldimethylsilyl chloride (1.11 g, 7.36 mmol), imidazole (0.501 g, 7.36 
mmol) and DMAP (30 mg, 0.246 mmol) and the reaction was--stirred at rt for 16 h. The 
reaction mixture was added water (SO mL) and extracted with dichloromethane (2 x 50 
mL). The combined organic layers were dried with MgS04, filtered and concentrated under 
reduced pressure. The crude mixture was purified by flash chromatography (gradient 
elution of 5-10% ethyl acetate in hexane) to yield silyl ether 163 (1.39 g, 77°/o) as a white 
solid (m.p. 92-95 °C). Rf 0.64 (30°/o ethyl acetate in hexane); [aJ5° -1.5 (c 0.35, CHCh); IR 
(film) 3315 (CC-HJ, 3235 (N-H), 2953, 2930, 2857 (C-H), 2123 (C-CH); 1H NMR ( 400 MHz, 
CDCh) 8 4.62 (1H, d,] = 8.7 Hz, NH), 3.77 (1H, dd,] = 9.8, 4.0 Hz, H1a), 3.66 (1H, dd,] = 10.0, 
5.2 Hz, H1b), 3.55 (1H, m, H2), 2.97 (2H, m, CH2S02), 2.55 (1H, m, H3a), 2.48 (1H, m, H3b), 
2.01 (1H, t, J = 2.8 Hz, Hs), 1.05 (2H, m, CH2Si), 0.88 (9H, s, C(CH3)3), 0.072 (3H, s, SiCH3), 
0.069 (3H, s, SiCH3), 0.04 (9H, s, Si(CH3)3); 13C NMR (100 MHz, CDCh) 8 80.2, 71.2, 64.1, 
53.8, 50.2, 25.9, :22.4, 18.4, 10.7, -1.9 (2C), -5.4; MS (ESI+) m/z 400 ([M + Na] +, 100%); 
HRMS (ESI+) calcd for C16H3sN03SSizNa: 400.177 4, found 400.1779 
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(S,E)-Ethyl 3-(N-(1-(tert-butyldimethylsilyloxy)pent-4-yn-2-yl)-2-
(trimethylsilyl)ethylsulfonamido)acrylate (164) 
1 3 
~ ''"-., TBSO ( ~ 5 
SESN ~ OEt 
0 
To a solution of silyl ether 163 (1.24 g, 3.28 mmol) in acetonitrile (25 mL) was 
added ethyl propiolate (0.418 g, 4.27 mmol) and N-methylmorpholine (0.431 g, 4.27 
mmol) and the reaction was allowed to stir at rt for 16 h. The reaction mixture was 
concentrated under reduced pressure to yield a brown oil. The crude mixture was purified 
by flash chromatography (10°/o ethyl acetate in hexane) to yield conjugated ester 164 
(1.44 g, 92%) as a pale yellow oil. Rt 0.24 (10°/o ethyl acetate in hexane); [aJ?t -1.0 (c 0.96, 
CHCb); IR (film) 3311 (CC-H), 2954, 2927, 2854 (C-H), 1712 (C=O), 1623 (C=C); 1H NMR 
(-400-M-Hz, -CDCb) 8 7.67 (1H, d,] = 14.3 Hz, Hz'), 5.54 (1H, d,] = 14.3 Hz, H11), 4.27 (1H, m, 
Hz), 4.17 (2H, q,] = 7.2 Hz, COzCHz), 3.91 (1H, m, H1a), 3.85 (1H, m, H1b), 3.19 (2H, m, 
CHzSOz), 2.71 (1H, m, H3a), 2.70 (1H, m, H3b), 2.03 (1H, t,] = 2.8 Hz, Hs), 1.26 (3H, t,] = 7.2 
Hz, CH3), 1.08 (2H, m, CH zSi-), 0.87 (9H, s, C(CH3)3), 0.06 (3H, s, Si(H3), 0.05 (3H, s, SiCH3), 
0.04 (9H, s, Si(CH3)3); 13C NMR (100 MHz, CDCb) 8 167.4, 141.2, 99.9, 80.2, 71.5, 63.2, 60.2, 
60.1, 49.9, 25.9, 19.8, 18.3, 14.5, 9.8, -1.8 (2C), -5.4; MS (ESI+) m/z 498 ([M + Na] +, 1000/o); 
HRMS (ESI+) calcd for C21 H4z NOsSSiz: 4 76.2322, found 4 76.2330 
(S,E)-N-(1- (tert-Butyldimethylsilyloxy)pent-4-yn-2-yl)-N-(3-hydroxyprop-1-enyl)-2-
-
(trimethylsilyl)ethanesulfonamide (165) 
1 3 
TBso] · ''~ s 
SESN ~ OH 
1' 3' 
To a solution of conjugated ester 164 (1.12 g, 2.36 mmol) in dichloromethane (47 
mL) was added a solution of diisobutylaluminium hydride in hexanes (1.0M, 9.44 mL, 9.44 
mmol) at -78 °C, then warmed to O °C and stirred for 2 h. The reaction mixture was then 
diluted with dichloromethane (SO mL), treated with water (0.5 mL), NaOH (3M, 0.5 mL) 
and water (1.5 mL) and dried with MgS04. The mixture was then stirred for a further 15 
min and filtered through a pad of CeliteTM, then concentrated under reduced pressure. The 
crude mixture was purified by flash chromatography (20°/o ethyl acetate in hexane) to 
yield allylic alcohol 165 (0.92 g, 89°/o) as a pale yellow oil. Rr 0.24 (20% ethyl acetate in 
hexane); [aJ5° -1.7 (c 1.34, CHCb); IR (film) 3410 (0-H), 3310 (CC-HJ, 2953, 2928, 2856 
(C-H), 1655 (C=C); 1H NMR (400 MHz, CDCb) 8 6.40 (1H, dd,] = 14.1, 1.2 Hz, H1'), 5.59 (lH, 
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dt,] = 14.1, 6.4 Hz, Hz'), 4.20-4.12 (3H, m, Hz, 8 31) , 3.85 (1H, m, H1a), 3.80 (1H, m, H1b), 3.11 
(2H, m, CHzSOz), 2.65-2.62 (2H, m, 8 3), 2.02 (1H, t,] = 2.8 Hz, Hs), 1.60 (1H, s, OH), 1.07 
(2H, m, CHzSi), 0.88 (9H, s, C(CH3)3), 0.059 (3H, s, SiCH3), 0.056 (3H, s, SiCH3), 0.03 (9H, s, 
Si(CH3)3); 13( NMR (100 MHz, CDCh) 8 127.6, 117.2, 81.1, 71.0, 63 .5, 62.3, 59.6, 49.4, 26.0, 
20.0, 18.3, 10.1, -1.8 (2C), -5.3; MS (ESI+) m/z 456 ([M + Na] +, 100°/o); HRMS (ESI+) m/z 
calcd for Cz1H39NOsSSizNa: 456.2036, found 456.2035 
(S,E)-3-(5-((tert-Butyldimethylsilyloxy)methyl)-1-(2-(trimethylsilyl)ethylsulfonyl)-
4,5-dihydro-1H-pyrrol-3-yl)prop-2-en-1-ol (166) 
H OH 
TBSO~· 
2 
A solution of allylic alcohol 165 (53.1 mg, 0.12 mmol) and allyl alcohol (17µL, 0.24 
mmol) in dichloroethane (10 mL) under an argon atmosphere was freezed-thawed-dried 
and Grubbs 2nd generation catalyst (5.2 mg, 6.1 µmol) was added. The reaction mixture 
was allowed to stir at 90 °C for 1 h under an argon atomosphere. The crude mixture was 
then adsorbed on to silica and purified by flash chromatography (20°/o ethyl acetate in 
hexane) to yield dihydropyrrole 166 (40.2 mg, 76 o/o) as a yellow oil. [a]f>° -63.5 (c 0.50, 
CHCh); Rr 0.22 (20% ethyl acetate in hexane); IR (film) 3431 (0-H), 2953, 2928, 2856 
(C-H), 1648 (C=C); 1H NMR ( 400 MHz, CDCh) 8 6.31 (1H, d,] = 15.6 Hz, H1 11), 6.21 (1H, s, 
Hz), 5.57 (1H, dt,] = 15.6, 5.6 Hz, Hz"), 4.18-4.11 (3H, m, Hs, H3"), 3.76 (1H, dd,] = 10.2, 4.2 
Hz, H11a), 3.56 (1H, dd,] = 9.8, 7.4 Hz, H11b), 2.93-2.89 (2H, m, CHzSOz), 2.86 (1H, m, H4a), 
2.62 (1H, dd, J = 15.8, 4.6 Hz, H4b) 2.17 (1H, s, OH), 1.00-0.95 (2H, m, CH zSi), 0.83 (9H, s, 
C(CH3)3), 0.02 (6H, s, Si(CH3)z), 0.00 (9H, s, Si(CH3)3); 13( NMR (100 MHz, CDCh) 
8 128.2, 128.1, 124.4, 122.4, 65.3, 63.2, 61.7, 4 7.4, 32.6, 25.9, 18.2, 10.0, -2.0, -5.31, -5.35; 
MS (ESI+) m/z 456 ([M + Na] +, 100%); HRMS (ESI+) m/z calcd for Cz1H 39 N04SSizNa: 
456.2036, found 456.2033 
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( S,E)-3-( 5-(( tert-Butyldimethylsilyloxy )methyl)-1-(2-(trimethylsilyl) ethylsulfonyl)-
4,5-dihydro- lH-pyrrol-3-yl)propenal (168) 
To a solution of dihydropyrrole (64.5 mg, 149 µmol) 166 in dichloromethane (5 mL) 
was added manganese dioxide (259 mg, 2.97 mmol) at rt and the mixture was stirred at 
this temperature for 1 h. The reaction mixture was filtered through a pad of CeliteTM and 
washed with dichlormethane (20 mL). The filtrate was concentrated under reduced 
pressure to yield a yellow oil which was used in the next step without purification. The 
crude mixture can be purified by flash chromatography (gradient elution 10°/o-20o/o ethyl 
acetate in hexane) to yield aldehyde 168 (58.1 mg, 90°/o) as a pale yellow solid. (m.p. 93-
111 °C). Rf 0.56 (30°/o ethyl acetate in hexane); [aJ5° -84.5 (c 0.39, CHCh); IR (film) 2949, 
2928, 2892, 2855 (C-H), 1669 (C=O), 1610, 1585 (C=C); 1H NMR ( 400 MHz, CDCh) 8 9.54 
. . 
(lH~ d, ]= 8;0 Hz, H3"), 7.23 (1H, d,] = 15.6 Hz, H1"), 6.83 (1H, s, Hz), 5.93 (1H, dd, J = 15.2, 
7.6 Hz, H2"), 4.37 (1H, app. dq,] = 10.8, 4.8, Hs), 3.78 (2H, d, J = 4.8, H1·), 3.76 (1H, dd, J = 
10.2, 4.2 Hz, H1·a), 3.09-3.03 (2H, m, CH2S02), 2.98 (1H, m, H4a), 2.75 (1H, dd,] = 15.6, 4.8 
Hz, H4b), 1.06-1.02 (2H, m, CH2Si) 0.87 (9H, s, C(CH3)3), 0.07 (6H, s, SiCH3), 0.06 (9H, s, 
Si(CH3)3); 13( NMR (100 MHz, CDCh) 8 193.2, 145.5, 138.3, 126.9, 120.1, 64.8, 63.0, 49.9, 
32.0, 25.9, 18.3, 10.3, -1.9, -5.2, -5.3; MS (ESI+) m/z 454 ([M + Na] +, 45%); HRMS (ESI+) 
m/z calcd for C19H3sN04SSiz: 432.2060, found 432.2061; C19H37NQ4SSizNa: 454.1880, 
.. 
found 454.1888 
(S,E)-3-(5-((tert-Butyldimethylsilyloxy)methyl)-1-(2-(trimethylsilyl)ethylsulfonyl) 
4,5-dihydro-lH-pyrrol-3-yl)propenamide (172) 
A suspension of sodium cyanide (41.7 mg, 851 µmol) in isopropanol (5 mL) was 
charged with ammonia for 5 min at O °C. Then, the resulting mixture was added a solution 
of aldehyde 168 (170 µmol) in dichloromethane (1 mL), followed by activated manganese 
dioxide (296 mg, 3.40 mmol) at O °C. The reaction mixture was allowed to warm up to 
room temperature and stir for 14 h. The mixture was then filtered through a pad of Celite™ 
and concentrated under reduced pressure. The crude mixture was then purified by flash 
chromatography (gradient elution: 6QD/o to 8QD/o ethyl acetate in hexane) to yield 
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acrylamide 172 (56.9 mg, 75 o/o) as a yellow oil. Rr 0.12 (50°/o ethyl acetate in hexane) ; 
[aJ5° -128.3 (c 0.23, CHCb); IR (film) 3443, 3350, 3189 (N-H), 2953, 2928, 2856 (C-H), 
1663 (C=O), 1629, 1598 (C=C); 1H NMR ( 400 MHz, CDCb) 8 7.36 (1H, d, j = 14.8 Hz, H1"), 
6.63 (1H, s, Hz), 5.65 (1H, d, J = 15.2 Hz, Hz"), 5.48 (2H, s, NH z), 4.29 (1H, ddt, J = 10.4, 6.4, 
4.4 Hz, Hs), 3.81 (1H, dd,j = 10.2, 3.8 Hz, H1·a), 3.70 (1H, dd,j = 10.2, 6.6 Hz, H1·b), 3.03-2.99 
(2H, m, CHzSOz), 2.95 (1H, m, H4a), 2.70 (1H, dd, J = 2.8 Hz, H4b), 1.04-1.00 (2H, m, CHzSi), 
0.87 (9H, s, C(CH3)3), 0.07 (6H, s, SiCH3), 0.05 (9H, s, Si(CH3)3); 13c NMR (100 MHz, CDCb) 8 
168.0, 135.8, 135.6, 120.2, 117.8, 65.1, 62.6, 49.1, 32.2, 26.0, 18.4, 10.3, -1.8, -5.16, -5.23; 
MS (ESI+) m/z 469 ([M + Na]+, 100°/o); HRMS (ESI+) m/z calcd for C19H3s Nz0 4SSizNa: 
469.1989, found 469.1989 
(S,E)-3-(5-((tert-Butyldimethylsilyloxy)methyl)-1-(2-(trimethylsilyl)ethylsulfonyl)-
4,5-dihydro-1H-pyrrol-3-yl)-N,N-dimethylpropenamide (171) 
H 0 
TBSO~ NMe2 s 
2 
To a solution of acrylamide 172 (26.2 mg, 59 µmol) in tetrahydrofuran (1 mL) was 
added sodium hydride (60°/o wt, 12 mg, 300 µmol) and iodomethane (19 µL, 304 µmol) at 
0 °C. The reaction mixture was allowed to stir for 1 h, then it w,ls treated w ith a few drops 
of methanol and concentrated under reduced pressure. The crude mixture was then 
partitioned between dichloromethane (10 mL) and water (10 mL) and the aqueous phase 
was extracted with dichloromethane (2 x 10 mL). The combined organic phases were 
dried with MgS04 and concentrated under reduced pressure. The crude material was then 
purified by flash chromatography (gradient elution: 40% to 700/o ethyl acetate in hexane) 
to yield dimethylacrylamide 171 (23.6 mg, 85 %) as a yellow oil. Rr 0.18 (50°/o ethyl 
acetate in hexane); [aJ5° -92.4 (c 0.15, CHCb); IR (film) 2953, 2927, 2855 (C-H), 1645 
(C=O), 1609 (C=C); 1H NMR ( 400 MHz, CDCb) 8 7.39 (1H, d, J = 14.8 Hz, H1"), 6.59 (1H, s, 
Hz), 6.04 (1H, d, ] = 15.2 Hz, Hz"), 4.30-4.23 (1H, m, Hs), 3.80 (1H, app. dd, j = 10.4, 4.0 Hz, 
H1·a), 3.69 (1H, app. dd,J = 10.4, 6.4 Hz, H1·b), 3.08 (3H, s, NMe), 3.01 (3H, s, NMe), 2.99-2.97 
(2H, m, CHzSOz)1 2.94 (1H, m, H4a), 2.71 (lH .. app. dd, J = 15.6, 4.8 Hz, H4b), 1.04-0.99 (2H, 
m, CHzSi), 0.87 (9H, s, C(CH3)3), 0.06 (6H, s, SiCH3), 0.04 (9H, s, Si(CH3)3); 13C NMR (100 
MHz, CDCb) 8 167.0, 135.7, 134.6, 120.9, 115.7, 65.2, 62.4, 48.8, 37.5, 36.0, 32.3, 25.9, 18.4, 
10.2, -1 .9, -5.18, -5.24; MS (ESI+) m/z 4 75 ([M + HJ +, 100%); HRMS (ESI+) m/ z calcd for 
C21H43Nz0 4SSiz : 475.2482, found 475.2485; m/z calcd for C21 H4z Nz0 4SSiz Na: 497.2302, 
found 497.2301 
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2-Azido-3-methoxybenzoic acid (187) 
OMe 
~N3 
VCOOH 
Preparation of triflyl azide: A solution of sodium azide (7.0 g, 108 mmol) in water 
(16 mL) and dichloromethane ( 6 m L) was stirred vigorously at O °C and then added triflic 
anhydride (3 mL, 18 mmol) dropwise. The reaction mixture was stirred at this 
temperature for 2 h and the organic and aqueous phase were separated. The aqueous 
phase was then extracted using DCM (6 mL) and the combined organic layers were 
washed with aq. sat. sodium hydrogencarbonate (10 mL) then used immediately in the 
next step. (CAUTION - Explosive on concentration. NEVER concentrate.) 
A solution of 2-amino-3-methoxybenzoic acid (1.0 g, 6 mmol) in dichloromethane 
was added triethylamine (2.5 mL, 18 mmol) and copper sulphate (47.8 mg, 0.3 mmol) in 
-· 
water (0.5 mL). The reaction mixture was cooled to O °C and added the freshly prepared 
solution of triflyl azide (18 mmol) in dichloromethane (12 mL) then methanol (4 mL). The 
reaction mixture was allowed to warm to rt and stirred at this temperature for a further 
1 h. The reaction was quenched by the addition of water (10 mL), acidified with aq. HCl (1 
M, 10 mL) and extracted with dichloromethane (2 x 25 mL). The combined organic 
extracts were dried with Na2S04, filtered and concentrated under reduced pressure. The 
crude residue was purified by flash chromatography (1 o/o acetic acid in a 2°/o 
dichlormethane in methanol solution) to give azide 185 (1.03 g, 89°/o) as a pale brown 
solid (m.p. 120 °C). Rt 0.28 (100°/o ethyl acetate); IR (film) 2975 (C-H), 2162, 2114 (N3), 
1690 (C=O); 1u NMR (300 MHz, CDCb) 8 7.73 (1H, dd,] = 7.8, 1.5 Hz, Ar-H), 7.20 (1H, t,J = 
~.1 Hz, Ar-H), 7.10 (1H, dd, ] = 8.1, 1.5 Hz, Ar-H), 3.96 (3H, s, Ar-CH3); 13C NMR (100 MHz, 
CD3QD) 8 171.3, 154.0, 128.2, 125.7, 124.9, 116.2, 105.1, 56.7; MS (ESI+) m/z 164 
([M - N2r, 100°/o), 192 ([M - Hr, 70%); HRMS (ESI-) m/z calcd for CsH6N3Q3: 192.0409, 
found 192.0409. 
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( S,E)-3-( 5-(Hydroxymethyl)-1-(2-(trimethylsilyl) ethylsulfonyl)-4,5-dihydro-1H-
pyrrol-3-yl)-N,N-dimethylpropenamide (174) 
A solution of dimethylacrylamide 171 (23.3 mg, 49.1 µmol) in ethanol (1 mL) was 
added cone. HCl (0.1 mL) and allowed to stir and rt for 1 h. The reaction mixture was 
concentrated under reduced pressure and partitioned between an aqueous saturated 
sodium bicarbonate solution (2 mL) and chloroform (5 mL). The aqueous layer was 
extracted with chloroform (3 x 5 mL). The combined organic layers were dried with 
MgS04, filtered and concentrated under reduced pressure to yield alcohol 17 4 as a yellow 
oil. The crude reaction mixture was used in the next step without purification. 1H NMR 
( 400 MHz, CDCh) 8 7.38 (1H, d,] = 15.2 Hz, H1 11), 6.63 (1H, s, Hz), 6.05 (1H, d,] = 15.2 Hz, 
Hz 11), 4.34-4.28 (1H, m, Hs), 3.77-3.76 (1H, m, H11), 3.07 (3H, s, NMe), 3.07-3.02 (2H, m, 
CHzS02), 3.02 (3H, s, NMe), 2.64 (2H, dd,] = 15.6, 5.6 Hz, H4) 1.03-0.99 (2H, m, CH2Si), 0.04 
(9H, s, Si(CH3)3); 13( NMR (100 MHz, CDCh) 8 166.8, 135.4, 134.7, 120.9, 116.4, 65.6, 63.3, 
48.1, 37.5, 36.0, 32.7, 10.2, -1.9. 
(S,E)-(3-(3-(Dimethylamino)-3-oxoprop-1-enyl)-1-(2-(trimethylsilyl)ethylsulfonyl)-
4,5-dihydro-1H-pyrrol-5-yl)methyl 2-azido-3-methoxybenzoate (185) 
A solution of alcohol 174 ( 49.1 µmol) in dichloromethane (1 mL) was added acid 
187 (11.4 mg, 59.0 µmol), N,N'-dicyclohexylcarbodiimide (12.1 mg, 58.6 µmol) and 4-
dimethylaminopyridine (1.2 mg, 9.8 µmol). The reaction mixture was allowed to stir at rt 
for 6 h. The reaction mixture was filtered and washed with dichloromethane (3 mL) and 
concentrated under reduced pressure. The crude mixture was purified by flash 
chromatography (500/o-100°/o ethyl acetate in hexane) to yield benzoate 185 (22.4 mg, 
85% over 2 step:s) as a yellow oil. Rr 0.41 (100°/o ethyl acetate); [a]f>° -47.2 (c 0.37, CHCh); 
IR (film) 2953, 2925, 2853 (C-H), 2114 (-N3), 1727, 1644 (C=O), 1609, 1595 (C=C); 
tH NMR ( 400 MHz, CD Ch) 8 7.43 (1H, d,] = 15.2 Hz, H1·J, 7.33 (1H, dd,] = 8.0, 1.6 Hz, HAr), 
7.12 (1H, t,J = 8.0 Hz, HAr), 7.02 (1H, dd,J = 8.4, 1.2 Hz, HAr), 6.66 (1H, s, Hz), 6.06 (1H, d,J = 
14.8 Hz, Hz"), 4.66 (1H, m, Hs), 4.49 (2H, d,] = 4.8 Hz, H1J, 3.91 (3H, s, OCH3), 3.13 (1H, dd,] 
= 15.6, 11.6 Hz H4a), 3.07(3H, s, NMe), 3.03-2.99 (2H, m, CH 2S02), 3.02 (3H, s, NMe), 2.75 
95 
(lH, dd, j = 15.6, 5.2 Hz, H4b), 1.03-0.98 (2H, m, CH2Si), -0.02 (9H, s, Si(CH3)3); 13( NMR 
(100 MHz, CDCb) 8 166.7, 165.6, 154.3, 135.3, 134.5, 128.4, 125.2, 124.1, 122.9, 120.6, 
116.2, 115.2, 66.5, 59.5, 56.4, 49.3, 37.4, 36.0, 32.8, 10.2, -2.0; MS (ESI+) m/z 536 ([M + HJ +, 
100°/o); HRMS (ESI+) m/z calcd for ( 23 H34Ns0 6SSi: 536.1999, found 536.2001; 
C23 H33Ns06SSiNa: 558.1819, found 558.1817 
The following compounds could not be fully characterised due to the limited 
amount of material obtained. 
(S,EJ-3-(1-(2-Azido-3-methoxybenzoyl)-5-(hydroxymethyl)-4,5-dihydro-lH-pyrrol-
3-yl)-N,N-dimethylpropenamide (75) 
·cx;OMe ?~ 
5 4 
2" 
N h ~ 0 
0 2 1" 
A solution of benzoate 185 (3.4 mg, 6.0 µmol) in acetonitrile (2 mL) was added 
cesium fluoride (7.7 mg, 50.7 µmol) and the mixture was allowed to stir at reflux for 16 h. 
The reaction mixture was cooled to rt and concentrated under reduced pressure. The 
crude residue was purified by flash chromatography (5°/o methanol in ethyl acetate) to 
yield benzamide 7 5 (1.4 mg, 590/o) as a yellow oil. Rf 0.38 (5% methanol in ethyl acetate); 
1
·H NMR (400 MHz, CDCb) 8 7.30 (lH, d,J = 15.2 Hz, H1"), 7.17 (lH, t,J = 8.0 Hz, Ar-Hl 6.98 
(lH, d, J = 8.4 Hz, Ar-HJ, 6.90 (lH, d, j = 7.6 Hz, Ar-HJ, 6.29 (lH, s, H2), 6.12 (lH, d, J = 15.2 
Hz, Hz"), 4.85-4.77 (lH, m, Hs), 3.94 (3H, s, OCH3), 3.92-3.86 (2H, m, H1·), 3.09 (3H, s, NMe), 
3.09-3.01 (2H, m, H4), 3.01 (3H, s, NMe). 
( S,EJ-3-( 1-(2-Azido-3-methoxybenzoyl)-5-formyl-4,5-dihydro- lH-pyrrol-3-yl)-N,N-
dimethylpropenamide (188) 
OMe ~1~ H 
5 4 
N h 0 
0 2 1" 
A solution of benzamide 184 (1.4 mg, 3.8 µmol) in dichloromethane (1 mL) was 
added tetrapropylammonium perutherate (1.5 mg, 4.3 µmol) and N-methylmorpholine-N-
oxide at O 0 C. The reaction mixture was allowed to stir at this temperature for 2 h. The 
reaction mixture was then filtered through a plug of silica and washed with 10°/o methanol 
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in ethyl acetate (10 mL) and 10°/o methanol in chloroform (10 mL). The filtrate was 
concentrated under reduced pressure to give aldehyde 188 (1.3 mg, 93°/o) as a yellow oil. 
1H NMR (400 MHz, CDCb) 8 8.05 (1H, s, H1 1), 7.52-7.48 (1H, t,] = 8.0 Hz, Ar-H), 7.31-7.26 
(1H, m, H1·,), 7.20-7.16 (1H, m, Ar-H), 7.01-6.93 (1H, m, Ar-H), 6.42 (1H, s, H2), 6.11 (1H, d,] 
= 14.0 Hz, H2"), 5.16-5.09 (1H, m, Hs), 3.94 (3H, s, OCH3), 3.08 (3H, s, NMe), 3.08-3.03 (2H, 
m, H4), 3.03 (3H, s, NMe), with contamination from some residual TPAP, NMO and NMM. 
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6.5 Experimental procedures for chapter 5 
2-Amino-3-hydroxy-4-methylbenzoic acid (193) 
Method A: 
OH 
~NH2 
llAcooH 
A solution of 3-hydroxy-4-methyl-2-nitrobenzoic acid (210 mg, 1.07 mmol) in 
methanol (10 mL) was added palladium on charcoal (10°/o wt, 21 mg) and stirred under a 
hydrogen atmosphere for 18 h. The reaction mixture was filtered through a pad of Celite™ 
and concentrated under reduced pressure to yield a red-brown solid. The crude material 
was purified by subjecting it to a plug of silica (ethyl acetate) to yield a pure sample of 
amine 193 (155 mg, 870/o) as a pink solid. 
Method B: 
Following a procedure previously reported by Giurg and co-workers,103 a 
suspension of palladium on charcoal (10 mg) in distilled water (1 mL) and methanol (2 
mL), 1 drop of aq. NaOH (3 M) and potassium borohydride (100 mg, 1.85 mmol) was 
added 3-hydroxy-4-methyl-2-nitrobenzoic acid (207.9 mg, 1.05 mmol) portionwise at 35-
40 °C. The reaction was allowed to stir at this temperature for a further 2 h, filtered and 
washed with methanol (2 mL). The filtrate was acidified to pH ca. 1 with aq. HCl (1 M) and 
washed with diethyl ether (3 x 20 mL ). The pH of the aqueous phase was then adjusted to 
pH 2 with aq. NaOH (3 M) and extracted with diethyl ether (3 x 20 mL). The combined 
organic extracts were dried over MgS04, filtered and dried under reduced pressure to give 
a pure sample of the title compound 193 (135.6 mg, 77°/o) as a pink solid. 
m.p. 194 °C (decamp.) (lit. 103 m.p. 234-236 °C lit.104 m.p. 213-215 °C); Rr 0.52 (100°/o ethyl 
acetate); IR (film) 3700-2400 (OH, NH, COOH), 2953, 2922, 2852 (C-H), 1650 (C=O), 1650, 
1610, 1549 (C=C); 1H NMR (400 MHz, CD30D) 8 7.33 (1H, d,] = 8.0 Hz, Ar-H), 6.38 (lH, d,] 
= 8.4 Hz, Ar-H), 2.21 (3H, s, Ar-CH3); 13( NMR (100 MHz, CD30D) 8 171.8, 143.1, 143.0, 
130.1, 124.0, 118.6, 110.7, 16.8; MS (ESI-) m/z 166 ([M - HJ-, 20°/o), 121 ([M - (H 20 + 
C O)]-, 100°/o); HRMS (ESI+) m/z calcd for CsHsN03: 166.0504, found 166.0500 
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2-Amino-3-(tert-butyldimethylsilyloxy)-4-methylbenzoic acid (194) 
OTBS 
~NH2 
llAcooH 
To a solution of benzoic acid 193 ( 41. 7 mg, 0.25 mmol) in dichloromethane ( 4 mL) 
was added tert-butyldimethylsilyl chloride (113 g, 0.75 mmol), imidazole (51 mg, 0.75 
mmol) and DMAP (3.1 mg, 0.025 mmol) and the reaction was stirred at rt for 16 h. The 
reaction mixture was added water (5 mL) and extracted with dichloromethane (2 x 10 
mL). The combined organic layers were dried with MgS04, filtered and concentrated under 
reduced pressure. 
The resulting crude mixture was then taken up In tetrahydrofuran (5 mL) and added . 
aq. NaOH (3 M, 3 mL) at rt and allowed to stir at this temperature for 5 mins. The reaction 
mixture was added aq. HCl (1 M, 10 mL) and extracted with diethyl ether (3 x 15 mL). The 
combined organic extracts were dried with MgS04, filtered and concentrated under 
reduced pressure. The crude material was purified by flash chromatography (gradient 
elution of 30-500/o diethyl ether in hexane) to yield silyl ether 194 (70.1 mg, quant.) as a 
white solid (m.p. 180 °C). Rt 0.35 (50% diethyl ether in hexane); IR (film) 3487, 3380 
(NH), 3300-2400 (COOH), 2952, 2929, 2856 (C-H), 1663 (C=O), 1614, 1587, 1533 (C=C); 
1H NMR (400 MHz, CDCh) 8 7.51 (1H, d,] = 8.4 Hz, Ar-H), 6.4.:4 (1H, d,] = 8.4 Hz, Ar-H), 
5.86 (2H, bs, NH), 2.22 (3H, s, Ar-CH3) 1 1.06 (9H, s, C(CH3)3), 0.22 (6H, s, Si(CH3Jz); 13C NMR 
(100 MHz, CDCh) 8 173.5, 144.7, 140.8, 133.9, 124.6, 118.2, 108.0, 26.2, 18.9, 18.1, -3.2; 
MS (ESI+) m/z 264 ([M + H - H20]+, 282 ([M + H]+, 70%), 320 ([M + K]+, 45%); HRMS 
(ESI+) m/z calcd for C14Hz4N03Si: 282.1525, found 282.1524 
Methyl 2-amino-3-hydroxy-4-methylbenzoate (196) 
OH 
~NH2 
UCOOMe 
To a solution of benzoic acid 193 (1.32 mmol) in toluene:methanol (3:2, 10 mL) was 
added, dropwise, a solution of trimethylsilyldiazomethane (2.0 M in diethyl ether, 920 µL, 
1.84 mmol) at O 0 C. The reaction was allowed to warm to rt and stir at this temperature for 
a further 30 min. The reaction mixture was concentrated under reduced pressure and the 
to give pure amino ester 196 (176.9 mg, 74°/o) as a red oil. Rt 0.21 (100;0 ethyl acetate in 
hexane); IR (film) 3490, 3379 (NH & OH), 3023 (Ar C-H), 2989, 2951, 2843 (C-H), 1688 
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(C=0)1 162t 15891 1543 (C=C); 1H NMR (400 MHz/ CD3QD) 8 7.39 (lH1 d1} = 8.0 Hz)1 6.42 
(lH1 d1 J = 8.4 Hz)1 3.84 (3H/ s/ O(H3)1 2.21 (3H/ s/ Ar-CH3); 13C NMR (100 MHz1 CD30D) 
8 168.91 141.31 140.81 128.21 123.01 117.91 109.81 51.61 16.2; MS (ESI+) m/z 150 ([M + H -
MeOH]\ 300/0)1 182 ([M + H] \ 30%); HRMS (ESI+) m/z calcd for ( 9H12 N03: 182.08171 
found 182.0816 
Methyl 2-azido-3-hydroxy-4-methylbenzoate (197) 
OH 
~N3 
~COOMe 
A solution of benzoate 196 (65.8 mg1 0.36 mmol) in aq. HCl (1 M1 2 mL) was added 
sodium nitrite (52 .2 mg, 0.76 mmol) at O °C and allowed to stir at this temperature for 30 
min. Then1 sodium azide (49.2 mg1 0.76 mmol) was added portionwise at O °C and the 
reaction was allowed to stir for a further 1 h. The reaction mixture was then added water 
(10 mL) and extracted with chloroform (3 x 15 mL). The combined organic extracts were 
dried with MgS04, filtered and concentrated under reduced pressure. The crude material 
was- purified by flash chromatography (50-100°/o diethyl ether in hexane) to provide the 
azide 197 (58.2 mg, 77%) as a red solid (m.p. 58 °C). Rr 0.48 (100°/o diethyl ether); IR 
(film) 3392 (OH)1 3094 (Ar C-H), 30001 29521 2918 (C-H), 2131 (N3), 1709 (C=0)1 16171 
1583 (C=C); 1H NMR (400 MHz1 CDCb) 8 7.13 (1H1 d1} = 7.8 Hz1 Ar-HJ, 6.92 (1H1 d1] = 7.2 
Hz1 Ar-H)1 3.86 (3H1 s, OCH 3)1 2.14 (3H1 s1 Ar-CH3); 13C NMR (100 MHz1 CDCb ) 8 178.7, 
163.31 139.61 133.81 122.5, 119.7 (2C)1 52 .81 17.0. 
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